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This section provides a medium through which Canadian
surgeons can declare themselves, briefly and informally, on
the day-to-day affairs of surgery.

►

Highly Selective Vagotomy: Forward or Backward
in the Surgical Treatment of Duodenal Ulcer?
►

)

v- -

How many major advances have been
r made in gastrointestinal surgery since the
introduction of vagotomy by Dragstedt?
-* * Regrettably, the answer is dismally few.
The great increase in our understanding
| A and knowledge of the pathophysiology of
many diseases unfortunately has not been
* ‘ translated into many important new
operations. Surgical results have certain
ly improved, but this can be attributed to
better selection of patients and more
sophisticated care pre- and postoperativev-». ly. Gastrointestinal surgeons today are
doing essentially the same operations as
►the surgeons of the previous generation.
When Johnston and Wilkinson1 and
v f Amdrup and Jensen2 independently sug
gested an entirely new approach to
vagotomy, based on the physiologic exv periments of Griffith and H arkins,3
there was considerable excitement. Highly
_ r selective vagotomy, by preserving the
vagal branches to the antrum, allowed the
r ysurgeon to dispense with the drainage
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procedure that appears to be an essential
addition to complete gastric vagotomy.
The advantages were recognized im
mediately. Because the gastrointestinal
tract is not entered, the operation is much
safer. As no drainage procedure is per
formed, there are fewer long-term side ef
fects. The only apparent disadvantage is
that the operation, if done properly, takes
longer to perform than a standard
vagotomy with a drainage procedure. The
one remaining question, therefore, was
the rate of recurrent ulceration.
The initial recurrence rate following
highly selective vagotomy was not only as
low as but even lower than after
vagotomy and drainage.4 These results
were treated with skepticism by some,
who wondered how fewer recurrences
could be achieved with the same degree
of acid reduction. There was anxiety
about the conversion of almost all pa
tients from insulin-test negative results to
insulin-test positive. There was concern
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about the possibility of reinnervation
from the antrum. However, many sur
geons and the majority of gastroentero
logists, particularly in Europe, hailed this
new operation as a major advance in the
treatment of duodenal ulcer. Enthusiasts
advocated its use not only for un
complicated duodenal ulcer but also for
duodenal ulcers complicated by pyloric
obstruction, perforation or hemorrhage,
for gastric ulcer, hiatus hernia and other
conditions. An operation with so little at
tendant morbidity was hard to eschew.
Has it stood the test of time? As recently
as 1980, no less an authority than the late
Dr. Morton Grossman was warmly en
dorsing it and advocating its wider use in
the United States.5
In this issue (pages 340 and 341) Mr.
Terence Kennedy reports on 512 highly
selective vagotomies performed over 15
years by a number of surgeons. There was
only one operative death and a proven
recurrence rate of 13% in those followed
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up for more than 5 years. That record is
impressive and is more convincing than
the reports of spectacular results obtain
ed by a single surgeon. What we need to
know is w hether highly selective
vagotomy should be recommended as the
best elective surgical treatment for all pa
tients with duodenal ulcer.
It is ironic that the strongest claim for
this operation (unsupported by any con
trol data) comes from the surgical depart
ment that so elegantly demonstrated the
feasibility and value of the prospective,
randomized, controlled surgical trial.6 It
is also worth recalling that the proven
recurrent ulcer rate after vagotomy and
drainage in that trial, involving many
surgeons, was only 2.5%. Kennedy states
that there are no published randomized
controlled data comparing highly selec
tive vagotomy with truncal vagotomy and
drainage, with a follow-up of 5 years or
more. To the shame of the surgical com
munity, this is strictly true. But we are not
entirely without good data. There have
been several controlled trials. Madsen and
Kronborg7 com pared the results of
highly selective vagotomy with selective
vagotomy and pyloroplasty after 5 'h to
8 years and found ulcer recurrence rates
of 26% and 14%, respectively. Elder and
colleagues8 in this Journal reported a
randomized trial of highly selective
vagotomy versus truncal vagotomy and
pyloroplasty in which the mean follow
up was 4 years. The rate of recurrent ulcer
following highly selective vagotomy was
21.4% compared with 7.5% following
vagotomy and pyloroplasty. Surprising
ly, there was no difference in the in
cidence of any side effect other than diar
rhea. Koo and associates9 compared
highly selective vagotomy with truncal
vagotomy and drainage after a median
follow-up of 4 years. Recurrence after
highly selective vagotomy was 18% and
after vagotomy and drainage was 12%.
Christiansen and associates10 reported a
2- to 5-year follow-up of highly selective
vagotomy compared with truncal vago
tomy and drainage and selective vago
tomy and drainage. The risk of ulcer
recurrence calculated by an actuarial
method was significantly higher after
highly selective vagotomy than after trun
cal vagotomy and drainage but not after
selective vagotomy and drainage. One of
the most worrisome features is that recur
rent ulceration after vagotomy and
drainage occurs within 2 years or pro
bably not at all, whereas after highly
selective vagotomy it is apparent that the

longer the patients are followed the more
recurrent ulcers are detected. The Leeds
group" has progressively increased its
reported recurrence rate after highly selec
tive vagotomy from 0% to 11%. At what
point will recurrent ulcers stop appearing?
The true recurrence rate of 35% after
gastroenterostomy alone was not recog
nized for more than 20 years.
None the less, some surgeons, armed
even with these facts, strongly advocate
highly selective vagotomy as the primary
operation for duodenal ulcer for two
reasons. First, recurrent ulcer can now be
treated successfully with powerful H2
blocking agents and second, if worse
comes to worst, the patient can be offered
another operation. The reason the patient
was offered an operation in the first place
was because we do not accept that lifetime
treatment with H2 blocking agents is ap
propriate for duodenal ulcer disease. How
safe and effective vagotomy and antrec
tomy (the operation generally recom
mended) will prove to be for failed highly
selective vagotomy is not yet known. But
is it reasonable to offer an operation that
even one of its originators predicts will
fail within 10 years 23% of the time?12
The ultimate defence of highly selective
vagotomy, of course, is the claim that if
the operation is done properly, the recur
rence rate will not be 23% but 2% to 6%.
If the operation is so difficult to do cor
rectly, should it be advocated for general
use? Why has there been no report of
long-term, independent, objective follow
up with such respectable recurrence rates?
Why have several interim reports13-15 of
controlled trials of highly selective
vagotomy, including one by Kennedy and
associates, not been followed by the
publication of detailed long-term results?
Those who stubbornly promote the
concept that highly selective vagotomy is
not only safer but is followed by fewer
sequelae and a similar number of recur
rent ulcers as vagotomy and drainage
must face the facts. Facts come only from
properly controlled prospective trials with
lengthy follow-up.
M ax M. C o hen ,
FRCS[C], FACS
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Accuracy of Noninvasive Peripheral Arterial Testing

Evaluation of peripheral arterial disease
*" by noninvasive methods has played an inv creasingly important role in patient
management as noted by Symes and col, ^ leagues in this issue (pages 345 to 347).
The clinical impression of arterial status
4 -*■is complemented by the objective, quan
titative evaluation of noninvasive testing.
•" Scientific evaluation of peripheral arterial
disease or procedures requires laboratory
* confirmation and noninvasive studies
. may be able to provide information not
available even by arteriography, thus inM * creasing the accuracy of diagnosis.
The accuracy of a noninvasive tech4 nique (true positive plus true negative
results divided by the total number of ex
aminations) varies depending on the pa
tient population studied. Accuracy also
v v depends on the threshold level chosen for
a positive test, which can vary according
to whether one is more concerned with
■
y y detection of patients with disease (sen
sitivity) or excluding those without disease
r (specificity). Assessment of accuracy also
requires a proper “ gold” standard for
V v comparison.
With respect to peripheral arterial
" r disease, the accuracy of clinical diagnosis
^alone may be very high. Baker and
associates1 compared clinical evaluation
y. by attending surgeons with noninvasive
laboratory testing (segmental pressures,
y y femoral Doppler recordings without spec
trum analysis and treadmill exercise) of
►102 patients. A similar, high degree of ac
curacy was obtained from both the nonin' Vasive studies and the attending surgeon,
who was correct in 98 patients and at least
partially correct in the other 4. The Jess
ys y experienced clinicians (surgical housestaff), however, did not fare as well, with
►only 62% totally correct anatomic diag
noses. The high degree of accuracy of the
- ^attending surgeon in this study may have
been influenced by the patient population
selected since all 102 patients were admitk ted to hospital for arteriography and thus
likely had severe disease which often
, ^ facilitates clinical accuracy. The patients
in whom diagnosis is more difficult are
> *those who have disease in both iliac and
femoral systems. Several different
\ methods have been used to detect com
bined segment disease. The technique of

combined segmental pressure measure
ments and pulse-volume recordings was
developed by Raines and associates.2
Segmental pressures at the common
femoral level are difficult to measure
since it is not possible to place the thigh
pressure cuff high enough. Combined
segmental pressure measurement and
pulse-volume recording may not accurate
ly predict the major contributing lesion
in combined segment disease.3 A study is
currently in progress at the Miami Heart
Institute to define the accuracy and
limitations of this method in combined
segment arterial disease.3
The other technique of noninvasive
testing evaluated by Symes and associates
was Doppler waveform analysis using
continuous wave Doppler ultrasound and
a spectrum analyser with calculation of
pulsatility index. This may help in dif
ficult cases, where the patient has com
bined disease. Johnston and associates,4
using a pulsatility index of 5.5 as a
threshold level, found 95% sensitivity and
specificity in detecting hemodynamically
important aortoiliac disease (correspond
ing to a resting aortofemoral pressure gra
dient of 10 mm Hg). Other investigators
have been less optimistic regarding the ac
curacy of the pulsatility index in diagnos
ing iliac disease,5,6 but their techniques
differed in a major fashion from that of
Johnston and colleagues.
The lack of a definite “ gold” standard
makes comparison of various techniques
difficult. The inadequacy of single-plane
arteriography to define hemodynamical
ly important aortoiliac disease has long
been appreciated.7 Some have used
aortofemoral pressure gradients as the
“ gold” standard of iliac disease at rest4
and after vasodilatation by papaverine.8
Noninvasive studies play a major role
in the management of the vascular pa
tient. Either combined segmental pressure
measurement and pulse-volume recording
or Doppler waveform analysis may be
adequate in the majority of patients. In
more complicated cases where there is
combined iliac and femoral disease,
evidence th a t combined segmental
pressure measurement and pulse-volume
recording allows precise anatom ic
diagnosis is not available. While con

troversial, preliminary evidence suggests
that Doppler waveform analysis may
facilitate diagnosis of combined segment
disease and give information in addition
to th a t supplied by single-plane
arteriography.4 In the occasional dif
ficult case of multilevel disease, even a
combination of clinical, noninvasive and
arteriographic methods may not give an
accurate hemodynamic diagnosis and
direct aortofemoral pressure measure
ments may be required. The comparison
of accuracy o f noninvasive techniques in
vascular disease is difficult because of the
variability of patient populations and lack
of a suitable “ gold” standard.

P eter Brown,

md , frcs[C]

Department of Surgery,
Queen’s University,
Kingston, Ont.
K7L 3N6

References
1. Bak er WH, Strin g ST, H ayes AC, T urn er D:
Diagnosis o f peripheral occlusive disease: comparison o f
clinical evaluation and noninvasive laboratory. Arch Surg
1978; 113: 1308-10

2.

Rain es JK, JAFFRIN MY, RAO S: A noninvasive pressurepulse recorder: development and rationale. M ed Instrum
1973; 7: 245-50

3. RAINES JK: The pulse-volume recorder in peripheral
arterial disease. In BERNSTEIN EF (ed): Noninvasive
Diagnostic Techniques in Vascular Disease, Mosby, St.
Louis, 1982: 360-9
4. JOHNSTON KW, KASSAM M, COBBOLD RS: Relationship
between Doppler pulsatility index and direct femoral
pressure measurements in the diagnosis of aortoiliac oc
clusive disease. Ultrasound M ed Biol 1983; 9: 271-81
5. F la n ig a n DP, C ollins JT, Sch w a rtz JA , O ’M ara
C, FLINN WR, BERGAN JJ, Yao JS: Hemodynamic and
arteriographic evaluation o f femoral pulsatility index. J
Surg Res 1982; 32: 234-8
6. THIELE BL, BANDYK DF, ZlERLER RE, STRANDNESS DE
JR: A systematic approach to the assessment o f aortoiliac
disease. Arch Surg 1983; 118: 477-81
7. J oh nston KW, DEMORAIS D, COLAPINTO RF: Difficulty
in assessing the severity o f aorto-iliac disease by clinical
and arteriographic methods. Angiology 1981; 32: 609-14
8. ARCHIE JP JR, FELDTMAN RW: Intraoperative assessment
o f the hemodynamic significance o f iliac and profunda
femoris artery stenosis. Surgery 1981; 90: 876-80

VOLUME 27, NO. 4, JU L Y 1984 / THE CANADIAN JOURNAL O F SURGERY

319

* i

Simplified Dressing for the Drained Empyema

Any empyema, complicated or not by a
bronchopleural fistula, must be drained
by a closed or open technique. Care of
the wound imposes a heavy burden on
medical and paramedical staff and dis
comfort to the patient is severe. The
pleural abscess releases a large volume of
infected secretions that not only irritate
the skin around the drain site but are a
constant source of reinfection. Frequent
dressing changes, costly in time and
material, are required and cannot be done
on an outpatient basis. Moreover, pro
longed bed rest and inactivity delay the
recovery o f these patients, who are
already severely debilitated, and increase
the risks of additional complications. Our
experience with enterostomy therapy gave
us the opportunity to design a closed
system technique that eliminates most of
these inconveniences.

Technique
The purpose is to assure the total col
lection of the purulent secretions into a
bag without spillage, skin irritation or air
trapping (Fig. 1). First, the skin around
the drain or the edges of the window is
cleaned and covered with a layer of water
proof protective coating (United Skin
Prep., United, Division of Howmedica
Inc., Guelph, Ont.) that will enhance the
holding power of the dressing. If the
pleural drain must be kept in place, stitch-

FIG. 3—Skin barrier square.

FIG. 1—Material required: A = pleural
drain, 3 = skin barrier washer and square,
4 = bag, 6 = vent.

i

ing must be avoided since it is painful and *
will eventually cut through the skin.
Therefore, the drain is cut 4 cm from the ^
thoracic wall and a heavy silk is tied
around it; then its free end is glued to the
skin with a thin layer of Karaya paste -*
(Hollister Inc., Willowdale, Ont.). Next,
a round washer of skin barrier (Hollister -* 1
Inc.) is applied around the edges of the
wound (Fig. 2) and is covered with an
adhesive blanket (10 x 10 cm) of the ^
*"
same material (Fig. 3). The inside edge of
the wound is sealed with additional A
Karaya paste to assure a watertight bar
rier. A urinary diversion bag (Hollister * *
Inc.) is glued to the skin barrier patch.
Further adhesion of the bag is guaranteed v
by a layer of Micropore Surgical Tape
j
(3M Canada Inc., London, Ont.) applied
to its external base. In the presence of a
bronchial fistula, venting of the bag is
assumed by a no. 14 French rubber drain
(Robi-Nel Catheter, Argyle, Division of
j
Sherwood Medical Industries Ltd., St. y „
Louis, Mo.) introduced through its up
per part and sealed with some tape (Fig.
4). The only care needed will then be the
j
emptying of the bag as required. Inspec- ’ V
tion of the wound, irrigation or bacterial
;
culture can be done through the fundus ^
of the bag. On an outpatient basis,
periodic controls may be extended to 10
to 15 days.
H
In our experience, this method has
!
simplified the treatment of drained em- ■< U
pyema. By eliminating the constant pain
and the anguish of a dirty weeping wound 4
and by permitting the patient an early
return home to normal activities, it has * v
brought about the essential elements of
l
a quick recovery and cut down con
siderably on hospital costs.
.,

G illes L a ro ch e , m d , frcsic ],
Section of Thoracic and
Cardiovascular Surgery,

facs

G illes D um ais , e t ,
Enterostomy Therapist,
Serge L a to uch e , e t ,
Enterostomy Therapist,

<

-

*

A.

V
♦ 4

FIG. 2—Drain with its anchor line and skin
barrier washer.
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FIG. 4—Final set up: sealed vented bag

Hotel-Dieu de Quebec,
11 C6te du Palais,
Quebec, PQ
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Operative Myocardial Protection
To the editors.—I would like to compli
ment Brown and Chiu on their excellent
paper “ Operative myocardial protection:
does an elevated level of creatine
phosphokinase-MB isoenzyme always in
dicate myocardial necrosis?” (Can JSurg
1984; 27: 80-3). Their answer in the
negative and their careful documentation
o f methods used, with myocardial needle
biopsy confirming the lack of extensive
infarction, puts the routine measurement
of creatine phosphokinase-MB isoenzyme
postoperatively into its proper perspective
as a quality control factor. Their myocar
dial temperature threshold of 25°C is cer
tainly higher than I would accept,1 but
their excellent clinical results cannot be
faulted. Eight years ago I also reported
a minimal effect of the duration of cross
clamping on creatine phosphokinase-MB
isoenzyme peak values,2 but we did not
perform the frequent analyses that make
Brown and Chiu’s study superior. I think
the explanation for why patients who
undergo valve replacement have higher
levels of enzyme release than those who
undergo coronary artery grafting is
covered by the authors’ formula on page
82. Certainly, in most patients with aor
tic valve disease and in many patients with
mitral insufficiency, the myocardial mass
at risk is markedly increased, compared
with that in the average patient with cor
onary artery disease.
G. F rank O. T y e r s ,

m d , fr c sic ], fa cs

Professor and Head,
Division of Cardiovascular
and Thoracic Surgery,
Vancouver General Hospital,
855 West 12th Ave.,
Vancouver, BC
V5Z 1M9
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Small-Bowel Varices
To the editors.—Drs. Ostrow and Blan
chard, in the discussion of their most in
teresting paper on bleeding small-bowel
varices (Can J Surg 1984; 27: 88-9), in
dicate that only a few similar cases have
been reported. I should like to report
briefly another patient with a bleeding
small-bowel varix.
A 16-year-old girl had had a ruptured ap
pendix with peritonitis when she was 1 year old.
It was satisfactorily treated and she had no fur
ther complications for 4 years when she was
discovered to have Banti’s syndrome and
underwent splenectomy. Apparently the caver
nous transformation of the portal vein was
unrecognized.
When the patient was admitted, she gave a
history of passing tarry stools for several days
but without hematemesis. A nasogastric tube
introduced into the stomach did not produce
blood and subsequently an upper gastro
intestinal series was reported as “ unremark
able” . She continued to pass blood and re
quired transfusion, so abdominal exploration
was elected. The stomach, duodenum and liver
appeared normal. On examination of the small
bowel, a loop was found adhering to the back
of the previous laparotomy incision. A large
vein could be seen running through the
mesentery across one side of the small intestine,
entering the abdominal wall near the umbilicus.
The rest of the small intestine did not appear
abnormal but distally was distended with
blood.
The varix was ligated in the mesentery and
the small intestine dissected from the ab
dominal wall. The vein entering the abdominal
wall was suture-ligated and the wound closed.
Subsequently, the patient did well and in the
2 years of follow-up had no further bleeding
episodes. She was subsequently lost to follow
up so her ultimate fate is unknown.

At operation there was no evidence of
multiple intramural jejunal varices but
only one large varix. The previous
splenectomy with the resultant smallbowel adhesion to the abdominal wall ap
parently established a vascular connection

between the portal and systemic venous
system that resulted in variceal hemor- .,
rhage at the jejunal level. It therefore ap
pears possible that in any patient with un- -* i
corrected portal hypertension, whether
due to hepatic or prehepatic obstruction, ”
varices may develop at anomalous sites, ^
with hemorrhage, particularly if there has
been previous peritonitis or abdominal ^
surgery and adhesions are present.
4 A

P.A. S a l m o n ,

m d , fr c sic ], fa cs

¥

Professor,
Department of Surgery,
University of Alberta,
Edmonton, Alta.
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Lymphoscintigraphy for
Staging Breast Cancer

j
*

y

To the editors.—In his editorial, “ Lymj
phoscintigraphy in the staging of breast " *
cancer” (Can J Surg 1983; 26: 487-8),
Shibata has obscured the simple facts we
presented. Our study (Can J Surg 1983;
26: 507-9) demonstrated that axillary
lymphoscintigraphy in its present state of -y
development is not a reliable indicator of
1
axillary lymph-node metastases. It is, <
however, worth further study. We also
prospectively tested the specificity of * '
preoperative internal mammary lymphoj
scintigraphy because of the possibility
|
that postoperative surgical artefact had <
confounded the data on which Ege and
]
Clark based their original conclusions.1 ,
Only one false-positive result was obtain
ed in the preoperative examination of 76 < patients with breast masses that were
subsequently proven to be noncancerous.
There is no doubt that the test is remarkably specific for nonmalignant disease.
The suggestive correlation of the abnor- ^
mal preoperative internal mammary scan
with the most sensitive biologic marker ^ i_
presently in use (involved axillary nodes)
and with recognized anatomical lym- A
phatic drainage pathways (medial and
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central location of the primary tumour in
the breast) may be purely coincidental,
k ^ Surgical excision of the whole internal
^
mammary lymph-node chain should be
4 performed to settle the question. Unfor
tunately, this is not ethically justifiable.
y l Alternatively, we need large numbers of
patients and long-term follow-up. We do
► not believe we have enough evidence to
start adjuvant therapy on the basis of an
*■ abnormal internal mammary lymphoscintigram in patients with negative axillary
nodes. We do believe this part of the
^ h study is worth continuing.
► N orman S. H ill , md , frcsic]
Leo J. Mahoney, md, ms, frcsic], facs
♦ >- Dennis W. J irsch , md , m sc , ph d ,
FRCS[C]
y

Department of Surgery,
St. Michael’s Hospital.

^

N. David G reyson, md , frcpicj
Department of Nuclear Medicine,
A 4 . St. Michael’s Hospital,
30 Bond St.,
, Toronto, Ont.
M5B 1W8
A »
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Esophagopericardial Fistula
*• > Producing Purulent Pericarditis
r

To the editors.—In a recent review,
vv Cyrlak and associates' reported what
they thought was the 50th documented
' * case of esophagopericardial fistula. They
noted that such fistulas are uncommonly
* related to operation and when they occur
postoperatively they are recognized
clinically within 2 years. We report a pav ► tient who had esophagopericardial fistula,
documented radiologically, and presented
► 22 years after repair of a lower esophageal
stricture.
►►
An 81-year-old woman was admitted suffer
ing retrosternal chest pain, which had been pre
sent for 12 hours. Twenty-two years earlier she
’ * had undergone excision of a benign lower
esophageal stricture with interposition of a je*” junal loop between the distal esophagus and
stomach (Merendino procedure2). Her heart
* rate was 115 beats/min, temperature was 37°C
and blood pressure 90/70 mm Hg with a
paradoxical pulse pressure of 30 mm Hg;
^
Kussmaul’s sign was present. The heart sounds
■ were soft and no pericardial rub was audible.
The findings on abdominal examination were
* unremarkable. The leukocyte count was 30 x
109/L . There was elevation of the ST-segment
' in the lateral leads. Chest roentgenogram
revealed an enlarged, globular cardiac
*'• silhouette. A two-dimensional echocardiogram
showed a large pericardial effusion.

Pericardiocentesis was performed and an in
dwelling catheter left for pericardial drainage.
The leukocyte count in the pericardial fluid was
74 x 109/L ; there was a predominance of
neutrophils. Gram-positive cocci and gram
negative bacilli were present on the smear.
Cultures subsequently grew Staphylococcus
aureus, a-hem olytic Streptococcus and
Clostridium perfringens. Roentgenogram after
a swallow of dilute meglumine diatrizoate
demonstrated a free passage from the jejunal
interposition graft to the pericardial space.
Esophagogastroduodenoscopy demonstrated a
stomal ulcer at the gastrojejunal anastomosis.
The fistula was not visualized.
After 2 weeks of pericardial drainage,
parenteral feeding and intravenously ad
m inistered penicillin, netilm icin and
metronidazole, her clinical status was unim
proved. Excision of the interposition graft and
fistula was performed. Wide pericardial to
pleural cavity drainage was achieved and
esophagogastric reconstruction was performed.
Her postoperative course was complicated by
septicemia and acute renal failure. The patient
died 7 weeks after admission. Autopsy revealed
evidence of extensive pericarditis and Candida
albicans was isolated from the pericardial sac.

Development of esophagopericardial
fistula as late as 22 years after operation
has not been reported before. Purulent
pericarditis in our elderly patient is typical
in many ways of the changed spectrum
of purulent pericarditis in the antibiotic
era. The general incidence of purulent
pericarditis has declined since 1944 and
its occurrence has become relatively more
common in adults, in women and follow
ing thoracic surgery.3 Fever is seldom
absent; in the series of Rubin and
Moellering4 only 4% of patients had no
fever. Anaerobic and aerobic gram
negative bacteria are being recognized
more frequently in this infection .5
The overall mortality for patients with
purulent pericarditis who are treated is
about 40% and when unrecognized the
disease is almost always fatal.3 Although
the diagnosis of purulent pericarditis is
undoubtedly facilitated by the use of twodimensional echocardiography, the unex
pected, fatal, late postoperative complica
tion in our patient underscores the need
for acute awareness of the condition.
Robert J. Burns, md , frcp [C]
Robert S. N itkin , md
David M artin , md
T imothy G. P rieur , md
Division of Cardiology,
Department of Medicine,
Toronto Western Hospital.
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Perforated Duodenal Ulcer
To the editors.—In response to the let
ters of Cohen and Fong (Can J Surg 1984;
27: 7), I wish to make the following com
ments. Perforation is a complication of
duodenal ulcer. Fortunately, with specific
drugs, peptic ulcer disease is not as com
mon as it was. Once they have undergone
plication, 30% to 50% of patients con
tinue to enjoy a trouble-free life. Surgery
for perforation should be safe, simple,
soon and just sufficient for the immediate
problem.
Definitive surgical treatment for pep
tic ulcer disease should be offered after
a medical regimen has failed, after biop
sy of the ulcer has been obtained, after
basal acid output and maximal acid out
put have been studied, after the gastrin
level has been ascertained and associated
disease has been ruled out. The patient
should be informed of the recurrence rate
of 5% to 7% after vagotomy and
drainage and of the crippling long-term
effects on nutrition and quality of life of
adding hemigastrectomy.
Dr. Jordan of Baylor University ad
vocates a drastic solution to a simple pro
blem — a “ no mortality” treatment is
preferable to “ accepted mortality” — by
being overly aggressive.
In socioeconomically backward areas
where patient compliance is not ensured,
definitive treatment as the initial treat
ment for perforation is not to my mind
academic or catholic in the case of a
disease whose etiology is still not known.

P aul F. W aters, md , frcsic]
Division of General Surgery,
Department of Surgery,
Toronto Western Hospital,
399 Bathurst St.,
Toronto, Ont.
M5T 2S8

M .P. CHATURVEDI, m d , FRCS[C],
FRCS(EDIN)
180 Tulip Ave.,
Floral Park, NY 11001
USA
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CANADA

17.

The procedure depicted above
(A)

is frequently required for optimal results in patients with
gastroesophageal reflux

.(B)

has no place in the management o f peptic ulcer disease complicated
by hemorrhage, obstruction, or perforation

(C)

has been shown to be associated with substantially lower rates of
recurrent peptic ulcer disease than antrectomy and truncal
vagotomy

(D)

diminishes the postoperative effects o f destruction or bypass of
the pylorus that complicate other operations for peptic ulcer

(E)

is based on anatomic discoveries made during the past two decades

For the incomplete statement above select the one answer that is best of the
five given. For the critique of Item 17 see page 406.
(Reproduced by permission from SESAP I V Syllabus: Surgical Education and
Self-Assessment Program No. 4. For enrolment in the Surgical Education and
Self-Assessment Program No. 4, please apply to the American College of
Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Histologic Sequelae of Endoscopic Sphincterotomy:
a Canine Experiment

>- ■■!

►
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Concern for the late formation of stric
tures at the site of an endoscopic
y v sphincterotomy has delayed the accep
tance of this procedure as treatment for
choledocholithiasis in otherwise healthy
patients. The authors addressed this
A
issue by comparing the biochemical and
histologic sequelae of sphincterotomy in
A
23 dogs with those in 10 sham-operated
I
controls.
.A i
Twenty-four hours after sphincter
l
4
otomy, hemorrhagic, edematous mucosa
surrounded the incision. Microscopically,
there was an acute inflammatory ex
udate bridging the mucosal surfaces.
Mucosal regeneration was sufficient after
1 week to cover the defect caused by
the cautery, although some inflammatory
changes were still evident.
A widely patent sphincterotomy orifice
was seen in 15 dogs followed up for 10
weeks. In three dogs, the fibres of the
papilla had reunited below the incision,
resulting in a choledochoduodenal fistula.
Histologically, complete healing of the
mucosal surface had occurred with no
evidence of scar formation or chronic in
flammation. Serum bilirubin and liver en
zyme measurements did not show
evidence of biliary obstruction due to the
sphincterotomy.
From the results of our study, there is
no evidence to suggest that an en
doscopic sphincterotomy is predisposed
to late stenosis.

From the *Department o f Surgery and
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Hospital, University o f Western Ontario,
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La crainte de voir apparattre tardivement
un retrecissement au niveau d'une
sphincterotomie endoscopique a retard^
('acceptation generate de cette interven
tion comme traitement de la choledocholithiase chez des patients par ailleurs en
bonne sant6. Les auteurs ont abordg ce
sujet par la comparaison des sequelles
biochimiques et histologiques de la
sphincterotomie chez 23 chiens par rap
port a 10 chiens t£moins soumis a une
operation simulee.
Vingt-quatre heures apres la sphincte
rotomie une muqueuse hemorragique et
oedemateuse entoure I'incision. Au
microscope on constate un exsudat
inflammatoire aigu recouvrant les surfa
ces muqueuses. Apres 1 semaine, la
regeneration de la muqueuse est suffisante pour couvrir les marques de caute
risation meme si des changements
inflammatoires sont encore evidents.
Un orifice de sphincterotomie bien per
meable a ete observe chez 15 chiens qui
ont ete gardes sous surveillance pour
jusqu'e 10 semaines. Chez trois chiens,
les fibres de ia grande caroncule
s'etaient reunies sous I'incision entratnant la formation d’une fistule
choledocho-duodenale. A I'histologie, on
observait une guerison complete de la
surface muqueuse sans signe de cica
trice ou d'inflammation chronique. Le
dosage de la bilirubinemie et des enzy
mes hepatiques n'a pas reveie de signe
d'obstruction biliaire attribuable a ia
sphincterotomie.
Les resultats de notre etude n'indi
quent pas que la sphincterotomie
endoscopique puisse predisposer & une
stenose tardive.

—^

—

strictures will form later at the site o f the
sphincterotom y.1'4 We attem pted to
resolve this issue by examining the
histologic sequelae o f electrosurgical
sphincterotomy, using a canine model.

Material and Methods
A cholecystectomy was performed at
the time o f laparotomy in 33 anesthetiz
ed mongrel dogs. Through a longitudinal
duodenotomy, the papilla o f Vater was
identified and cannulated with a sphincterotome designed for endoscopic use.
In 23 dogs (group 1), a sphincterotomy
1 to 1.5 cm long was performed by ap
plying blended electrocautery current to
the raised cutting wire. The duodenotomy
and laparotomy incisions were then clos
ed and the animals were allowed to
recover.Ten control dogs (group 2) under
went cholecystectomy and duodenotomy,
but a sphincterotomy was not performed.
All group 2 dogs and 15 group 1 dogs
had serum bilirubin and liver enzyme
levels measured daily for the first week
postoperatively and thereafter at weekly
intervals for 10 weeks. The remaining
eight dogs in group 1 were sacrificed at
varying intervals from 24 hours to 1 week
postoperatively to investigate the early
changes caused by the electrocautery
incision.
At the time o f sacrifice, the duodeno
tomy was reopened and the sphincter
otomy orifice examined. After excision
o f the choledochoduodenal junction,
histologic sections across the sphincter
otomy were examined to ascertain the
changes and the degree o f healing at the
incision site.

Results
Endoscopic sphincterotomy is now the
preferred method for treating retained or
recurrent biliary calculi.1 Although its
application is unchallenged in the highrisk surgical patient, many surgeons
prefer the classic operative approach to
common-bile-duct calculi in otherwise
healthy patients, because o f concern that

The postoperative course was similar in
both groups, with no complications that
we could attribute to the sphincterotomy.
Two dogs in group 2 died as a result o f
viral epidemics in the animal storage area,
one 4 weeks and the other 6 weeks
postoperatively.
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Fig. la

Fig. lb

FIG. 1—(a) Duodenal papilla (arrow) in control dog. (b) Intramural portion of common bile duct. Lumen of common bile duct is filled
with papillary projections of bile-duct mucosa, separated from lumen of duodenum by roof of smooth muscle and duodenal mucosa (hematoxylin- -•*
phloxine-saffron stain, reduced by 51% from x 80).
* ^
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Fig. 2a

Fig. 2b

FIG. 2—(a) Sphincterotomy after 24 hours. Incision surrounded by hemorrhagic and edematous mucosa, (b) Histologic section taken
across sphincterotomy after 24 hours. Acute inflammatory exudate lining incision, with hemorrhage and edema in surrounding tissue (hematoxylinphloxine-saffron stain, reduced by 51% from x 80).

•«

•<

A

j

A

Fig. 3a
Fig. 3b
(- j<
FIG. 3—(a) After 10 weeks, sphincterotomy fully healed. Divided fibres of papilla visible (arrow), with patent sphincterotomy extending
proximally. (b) Histologic section shows incision lined by mature mucosal epithelium without evidence of inflammation or scar tissue at mucosal k
interface (hematoxylin-phloxine-saffron stain, reduced by 51% from x 80).
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The serum bilirubin and liver enzyme
(alkaline phosphatase, glutamic oxalo
acetic transaminase and glutamic pyruvic
transaminase) levels were moderately
elevated after the first postoperative
►
week, then rapidly returned to normal
►►in both groups and remained normal
for the duration of the study. No persis
► tent or increasing biliary obstruction was
evident, and there was no notable dif
ference between the two groups.
The duodenal papilla in normal dogs
(group 2) (Fig. la) consisted of a small
mucosal elevation with a central opening
for the common bile duct. From this
point, the common duct ascended intramurally in the duodenal wall for a
►> variable distance before emerging as the
common bile duct proper. A microscopic
section across the intramural portion of
the common bile duct (Fig. lb) showed
y f that its lumen was filled with papillary
projections of bile-duct mucosa and was
separated from the duodenal lumen by a
septum of smooth muscle and duodenal
mucosa.
At 24 hours postsphincterotomy, gross
inspection revealed h em orrhagic,
edematous mucosa surrounding the
sphincterotomy site (Fig. 2a). A histologic
section taken across the sphincterotomy
(Fig. 2b) showed the base of the incision
lined by an acute inflammatory exudate,
with hemorrhage and edema in the sur
rounding tissue. Despite this surprising
degree of early local reaction, healing pro
gressed rapidly and was nearly complete
in the group 1 dogs examined at 1 week
postoperatively.
At 10 weeks, all 15 dogs had a widely
patent sphincterotomy orifice (Fig. 3a)
with no gross signs of scarring or ongo
ing inflammation. In three dogs, the
papillary fibres had reunited below the
sphincterotomy, creating, in effect, a pro
xim al choledochoduodenal fistula.
Histologic examination of the healed
sphincterotomy at 10 weeks (Fig. 3b)
demonstrated a lining of mature duodenal
and common-bile-duct mucosa with ac
curate mucosal healing in all areas. There
was no evidence of scar tissue or chronic
inflammatory changes at the mucosal in
terface or in the surrounding tissues that
might predispose to late stenosis.
Discussion
Endoscopic sphincterotomy successful
ly clears the common bile duct in 90.5%
to 93.8% of patients with choledocholithiasis, and is associated with a mortali
> s ty of less than 1.5% in large series.2,5'7
Late stenosis at the sphincterotomy site
is uncommon, occurring in only 1.0% of
patients followed up from 1 to 5 years.3,5
In early animal experiments, Kawai and
associates8 studied the feasibility of electrosurgical sphincterotomy in five dogs.

They found no visible evidence of fibrosis
or stenosis 2 to 4 weeks postoperatively.
Tanaka and associates9 studied three
monkeys 10 to 12 months following
sphincterotomy. They found that ac
curate mucosal healing had occurred in
all cases, but failed to show convincing
histologic proof of these claims. Other
investigators10 have demonstrated the
safety of electrosurgical sphincterotomy
in animals, but have not examined the in
cision to assess its potential for late
scarring.
In our study, we found no evidence to
suspect that an electrosurgical sphinc
terotomy is prone to late stenosis. The
sphincterotomy remained widely patent
throughout the study period, with no
visual evidence of scarring or chronic in
flammation. Moreover, histologic ex
amination of the incision 10 weeks after
sphincterotomy confirmed the presence of
accurate mucosal healing with a remark
able absence of scar tissue formation and
chronic inflammation at the mucosal
interface.
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Conclusions
From our study on the healing of an
endoscopic sphincterotomy in a canine
model, we found that within 24 hours an
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Blunt Splenic Trauma: Diagnosis and Management
To examine the morbidity and mortality
associated with blunt splenic injuries, the
authors reviewed the results in 106 such
patients treated in the Sunnybrook
Regional Trauma Unit between June 1,
1976 and June 30, 1983.
Initial assessment included peritoneal
lavage in 86 patients. No patient with
known or suspected splenic injury was
treated nonoperatively nor were any pa
tients found to have had splenic injuries
missed at the initial assessment.
Seventy-one splenectomies and 35
splenorrhaphies were performed. The
overall mortality was 25% and 10 sur
viving patients had serious complica
tions. The splenic injury itself was never
the cause of death. Only one patient
who initially underwent splenorrhaphy
later required splenectomy.
It is concluded that blunt splenic injury
is rarely the cause of death or serious
morbidity when a policy of immediate
diagnosis and operative treatment is
carried out. Furthermore, in selected
patients, splenorrhaphy is a safe and
effective treatment.
Dans le but d'evaluer la morbidity et la
mortality rattachees aux traumatismes
fermes de la rate, les auteurs passent en
revue les rgsultats obtenus chez 106
patients victimes de telles blessures qui
ont ete traites au Sunnybrook Regional
Trauma Unit entre le 1er juin 1976 et le
30 juin 1983.
Chez 86 patients, I'examen initial comprenait un lavage peritoneal. Aucun
patient ayant un traumatisme splenique
diagnostique ou soupconne n'a ete traite
de fagon non chirurgicale; de meme
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aucun patient chez qui on a confirme
une lesion de la rate n'a echapp£ a I'exa
men initial. Soixante-et-onze splenecto
mies et 35 splenorraphies ont ete pratiquees, Le taux de mortaiite globale a
ete de 25% et 10 survivants ont eu
des complications serieuses. En soi, le
traumatisme splenique n'a jamais ete la
cause du deces. Des patients qui ont
subi une spienorraphie, un seul a par la
suite necessite une spienectomie.
On conclut qu'un traumatisme splenique
ferme est rarement mortel ou la cause
d'une morbidite serieuse quand on
recourt systematiquement a un diagnos
tic immediat et a la chirurgie. De plus,
chez des patients choisis, la spienorra
phie s'avdre un traitement sur et
efficace.

The management of splenic injury in
adults continues to be controversial. The
methods of diagnosis, treatment and con
sequences of splenectomy have not yet
been fully agreed upon. Splenic rupture
can be spontaneous or caused by pene
trating, blunt or operative trauma.
At the Sunnybrook Regional Trauma
Unit all adult patients with splenic injury
due to blunt trauma have been managed
uniformly and this paper reviews the
results of their management.
Patients and Methods
Only patients aged 16 years and older
with splenic injuries caused by blunt
traum a were included. Excluded were all
patients with penetrating trauma, those
initially operated upon elsewhere and
transferred to Sunnybrook Medical Cen
tre for postoperative care and all patients
who died in the Emergency Department
and were found at autopsy to have splenic
trauma.
O f 1378 patients admitted to the
Regional Trauma Unit at Sunnybrook
Medical Centre between June 1, 1976 and
June 30, 1983, 136 had splenic injuries.
In 106 patients the splenic injury was due
to blunt trauma and they were cared for
entirely at Sunnybrook Medical Centre;
22 were operated upon elsewhere, 7 died

■*

* *

- i

before receiving definitive care and 1 suffered penetrating splenic trauma. The 106
patients are the subject of this report.
There were 29 women and 77 men and ,
they were predominantly young (Fig. 1).
When the trauma unit is notified that-t -*
a patient is being transported to Sun
nybrook, residents of the appropriate ser- ’•
vices are called to the trauma room in the
Emergency Department. They include a
trauma team leader and residents in .
general surgery, anesthesia, orthopedics
and neurosurgery. As soon as the patient« v
arrives, resuscitation and evaluation are
carried out. Indications for operation for F
an intra-abdominal injury may be clear.
If not, or if the abdomen cannot be
evaluated because of coma, alcoholic in
toxication or spinal cord injury, open
peritoneal lavage is carried out in
the trauma room. If the lavage fluid is
grossly bloody or if its erythrocyte <
count is greater than 0.02 x 1012/L
(20 000/mm3), its leukocyte count more 4
than 0.5 x 109/L or its amylase level is
more than 1750 U/L, laparotomy is done. •' s
Until Jan. 1, 1979, all splenic injuries
were managed by splenectomy. Since '* 1
then, splenorrhaphy has been performed
if possible. Antibiotics are not given ’
prophylactically.
^
An abbreviated injury severity score
(1980 version) was calculated for each pa- < tient according to the rules of the
American Association for Automotive <
Medicine.1 This system of scoring was
introduced in 1974 by the Maryland In- * *
stitute for Emergency Medicine.2 Each
organ system injured is assigned a number
from 1 (minor injury) to 5 (critical in- „ jury). The overall injury severity score is
the sum of the squares of the individual <
organ system scores.
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Statistical comparisons of injuries sus
tained by surviving patients and nonsurviving patients were carried out, using the
X2 test in a 2 x 2 contingency table.
►Comparisons of injury severity scores
were carried out with an unpaired /-test.
^ ^Results were considered significant if p
. was less than 0.05.
^ Findings
► Motor vehicle accidents accounted for
91 % of the injuries in the 106 patients and
K the remainder were primarily due to falls.
A positive result from peritoneal lavage
k was the main indication for laparotomy
in 82% of the patients. Ten percent,
however, had obvious intra-abdominal
r injury — usually indicated by a ruptured
hemidiaphragm on chest roentgenogram.
r' fThe others underwent surgery on the basis
of a clinical diagnosis of intra-abdominal
injury. In 102 of the 106 patients, other
injuries were present (Tables I and II).
’ 1 Surviving patients had an average of 2.3
^ while nonsurviving patients had an
average of 2.9 other organ systems inj, *jured (Fig. 2). The severe nature of these
injuries is reflected in the distribution of
A injury severity scores (Figs. 3 and 4).
All patients with evidence of, or with
a possibility of, intra-abdominal injury
were operated upon immediately. No patient with negative findings on peritoneal
lavage or thought clinically to have no
intra-abdominal injury had signs or
..symptoms suggestive of splenic injury
subsequently. Seventy-one patients under► went splenectomy and 35 splenorrhaphy
(Table III).
->■ No splenorrhaphies were performed
before Jan. 1, 1979. Since then, this form
‘ of management has become increasingly
popular (Fig. 5). Complications of the in
juries and their management have been

surprisingly few. In 10 patients (13% of
survivors) there were 12 complications.
These included subphrenic abscess, pan
creatic injury, pulmonary embolism and
upper gastrointestinal bleeding. All but
one had had a splenectomy. The mean ( ±
SEM) injury severity score for those pa
tients who had complications was 38.6 ±
11.0. Seventy-nine of the 106 patients sur
vived their injuries and were discharged
from hospital. The mean injury severity
score of the 79 survivors was 34.5 ± 11.3
and of the 27 nonsurvivors 52.4 ± 10.4
(Table IV and Fig. 4). The mean injury
severity score of all survivors was

FIG. 2—Number of organ systems injured
other than gastrointestinal tract. White bars =
survivors, black bars = nonsurvivors.

significantly (p < 0.005) different from
the score of those who died. Fifteen
(56%) of the 27 nonsurvivors died of
closed head injuries, 7 (26%) died of un
controllable hemorrhage from severe
hepatic injuries and retroperitoneal
bleeding, 4 (15%) survived their prolong
ed hypovolemic shock only to succumb
to multiple organ system failure. One pa
tient with multiple fractures and a flail
chest died of pulmonary embolism.
D isc u ssio n

The diagnosis and management of

FIG. 3—Splenectomy (white bars) or
splenorrhaphy (shaded bars) and injury severity
score.

T a b le I l l - O p e r a t i v e M a n a g e m e n t
P ro c e d u re

N o . |% )

S p le n e c t o m y

71 (6 7 )
0

P a r t ia l s p le n e c to m y

8 (8 )

S p le n ic s u t u r e

2 2 (2 1 )

H e m o s t a t ic a g e n t

5 (5 )

None

T a b le 1-- A s s o c ia t e d In ju r ie s
N o n s u rv iv o r s ,

S u r v iv o r s ,
n o . ( % ) (n -

In ju ry

n o . ( % ) (n -

79)

3 3 (4 2 )

*

Face

1 8 (2 3 )

*

B lu n t c h e s t

3 8 (4 8 )

O th e r in t r a a b d o m in a l

3 2 (4 1 )

G e n ito u r in a r y

1 4 (1 8 )

6 (2 2 )

M u lt ip le s y s te m s

4 9 (6 2 )

1 7 (6 3 )

C e n t r a l n e rv o u s s y s te m o r s p in a l c o rd

27)

FIG. 4—Survivors (white bars), nonsur
vivors (black bars) and injury severity score.
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FIG. 5—Splenectomy (white bars), splenor
rhaphy (shaded bars) and date of admission.
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blunt splenic injury has undergone a
marked change in the last 10 years.
Diagnosis made on the basis of physical
examination and clinical suggestion is dif
ficult in patients with multiple injuries.
Peritoneal lavage, when carried out
through a mini-laparotomy incision, is a
safe and rapid method of detecting the
presence of intra-abdominal blood in the
patient who has received blunt trauma.
False-negative results are extremely rare
and false-positive findings can be avoid
ed by careful insertion of the catheter.3
Peritoneal lavage provides a rapid method
of determining the necessity for laparo
tomy while the patient is still in the
emergency department and eliminates the
need for time-consuming radiologic or
nuclear medical tests. We believe that the
policy of observation of adult patients
with possible splenic injuries is to be con
demned. To wait for generalized peri
tonitis or hypotension secondary to
hypovolemia to develop is to invite
complications.
Although the diagnosis of blunt splenic
injury has been greatly simplified and ex
pedited in the last 10 years, its manage
ment has become more complex. Two
factors account for this complexity. First,
the Hospital for Sick Children in Toron
to has amply demonstrated the efficacy
of conservative management of splenic in
juries in children.4 This has occasional
ly been tried in adults, but no results have
been published. Over 90% of the patients
in this series had injuries to other organs,
many of which required one or more
operative procedures. In particular, 41%
c our surviving patients and 74% of
those who died had other intra-abdominal
injuries. In this group it would be difficult
to select those with splenic injury as their
only intra-abdominal injury. Further
more, it would be hazardous to subject
even patients with isolated splenic injury
to prolonged anesthesia for orthopedic
procedures, as it would be difficult to
determine the cause of any hypotensive
episodes. Thus, we believe that it is
simpler and safer to treat all splenic in
juries by immediate operation.
The second factor that has increased
the complexity of treatment is the sugges
tion that splenectomy can have adverse
effects on host-defence mechanisms.
Total splenectomy in childhood has
definitely been shown to result in an in
creased incidence of overwhelming sep
ticemia leading to rapid death.5 In
adults, however, it has been very difficult
to prove that overwhelming postsplenec
tomy sepsis even exists. One study in
adults suggested an incidence of
postsplenectomy sepsis of 2.2.% in 45
months of follow-up of healthy adult pa
tients who underwent splenectomy for a
variety of reasons.6 A matched group of
patients who underwent other operations
332

had no deaths due to sepsis in this period.
Although this study suffers from the
usual problems of a retrospective chart
review, it does appear to indicate a small
but definite risk associated with asplenia
in the adult. The pathophysiology of this
state has recently been reviewed.5 This
has led to numerous attempts to salvage
splenic tissue. Suggested methods have
ranged from a nonoperative approach
(already condemned) to operative salvage
of the spleen to implantation of splenic
tissue into the peritoneal cavity7 or por
tal vein.8 The only form of splenic con
servation we have experience with is a
direct attack on the bleeding site. This in
cludes partial splenectomy,9 splenic
suture, splenic artery ligation,10 the ap
plication of a hemostatic agent and no
treatment (Table III). In our series, no
partial splenectomies or splenic artery
ligations were carried out. It is our belief
that if the spleen has been so damaged
that only a partial splenectomy can
salvage a portion of it, it is better to pro
ceed with total splenectomy to save time
and reduce blood loss in these multiply
injured patients. The splenic vessels pass
out radially from the hilum of the spleen,
dividing the spleen into several poorly
defined segments.11 This anatomical ar
rangement makes partial splenectomy
technically possible. It also allows the
spleen to be sutured by passing the sutures
at right angles to the vessels. Of our 35
patients who underwent splenorrhaphy,
8 required sutures to control bleeding.
However, we have not had success in at
tempting to suture disrupted hilar vessels.
Patients with this injury should undergo
a total splenectomy. Most patients (22 of
35) required simply the application of
hemostatic agents (e.g., Avitene, Oxycel)
and laparotomy sponges to the bleeding
site to obtain hemostasis. Usually 5 to 10
minutes of such packing is all that is re
quired. Five patients had small capsular

tears which had stopped bleeding by the
time the spleen could be observed at
laparotomy. It is interesting that whereas
most splenic injuries in childhood will
stop bleeding spontaneously, in our adult *
series, at least 30 of 35 did not.
^
Special mention should be made of one
patient. At the time of operation, this pa- 4
tient was in severe hypovolemic shock due
to multiple injuries resulting from an -> 1
automobile accident. The splenic injury
was repaired with hemostatic materials *
and sutured and other injuries were at
tended to. Twelve hours later, the patient7 M
was operated upon again because of con
tinued intra-abdominal bleeding. At
laparotomy, there was a blood clot about T 4
the spleen, and a previously repaired blad
der injury was actively bleeding. The
spleen was removed and the bladder
■
repaired a second time. However, the pa-"* +
tient died later the same day from irrever
sible hypovolemic shock. This case il- 7
lustrates the principle that hemodynami- A ,
cally unstable patients who require large *
quantities of blood with the subsequent, *
almost inevitable, coagulopathy are not
candidates for splenic repair.
* j.
A retrospective chart review is a poor
method of determining complication *
rates. Only complications noted in the
chart are tabulated. Nevertheless, it is
clear that the complication rate associated
with the operative management of splenic
injuries is reasonably low. Only 13% of „
our surviving patients had complications
that could possibly be attributed to the v ^
splenic injury. All but one had undergone
total splenectomy. Two pancreatic fis- 4
tulas were noted, at least one of which
j
was likely an iatrogenic injury. Six pa- 7 ■>
tients had sepsis — one had a wound in1
fection, four had intra-abdom inal 7
abscesses and one had severe pneumonia.
j
Patients who had abscesses had other
j
intra-abdominal injuries — usually liver ^
lacerations or bowel perforations — that

Table IV--Mean Injury Severity Scores
Group
All survivors
Survivors with complications
Survivors without complications
Survivors with splenectomy
Survivors with splenorrhaphy
Nonsurvivors

No. of
patients
79
10
68
50
28
27

Score,
mean ± SEM
34.5
38 .6
33.8
35 .8
32.1
52.4

+
±
+
+
+
±

11.3
11.0
11.1
11.4
11.0
10.4

Table V—Morbidity and Mortality in Patients
_______________________ Who Underwent Splenectomy and Splenorrhaphy
Splenectomy
Splenorrhaphy
Group___________________________________________ In = 71)_______________________ (n - 35)
Survivors
Survivors with complications

50
9

29
1
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clearly contributed to the onset o f sepsis.
Four patients had miscellaneous complications — jaundice, pulmonary em
bolism and stress upper gastrointestinal
^ bleeding — that were at least partially a
result o f the splenic injury and its treat► kment. Most noteworthy is that the 35 pa
tients who underwent splenorrhaphy had
^ only one complication associated with this
treatment (stress gastrointestinal bleedr
ing). On the other hand, patients treated
^ by splenorrhaphy had less severe injuries
than those who required splenectomy,
.although the difference in injury severity
score was not substantial.
*O f the 106 patients operated upon at
Sunnybrook Medical Centre, 27 died —
' r a mortality o f 25%. This contrasts with
a mortality o f 18.6% in a large series o f
* patients at the University o f Texas.12
v fOur slightly higher mortality likely
reflects the fact that 85% o f our trauma
► patients are referred from other centres
and hence tend to have more serious inI* * juries. As might be expected, most o f our
patients who died had severe head injuries
k (56% ). Uncontrollable hemorrhage and
^ ^prolonged shock accounted for only 11
i
deaths. In the large Texas series, shock
k was the commonest cause o f death.

Again, we believe that the difference is
due to the contrasting patient popula
tions. Our mortality could only be im
proved by the more rapid transportation
o f critically injured patients to wellequipped and well-staffed emergency
departments.
In Table V, we compare morbidity and
mortality o f patients who underwent
splenectomy or splenorrhaphy. However,
as noted above, this does not indicate that
splenorrhaphy is a safer operation than
splenectomy; rather, patients treated by
splenorrhaphy tended to be less severely
inju red
than
those
treated
by
splenectomy.
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Value of High-Resolution Computerized Tomography in
Localizing Diseased Parathyroid Glands
Eighteen p a tie n ts w ith h yperpara
th y ro id is m u n d e rw e n t h ig h -re so lu tion
com puterized to m o g ra p h y o f the neck
and superior m ed ia stin u m to assess the
accuracy o f th e m eth o d in localizing
diseased p a ra th yro id glands preoperatively. The to m o g ra m s w e re co rrelated w ith
surgical and p a th o lo g ica l fin d in g s. Four
scans w e re te c h n ic a lly u n sa tisfa cto ry. O f
th e rem aining 14 scans, 8 sh o w e d an
enlarged p a ra th y ro id gland; in 7 cases,
th e scan c o rre c tly id e n tifie d th e location
o f th e diseased gland w h ile in 1 case,
th e side o f th e lesion w a s in co rre ct. The
o th er six scans did n o t s h o w an a b n or
m al p a ra th yroid. These glands varied in
size from 0 .0 5 to 5 .0 c m 3 a t th e tim e o f
pa tho lo g ica l exa m in a tio n . Three pa tie nts
w ere u n dergoing re-e xp lo ra tio n fo r per
s iste n t disease; te c h n ica lly acceptable
scans w e re o b tained in tw o and, in both,
th e lo cation o f th e adenom a w a s co rre c t
ly id e n tifie d. Excluding p a tie n ts w ith
te ch n ica lly u n s a tis fa c to ry scans, th is
technique has a s e n s itiv ity o f 5 0 %
(7 /1 4 ) and a fa lse -n e g a tive rate o f 4 3 %
(6 /1 4 ) in d e p en d e n t o f gland size.
H ow ever, in th e e ig h t scans in te rp re ted
as p o sitive , th e c o rre c t side o f the lesion
w as localized in 7 (8 8 % ).
This te c h n iq u e is n o t recom m ended for
routine p re o p e ra tive loca liza tio n b u t m ay
be o f value in re-e xp lo ra tio n fo r persis
te n t disease.

D ix-huit p a tie n ts s o u ffra n t d ’ hyperparathyroi'die o n t subi une to m o d e n sito m 6 trie a haute reso lu tio n du cou e t du
m ediastin superieur afin d 'e va lu e r la pre-
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cision de c e tte m ethode quand il s 'a g it
de localiser des p a rathyroides pathologiques en preoperatoire. Les tom ogram m es
o n t 6t6 m is en parall&le avec les constata tio n s chirurg ica le s et les resultats de
p a th o lo g ic. Q u a tre scintigraphies etaient
te ch n iq u e m e n t in satisfaisantes. Sur les
14 autres to m o g ra ph ie s, 8 revelaient des
pa ra th yroide s h y p e rtro p h ie s ; dans 7
cas, la scin tig ra p h ie id e n tifia it correctem e n t la lo ca lisa tio n de la glande malade
alors que dans le dernier cas, le cote de
la is io n e ta it erronee. Les six autres
to m o g ra p h ie s n ’ o n t revele aucune
pa ra th yroide anorm ale. La taille de ces
glandes va ria it de 0 .0 5 e 5 .0 cm 3 au
m om e n t de I'exa m e n pathologique. Trois
p a tie n ts su b issa ie n t une seconde in te r
ve n tio n e xp lo ra to ire pour la persistance
de la m aladie; une to m o g ra ph ie te ch n i
q u em ent a cceptable a ete obtenue dans
deux cas p e rm e tta n t les deux fo is de
localiser co rre cte m e n t I'adenom e. Si I'on
e x c lu t les p a tie n ts d o n t la scintigraphie a
ete te ch n iq u e m e n t in satisfaisante, la sen
s ib ility de la te ch n iq u e a ete de 50%
(7 /1 4 ) et le ta u x de fa u x n£ g atifs de
4 3 % (6 /1 4 ), in d ependam m ent de la taille
de la glande. T o u te fo is , sur les huit
to m o g ra ph ie s p o sitive s, le co te p a tho lo 
gique a et6 localise co rre cte m e n t 7 fois
(88% ).

C e tte te ch n iq u e n 'e s t pas recom m andee com m e m oye n system atique de lo ca 
lisa tio n prgoperatoire. Elle peut to u te fo is
etre u tile lo rs q u 'il s 'a g it de rgevaluer une
m aladie p e rsistante.

Once considered rare, primary hyper
parathyroidism is now being diagnosed
more frequently and at an earlier stage.
The widespread availability of the
multichannel autoanalyser for routine
determination of serum calcium concen
tration and highly sensitive assays for
parathyroid hormone facilitate diagnosis
and treatment. Surgery for primary
hyperparathyroidism, especially when
performed infrequently, can be difficult
because the parathyroid glands are small
and their location is variable. Numerous
preoperative localization techniques have
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been tried in an effort to aid the surgeon ""
at the time of exploration.
The purpose of this study was to assess
the accuracy and value of computerized ,
tomography of the neck and medias
tinum, using a high-resolution techniques •>
for preoperative localization of diseased
parathyroid glands.
*

Materials and Methods
4

Eight men and 10 women (age range
from 19 to 75 years, mean 55 years) with* *•
hyperparathyroidism were studied in a
consecutive, prospective manner. The A
diagnosis was primary hyperparathyroid
ism in 17 patients and tertiary hyper
parathyroidism in 1 patient. Fifteen pa
tients underwent primary neck explora- H
tion and 3 patients had reoperation for ^
persistent disease following neck explora
tion elsewhere. All had abnormally/ /
elevated serum calcium and plasma
!
parathormone levels preoperatively.
4
Our surgical technique and philosophy
i
have been described in detail previously.1y '
Both sides of the neck are carefully ex
plored and an attempt is made to iden - "
tify all parathyroid glands. All normal-^
appearing glands are biopsied for
histologic confirmation and all grossly
abnormal-appearing glands are excised.
Computerized tomography was per-* v
formed immediately preoperatively at the
j!
Montreal Neurological Institute by a *
high-resolution technique used to in
vestigate carotid and cerebral abnor* ^
malities. This technique employs high v
voltage (140 kV) and a high-resolution
comb that produces an enlarged image. < ,
The patients were scanned from the hyoid
j
bone to the superior mediastinum every -< i
13 mm. Scan interpretations were based
j
upon a final retrospective, but blinded,'' reading by a skilled tomographer. All
findings were correlated with the intra- *
operative findings and the final patho- y
logical description of the gland, including
gross size, weight and histologic findings. f

Results

fM

In four patients the scans were un- f
satisfactory for interpretation; in three the
;
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presence of surgical clips created artefacts
and in one the scan was technically poor.
^ In the remaining 14 patients, an abnor
mality was identified in eight scans, but
^ no abnormality was seen in six.
In the eight patients whose scan showt Fed an abnormality, the scanning tech
nique correctly identified the location of
► the diseased gland in seven. All of these
patients had single adenomas, which were
► more than twice normal gland size (Figs.
1 and 2). In the one patient in whom
tomography incorrectly identified a
^ .diseased gland, the scan unequivocally
suggested a right-sided lesion instead o f
F the left-sid ed adenom a found at
operation.
1 > In six patients, the scan failed to iden
tify any enlarged abnormal parathyroid
^ tissue. Of these, four patients had single
^adenomas while two had multigland
^hyperplasia (Fig. 3).
Three patients underwent reoperation
for persistent hypercalcemia following
* k. neck exploration at other institutions. AH
were found to have parathyroid adeno►mas in the superior mediastinum. In one
the scan was technically unacceptable. In
A Athe two others the lesion was correctly
k identified by computerized tomography
(Fig. 4).
In patients whose scan was positive, the
glands ranged in size from 0.1 to 3.0
cm3. In the six patients with a negative
scan, the abnormal parathyroid glands
*- were o f similar size, ranging from normal
to grossly enlarged (Table I).

stration o f the venous phase should be
carried out before the venous sampling
for accurate localization and interpre
tation.8 The patients are therefore sub

jected to the described risks o f arterio
graphy as well. The combined procedure
has an accuracy o f greater than 90% in
some series but requires considerable time

FIG. 1—Computerized tomogram of neck
in 53-year-old man with primary hyper
parathyroidism demonstrates large, welldefined, rounded mass (arrow) 1.5 cm in
diameter to left of esophagus, indenting left
posterolateral wall of trachea at T l.

FIG. 3—Five hyperplastic glands found at
operation on 60-year-old woman with primary
hyperparathyroidism.
Computerized
tomogram had failed to demonstrate any ab
normality despite several grossly enlarged
glands.

FIG. 2—Same patient as in Fig. 1. Large
adenoma was found in superior pole of left
lobe of thymus at operation.

FIG. 4—Computerized tomogram of
mediastinum in 53-year-old woman with per
sistent primary hyperparathyroidism following
neck exploration reveals lesion above arch of
aorta, 2 cm anterior to trachea. Parathyroid
adenoma was identified at operation at this
location.

v Discussion
^ ”

Many techniques have been described
for preoperative identification and
[ v localization o f diseased parathyroid
^glands. Radionuclide scanning with
selenomethionine has been advocated.2
y. This modality has not become popular
because the false-positive rate is greater
~ r than 50%. Cine-esophagography has a
reported accuracy o f only 25%3 and is
►reliably positive only if the abnormal
gland is located adjacent to the esophagus
V *and is associated with markedly elevated
^ levels o f serum calcium and plasma
parathyroid hormone. Thyroid lymphoy , graphy, originally described by Kato and
associates,4 has been reported to be
r- highly accurate but only in a small series
o f four patients. Thermography, with an
> ►accuracy o f less than 40% ,5 cannot
|
detect mediastinal glands or identify the
r exact number o f diseased glands. Arteri
ography provides accurate localization in
3 50% to 77% o f cases.6,7 However, this
, technique carries serious risks o f arterial
occlusion and neurologic sequelae.
A 4 Venous catheterization with serial
i sampling for parathyroid hormone levels
* can be sensitive and accurate in experi
enced hands. Arteriography with demon

Table 1 -P a tie n t D ata
Scan

Patient
no.

Diagnosis

Gland
volum e, cm 3

i
2
3
4
5
6
7
8
9
10
11
12
13
14
15

A
A
A
A
A
A
A
A
H
H
A
A
A
A
A

0 .1
0 .5
1 .2
1 .3
1 .5
2 .0
3 .0
3 .0
0 .0 5 -0 .1 3
1 .5
1 .5
1 .8
5 .0
0 .6

16
17
18

A
A
A

1 .0
3 .0
-

Positive (n = 81

N eg a tive In = 6)

U nsa tisfacto ry
In = 4)

A - single adenom a, H - hyperplasia.
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and expertise. It is generally reserved for
complicated cases when the patient must
undergo re-exploration. Ultrasonography,
using sensitive, small probes, has an ac
curacy of greater than 70% when the
glands are more than 1 cm in diameter or
weigh more than 1 g.9
In the present study, 18 consecutive pa
tients underwent preoperative com 
puterized tomography o f the neck and
mediastinum using a sensitive highresolution technique. In four (22%) pa
tients, the scans were unacceptable. In the
remaining 14, scanning resulted in correct
localization o f the site o f diseased glands
in 7 for a true-positive ratio or sensitivi
ty o f 50% (7 o f 14). There was a false
positive result in 7% (1 o f 14). The false
negative rate was 43% (6 o f 14). Despite
the poor sensitivity and a high rate of
negative scans associated with this tech
nique, it is noteworthy that when an ab
normality was detected (eight patients) it
was correct in 88% (seven). Moreover,
when the abnormal parathyroid gland
was located in the mediastinum (three pa
tients), the high-resolution technique cor
rectly localized the abnormality in both
patients in whom an acceptable scan was
obtained. The low density o f mediastinal
fat may render enlarged parathyroid
glands more visible in this location.

Similar results have been reported in a
small series by Doppman and colleagues.10
Many factors may be responsible for
the high number o f negative neck scans.
As can be seen in Table I, both greatly
and minimally enlarged glands were miss
ed. Therefore, size alone is not critical for
detection by this technique. The slice
thickness o f 13 mm may play a role. The
close proximity of a major artery and
veins with their branches viewed in crosssection and the proximity to the thyroid
gland with similar density and frequent
irregular outline may present further
difficulties.
In patients with hyperparathyroidism,
surgery is successful in over 90% of cases
if performed by a competent, experienced
surgeon. Invasive, costly and potentially
hazardous procedures are not required
preoperatively. All noninvasive pro
cedures described to date have poor sen
sitivity, including computerized tomo
graphy, despite the use o f a high-resolution technique as described here. Com
puterized tomography o f the neck and
mediastinum therefore appears to be of
limited value for routine preoperative
localization o f diseased parathyroid
glands. The need for reader expertise, the
high cost and exposure to radiation are
all factors to be considered, in addition

to the low yield independent of gland size.
However, this technique may be valuable
in those patients who undergo re-explo
ration for persistent disease, particularly
if it is located in the mediastinum.
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including conditions accompanied by fever.
CONTRAINDICATIONS: Status asthmaticus, pre-existing respiratory
depression or convulsive states, hypersensitivity to oxycodone or
acetaminophen.
WARNINGS: Drug dependence: Oxycodone can produce drug depen
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abused. Psychic dependence, physical dependence and tolerance may
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Usage in ambulatory patients: Oxycodone may impair the mental and/or
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tasks such as driving a car or operating machinery. The patient using
PERC0CET should be cautioned accordingly.
Interaction with other central nervous system depressants: Patients
receiving other narcotic analgesics, general anesthetics, monoamine
oxidase inhibitors, tricyclic antidepressants, phenothiazines, other
tranquilizers, sedative-hypnotics or other CNS depressants (including
alcohol), concomitantly with PERC0CET may exhibit an additive CNS
depression. When such combined therapy is contemplated, the dose of
one or both agents should be reduced.
Usage in pregnancy: Safe use in pregnancy has not been established
relative to possible adverse effects on fetal development. Therefore,
PERC0CET should not be used in pregnant women unless, in the
judgment of the physician, the potential benefits outweigh the possible
hazards. The administration of PERC0CET to obstetrical patients in labour
may be associated with respiratory depression of the newborn.
Usage in children: The more potent formula, PERC0CET, should not be
administered to infants or children. However, PERC0CET-DEMI, containing
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336

patients such as the elderly or debilitated, because of the danger of
cardiac or respiratory depression, as well as to those patients with
hemorrhage, severe impairment of hepatic, respiratory or renal function,
hypothyroidism, Addisons' disease, prostatic hypertrophy or urethral
stricture.
Headache: Because headache often involves a significant psychological
component, a narcotic analgesic should only be employed for the
treatment of headache when no other treatment is effective, in order to
minimize the risk of psychological and physical dependence.
Drug interactions: The CNS depressant effects of PERC0CET may be
additive with those of other CNS depressants. See WARNINGS.
Other: Patients should be instructed to store PERC0CET, as for any
medication, safely out of the reach of children.
>
ADVERSE REACTIONS: The most frequently observed adverse reactions
include light-headedness, dizziness, sedation, nausea and vomiting.
These effects seen* to be more prominent in ambulatory than in non
ambulatory patients, and some of these adverse reactions may be
alleviated if the patient lies down.
Other adverse reactions include euphoria, dysphoria, constipation and
pruritus.
SYMPTOMS AND TREATMENT OF 0VER00SAGE: Signs and symptoms:
Serious overdosage with PERC0CET is characterized by respiratory
depression (a decrease in respiratory rate and/or tidal volume. CheyneStokes respiration, cyanosis), extreme somnolence progressing to stupor
or coma, skeletal muscle flaccidity, cold and clammy skin, and
sometimes bradycardia and hypotension. In severe overdosage, apnea,
circulatory collapse, cardiac arrest and death may occur. The ingestion
of very large amounts of PERC0CET may, in addition, result in acute
acetaminophen intoxication, characterized by anorexia, nausea, vomiting
and sweating within two or three hours of ingestion, and possibly cyanosis
with methemoglobinemia. Within 48 hours, liver function tests rise
abnormally, and the liver becomes enlarged and tender. Within three to
five days jaundice, coagulation defects, myocardiopathy, encephalopathy,
and renal failure occur, followed by death due to hepatic necrosis. The
ingestion of 10 g of acetaminophen is considered to result in intoxication,
with the possibility of a fatal outcome if the amount exceeds 15 g.
Hepatotoxicity occurs when plasma levels of 300 jig/m l are observed
within four hours of ingestion.
Treatment: Primary attention should be given to the re-establishment of
adequate respiratory exchange through provision of a patent airway and
the institution of assisted or controlled ventilation. The narcotic antagonist
naloxone is a specific antidote against the respiratory depression which
may result from overdosage or unusual sensitivity to narcotics, including

oxycodone. Therefore, an appropriate dose of this antagonist should be
administered, preferably by the intravenous route, simultaneously w jttK
efforts at respiratory resuscitation. Since the duration of action of
oxycodone may exceed that of the antagonist, the patient should be kept
under continued surveillance and repeated doses of the antagonist shoatd *
be administered as needed to maintain adequate respiration. The
instructions contained in the package insert provided by the manufacturer.
should be carefully observed.
An antagonist should not be administered in the absence of clinically
significant respiratory or cardiovascular depression.
Oxygen, intravenous fluids, vasopressors and other supportive J
measures should be employed as indicated.
1
Gastric emptying by emesis or lavage may be useful in removing v
unabsorbed drug, and should be carried out at an early stage of
treatment. Plasma levels of acetaminophen should be determined* If
hemodialysis is carried out within ten hours of ingestion, it may be of
some value.
|
The drug PARV0LEX® (N-acetylcysteine, Allen & Hanburys) is a spe# fic*V
antidote for acetaminophen intoxication. For directions for use, refer to
the manufacturer's Product Monograph or the CPS.
^
DOSAGE AND ADMINISTRATION: Dosage should be adjusted according
to the severity of the pain and the response of the patient. It may
occasionally be necessary to exceed the usual dosage recommended
below in cases of more severe pain or in those patients who have become
tolerant to the analgesic effect of narcotics. The usual adult dose is one
tablet every six hours as needed for pain.
DOSAGE FORMS: PERC0CET, supplied as white, scored tablets each
containing oxycodone hydrochloride, 5.0 mg and acetominophen 325^ng.*
in bottles of 100 and 500 tablets. Also available as PERC0CET-DEMI,
containing half the amount of oxycodone, and with the same amount of
acetaminophen, in bottles of 100 tablets.
Precaution: This product has the
potential for being abused.______
Full product monograph available on request

Du Pont Pharmaceuticals
Mississauga,
Ontario L5M 2J4
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Acetaminophen +

Oxycodone

One tablet usually relieves pain w ithin 15 minutes
And pain stays away for up to 6 hours
W ith less risk of constipation than codeine
Or gastrointestinal disorders like ASA
Du Pont P h a r m a c e u tic a ls
Precaution: This product has the
potential fo r b e in g abused.______

Mississauga, Ontario L5M 2 J4
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PIPRACIL

piperacillin
sodium

An Extended Spectrum of Activity

Pipracil is an effective advanced agent for
gram negative, gram positive and
anaerobic infections.
Pipracil (piperacillin sodium) is a major
advance in presumptive antibiotic therapy.
The bactericidal spectrum of Pipracil is
broader than other antibiotics, such as the
aminoglycosides, cephalosporins, penicillins
and clindamycin. Yet Pipracil has an excel
lent clinical safety profile, with a low sodium
content and with no reported nephrotoxicity,
ototoxicity or pseudomembranous colitis.
In addition, Pipracil achieves excellent
concentrations in body tissues and fluids.
By providing a high degree of efficacy

in a wide range of mixed infections, Pipracil
is a logical therapeutic alternative for pre
sumptive therapy in surgery, urology and
gynecology, including patients with
impaired host defences.
|)|
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A / ^ * ¥ ¥ The Spectrum of a
l l .
>11 v Combination in
One Advanced Agent

/

Cyanamid Canada Inc.
Toronto
•Pipracil is a trade mark of Ledcrle Piperacillin, Inc.
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PIPRACIL

efacillin sodium

tertbAntibiotic for Intravenous and Intramuscular Use
*TI0N$ AND CLINICAL USES: Treatment of serious infections caused by susceptible strains of the designated
•Isms in the conditions listed below.
fra-Abdominal Infections including hepatobiliary and surgical infections caused by Escherichia coli. Pseudos aeruginosa, enterococci. Clostridium sp„ anaerobic cocci, and Bacteroides sp., including B. fragilis.
Uruary Tract Infections (complicated and uncomplicated) caused by Escherichia coli, Klebsiella sp., Pseudomonas
lirrcsa, Proteus mirabilis and enterococci. Also uncomplicated urethritis caused by Neisseria gonorrhoeae.
Gynecological Infections including endometritis and pelvic inflammatory disease caused by Bacteroides sp.,
JingB. fragilis, anaerobic cocci, Neisseria gonorrhoeae, and enterococci (Streptococcus faecalis).
Septicemia caused by Escherichia coli, Klebsiella sp., Serratia sp., Proteus mirabilis, S. pneumoniae, enterococci,
jomonas aeruginosa, Bacteroides sp., and anaerobic cocci.
Lowgr Respiratory Tract Infections caused by Escherichia coli, Klebsiella sp., Enterobacter sp., Pseudomonas
jinosa, Serratia sp., Haemophilus influenzae, Bacteroides species and anaerobic cocci. Although improvement
leen noted in patients with cystic fibrosis, lasting bacterial eradication may not be achieved.
^ n aad Skin Structure Infections caused by Escherichia coli, Klebsiella sp., Serratia sp., Acinetobacter sp,
jbacter sp., Pseudomonas aeruginosa, indole-positive Proteus sp., Proteus mirabilis, Bacteroides sp., including
igilis, anaerobic cocci and enterococci.
Bo#s and Joint Infections caused by Pseudomonas aeruginosa, enterococci, Bacteroides sp.. and anaerobic cocci.
PIPRACIL* is useful for the treatment of mixed infections and presumptive therapy prior to the identification
causative organisms; infections produced by organisms resistant to other penicillins, some aminoglycosides
leptaiosporins; and infections at various sites caused by streptococcus species including Group A beta-hemoStreptococcus and Streptococcus pneumoniae.
PIPRACIL* may be administered as single drug therapy in some situations where normally two antibiotics
t bffemployed. In vitro synergism has been shown between Piperacillin and some aminoglycosides in some
jrial strains. PIPRACIL* has been used clinically with aminoglycosides, especially in patients with impaired host
ices. Both drugs were used in full therapeutic closes.
PfPRfiCIL* can be used safely in combination with a penicillinase-resistant penicillin, e.g. oxacillin, in mixed
tions when beta-lactamase-positive Staphyloccus aureus is isolated along with piperacillin-susceptible
niqpis. It may be administered concomitantly with a cephalosporin, provided that an additive or synergistic
acterial action of the two antibiotics is ascertained through in vitro tests. Based on in vitro data, cefoxitin should
le given with piperacillin when Pseudomonas infections are suspected or confirmed.
I^eciiiise PIPRACIL* is excreted not only renally, but also by the biliary route, it can be used in patients with
tobiliary infections, or severely restricted kidney function, and in patients who have had nephrotoxic reactions
her drugs, with appropriate adjustment of dosage (See DOSAGE).
Api&opriate cultures should be made for susceptibility testing before initiating therapy and therapy adjusted,
propriate, once the results are known.
RAINDICATIONS: A history of allergic reactions to any of the penicillins and/or cephalosporins,
ttftssfSerious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients
lying therapy with pencillins. These reactions are more apt to occur in persons with a history of sensitivity to
iple allergens.
Cross-sensitivity of patients to penicillins and cephalosporins has been reported. Before initiating therapy with
ACILT careful inquiry should be made concerning previous hypersensitivity reactions to penicillins, cephalospoand other allergens.
If an allergic reaction occurs, the antibiotic should be discontinued.
SERIOUS ANAPHYLACTOID REACTIONS REQUIRE IMMEDIATE EMERGENCY TREATMENT WITH EPINEPHRINE,
i p i * INTRAVENOUS STEROIDS, AIRWAY MANAGEMENT, INCLUDING INTUBATION, SHOULD ALSO BE ADMINIS*D AS NECESSARY.
IUTI0NS: Bleeding manifestations have occurred in some patients receiving beta-lactam antibiotics including
iciliin. These reactions have sometimes been associated with abnormalities of coagulation tests such as
lg time, platelet aggregation and prothrombin time and are more likely to occur in patients with renal failure,
f bleeding manifestations or significant leukopenia occur. PIPRACIL* should be discontinued and appropriate
bpy instituted.
The possibility of the emergence of resistant organisms and the development of superinfections should be
in mind, particularly during prolonged treatment.
Aswith other penicillins, patients may experience neuromuscular excitability or convulsions if higher than
mmended doses are given intravenously.
Dosage adjustment should be made in renal insufficiency.
PIPRACIL* is a monosodium compound containing 1.98 milliequivalents (45.5 mg) of Na+per gram based on
;ontent which includes the U.S.P. allowed average. The calculated value, based on molecular weight is 1.85
J q (42 55 mg.). Periodic electrolyte determinations should be made in patients with low potassium reserves
the possibility of hypokalemia should be kept in mind with patients who have potentially low potassium
ves, receiving cytotoxic therapy or diuretics. Electrolyte and cardiac status should also be monitored during
ngecMreatment in patients with impaired cardiac function.
Prior to treatment, patients with gonorrhea should also be evaluated for syphilis. Specimens for darkfield
| ination should be obtained from patients with any suspected primary lesions, and serologic tests should be
irlired. In all cases where concomitant syphilis is suspected, monthly serological tests should be made for a
mum of 4 months.
I The use of some penicillins (ampicillin, amoxicillin) has been associated with morbilliform rashes in some
& oPTnfectious mononucleosis. PIPRACIL* should be used with caution in the treatment of patients with infecs mononucleosis.
Interactions:The mixing of PIPRACIL* with an aminoglycoside in vitro can result in substantial inactivation of the
noglycosides.
je During Pregancy or Lactation: Safety of PIPRACIL* use in pregnant women has not been determined. Because
aal reproduction studies are not always predictive of human response, this drug should be used during pregnancy
n f clrarly needed. It has been found to cross the placenta in rats. Caution should be exercised when PIPRACIL*
Jministered to nursing mothers. It is excreted in low concentrations in milk.
itr,ic Use: Dosages for children under the age of 12 have not been established.
ERSE REACTIONS: PIPRACIL* is generally well tolerated. The most common adverse reactions have been local in
ire, following intravenous or intramuscular injection. The following adverse reactions may occur:
J-ocg! Reactions - In clinical trials thrombophlebitis was noted in 3.8%of patients. Pain, erythema, and/or indurafat the injection site in 1.9% of patients. Less frequent reactions: ecchymosis, deep vein thrombosis and
atomas.
Hypersensitivity Reactions-Rash was noted in 1.9% of patients. Drug fever 2.1%. Less frequent findings: pruitis,
icuiar eruptions, positive Coombs tests.
Gastrointestinal - Diarrhea and loose stools were noted in 2.8% of patients. Less frequent reactions: vomiting,
•fca, tftoody diarrhea.
| Hepatic - Increases in liver enzymes (LDH, SGOT, SGPT), hyperbilirubinemia. Rarely, cholestatic hepatitis.
I Penal-Elevations of creatinine or BUN.
Central Nervous System - Headache, dizziness, fatigue.
Hemic and Lymphatic-Reversible leukopenia, neutropenia, thrombocytopenia and/or eosinophilia, bleeding and
teases in prothrombin time have been reported. Reversible leukopenia (neutropenia) is more apt to occur in
fcntsVeceiving prolonged therapy at high dosages or in association with drugs known to cause this reaction.
Serum Electrolytes - Individuals with liver disease or individuals receiving cytotoxic therapy or diuretics, were
irteArarely to demonstrate a decrease in serum potassium concentrations with high doses of PIPRACIL*
Musculo-Skeletal- Rarely, prolonged muscle relaxation.
l Other-Superinfection, including candidiasis.
bGt ,$D ADMINISTRATION: PIPRACIL* may be administered by the intramuscular route or intravenously by injec
tor infusion. Dosage and route of administration should be determined by the severity of the infection and
iJition of the patient. The usual dosage for serious infections is 3 to 4 grams given every 4 to 6 hours as a 20 to 30
kittt infusion administered intravenously.
rThe maximum daily dose usually administered to adults is 24 g/day, although higher doses have been used.

Type of Infection
Serious infections such as septicemia, nosocomial pneumonia, intraabdominal infections, aerobic and anaerobic gynecologic infections,
and skin soft-tissue infections.
Complicated urinary tract infections.
Uncomplicated urinary tract infections and most community-acquired
pneumonia.
Uncomplicated gonococcal urethritis.
*One gram of probenecid given orally 1/2 hour prior to injection.
Dosage In Renal Impairment
Urinary Tract
Urinary Tract
Creatinine
Infection
Infection
Clearance
(complicated)
(uncomplicated)
mL/min.
>40
20-40
<20

Usual Total
Daily Dosage
12-18 gl.V.
(200-300 mg/kg)

Frequency of
Administration

8-16 gl.V.
(125-200 mg/kg)
6-8 g I.M. orl.V.
(100-125 mg/kg)
2 g I.M*

Every 6 to
8 hours
Every 6 to
12 hours
Single dose

Every 4 to
6 hours

Serious Systemic
Infection

No dosage adjustment necessary
No dosage adjustment necessary

12 g/day 4 g every 8 hrs.
9 g/day 3 g every 8 hrs.
8 g/day 4 g every 12 hrs.
6 g/day 3 g every 12hrs.
6 g/day 3 g every 12 hrs.
Hemodialysis removes 30-50% of piperacillin in 4 hours;
6 g/day 2 g every 8 hrs.
1 g additional dose should be administered following each dialysis period.

Patients on
Hemodialysis*
For patients with renal failure and hepatic insufficiency, measurement of serum levels of PIPRACIL* will provide
additional guidance for adjusting dosage.
Infants and Children - Dosages in infants and children under 12 years of age have not been established.
The average duration of PIPRACIL* treatment is from 7 to 10 days, except for gynecologic infections, in which
it is from 3 to 10 days; the duration should be guided by the patient’s clinical and bacteriological progress. For most
acute infections, treatment should be continued for at least 48 to 72 hours after the patient becomes asympto
matic. Therapy for Group A beta-hemolytic streptococcal infections should be maintained for at least 10 days to
reduce the risk of rheumatic fever of glomerulonephritis.
ADMINISTRATION
Intramuscular: When indicated by clinical and bacteriological findings, intramuscular administration of 6 to 8 g. daily
of PIPRACIL* in divided doses, may be utilized for initiation of therapy and this route may be considered for m ainte
nance therapy after clinical and bacteriologic improvement has been obtained with intravenous piperacillin sodium
treatment. Administration should not exceed 2 g. per injection at any one site.This route has been used primarily in
the treatment of patients with uncomplicated gonorrhea and urinary tract infections.
Adults and Children MoreThan 12 Years of Age: The reconstituted solution is given by deep intramuscular injection. The
preferred site of injection is the upper outer quadrant of the buttock (i.e. gluteus maximus). Also may be given in the
mid-lateral muscles of the thigh. The deltoid area should be used only if well developed, and then only with caution
to avoid radial nerve injury. Intramuscular injection should not be made into the lower or mid-third of the upper arm.
Intravenous: The intravenous route should be used in the treatment of serious infections.
Direct Intravenous (Bolus) Injection:The vials should be reconstituted with 5 mL of suitable diluent listed below
and the resulting solution should be injected slowly over a period of 3 to 5 minutes to help avoid vein irritation.
Intravenous Infusion: A dilution of at least 15 mL per gram is recommended to reduce potential for vein irritation.
The reconstituted and diluted solution may be administered by intermittent or continuous drip. Intermittent infusion
should be administered over a period of about 30 minutes. During intermittent infusion it is desirable to discontinue
the primary intravenous solution. Any unused portion must be discarded. For continuous infusion the solution may
be administered over a longer period of time.
RECONSTITUTION
For Intramuscular Use: Solutions for Reconstitution: Sterile Water for Injection, or if required
*Bacteriostatic Water for Injection,
**Lidocaine HC1 0.5 or 1% (without epinephrine)-For Intramuscular Use Only.
For Intravenous Use: Solutions for Reconstitution: Sterile Water for Injection, or if required,
‘ Bacteriostatic Water for Injection.
•Either parabens or benzyl alcohol.
**Lidocaine HC1 is contraindicated in patients with a known history of hypersensitivity to local anesthetics of
the amide type.
RECONSTITUTION TABLE
Approximate
Approximate
VOLUME OF
Product
Average Concentration
Available Volume
Diluent to be added
Size
1 g/2.5 mL
5.0 mL
4.0 mL
Vials 2 g
1 g/2.5 mL
7.5 mL
6.0 mL
3g
1 g/2.5 mL
10.0
mL
7.8
mL
4g
Infusion Bottles
17 mL
15 mL
3g
23 mL
20 mL
4g
The prepared solution may be further diluted to the desired volume with any of the solutions for intravenous
infusion listed below.
The contents of the 3 and 4 g infusion bottles should be diluted to at least 15 mL per gram.
The appropriate quantity of reconstituted solution may be added to an intravenous bottle or bag containing
any of the solutions for intravenous infusion listed below.
Solutions for Intravenous Infusion:
Intravenous Admixtures:
Intravenous Solutions:
Normal Saline (+KCL 40 mEq).
5% Dextrose in Water [D5W]
5% Dextrose/Water [D5W] (-H<CL 40 mEq).
0.9% Sodium Chloride (Normal Saline) [NS].
5% Dextrose/Normal Saline [D5NS] (+KCL 40 mEq).
Dextrose 5% and 0.9% Sodium Chloride [D5NS].
Ringer’s Injection, U.S.P. (+KCL 40 mEq).
Lactated Ringer's Injection, U.S.P.
Lactated Ringer’s Injection, U.S.P. (+KCL 40 mEq).
Dextran 6% in 0.9% Sodium Chloride.
STABILITY OF SOLUTIONS: PIPRACIL* is stable in both glass and plastic containers when reconstituted with recom
mended diluents and further diluted with the indicated intravenous solution and intravenous admixtures.
Stability studies have demonstrated chemical stability (pH, potency and clarity) through 24 hours at room
temperature and up to 72 hours refrigerated. Appropriate consideration of aseptic technique, however, recom
mends discarding unused portions after storage for 24 hours at room temperature or 48 hours refrigerated. If used
as a multi-dose container, the vials must be reconstituted only with the bacteriostatic diluents noted above.
INCOMPATIBILITY: Because of chemical instability, PIPRACIL* should not be used for intravenous administration with
solutions containing sodium bicarbonate
PIPRACIL* should not be added to blood products, protein hydrolysates or amino acids.
When PIPRACIL* is given concurrently with aminoglycosides, it is recommended that both drugs be used in full
therapeutic doses, but administered separately. PIPRACIL* should not be mixed with an aminoglycoside in a
syringe or infusion bottle, since this can result in inactivation of the aminoglycoside.
DOSAGE FORMS: PIPRACIL* (sterile, lyophilized piperacillin sodium) is available in vials containing amounts of pipera
cillin sodium equivalent to 2 ,3 and 4 grams of piperacillin. Available in boxes of 12 vials.
Product Numbers: 2 g /v ia l-3879-48 3 g/vial-3882-49 4 g/vial-3 8 8 0 -5 0
Available in 100 mL size infusion ("piggyback") bottles, containing sterile, freeze-dried piperacillin sodium
powder equivalent to 3 and 4 grams of piperacillin. Boxes of 12 infusion bottles.
Product Numbers: 3 g /b o ttle s-3882-41 4 g /b o ttle s-3880-42
Piperacillin Sensitivity Discs impregnated with 100 ug of piperacillin are also available.
Storage:
PIPRACIL* vials and infusion bottles should be stored at controlled room temperatures of 15-30°C (59-86°F).
Piperacillin Sensitivity Discs should be refrigerated upon receipt. Product Monograph available on request.
•PIPRACIL is a trade mark of Lederle Piperacillin, Inc.
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Long-Term Results of Proximal Gastric Vagotomy
Proximal gastric vagotomy without
drainage for duodenal ulcer was perform
ed in 304 patients between 1969 and
1977. There was one operative death
(0.3% ) and two patients required secon
dary drainage (0.6% ). Eleven patients
died subsequently of unrelated causes.
Follow-up 5 to 13 years after operation
was conducted on 242 patients (80%).
Of these, 141 were asymptomatic and
48 had only trivial symptoms, a success
rate of 78% . Thirty-two patients had
recurrent ulcer and 2 of them had
Zollinger-Ellison syndrome. When these
two were excluded, the recurrence rate
was 12.4% . Two patients had
duodenitis.
Seven patients had unexplained pain
and some of them may ultimately be
shown to have recurrence. Appreciable
esophageal reflux was seen in eight pa
tients. Other symptoms, nearly all mild,
were dumping in one, diarrhea in seven
and bile reflux in six.
Recurrent ulcer was treated by
cimetidine initially in all 32 cases but
ultimately by repeat vagotomy and an
trectomy in 27, with no deaths and only
one further recurrence (Zollinger-Ellison
syndrome). After operative correction,
the ultimate success rate (Visick grades I
and II) was 90% .
Entre 1969 et 1977, une vagotomie
gastrique proximate sans drainage a ete
pratiquee chez 304 patients. Un patient
est decede peroperativement (0.3% ) et
deux patients (0.6% ) ont necessity un
drainage secondaire. Onze patients sont
decedes par la suite, de causes n'ayant
aucun rapport avec ('intervention. Un
examen de controle a 6t6 effectue de 5 a
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13 ans apres I'operation chez 242 pa
tients (80% ). De ceux-ci, 141 etaient
asymptomatiques et 48 n'avaient que
des symptomes banals, pour 78% de
bons resultats. Trente-deux patients
avaient eu une recidive ulcereuse et 2
souffraient du syndrome de ZollingerEllison. En excluant ces deux derniers le
taux de recidive s'etablit a 12.4% . Deux
patients souffraient de duod6nite.
Sept patients se plaignaient de
douleurs inexpliquees et il est possible
que, dans le futur, on constate chez eux
une recidive. Un reflux gastrique ap
preciable a ete observe chez huit pa
tients. Les autres symptomes, presque
tous benins, comprennent "dumping"
chez un, diarrhee chez sept et reflux
biliaire chez six.
Les 32 cas de recidive ulcereuse ont
6te traites initialement a la cimetidine
mais 27 d'entre-eux ont finalement eu
une deuxi&me vagotomie avec antrectomie; il n'y eut aucun autre d£c£s et
une seule autre rechute (un syndrome de
Zollinger-Ellison). Apres correction
operatoire le taux final de bons resultats
(les grades I et II I'echelle de Visick)
s'etablit 90% .

h

&

operative death (0.2%). Primary drainage
was required in 25 patients with stenosis
of the gastric outlet. Of these operations, v
304 were performed more than 5 years
ago; 11 patients have died of various ,,
unrelated causes and 242 patients (80%)
have now been followed up for between-*
5 and 13 years.
Recurrence
*

*

Ulceration recurred in 32 patients 4
(13.2%), but 2 of these were shown to
have Zollinger-Ellison syndrome and* *
should probably be excluded, leaving a
corrected recurrence rate of 12.4%. In *
published follow-up data, exceeding 5
years, of 1370 patients from seven dif
ferent countries, the mean recurrence rate
was 13.1% ,soour experience appears to
be average. Much lower recurrence rates
have been reported by individual
surgeons, giving their personal experi- v
ence.7 There are no published random
ized, controlled data comparing recur- -y
rences after proximal gastric vagotomy
with those 5 or more years after truncal -* vagotomy and drainage.
The clinical results were expressed as *
modified Visick gradings, in which grades
I and II are regarded as successful, and"
are shown in Table I. The success rate was 4
78.1%, but it should be noted that 58%
were graded Visick I, indicating that the ,
patients had no symptoms of any kind.
The Visick II patients had various vague -<
symptoms, including a feeling of fullness
in many cases. This was due to loss o f’*
receptive relaxation of the gastric fundus.

Sixty-two years ago, Andre Latarjet1
described the principal nerves of the lesser
curve and 14 years ago, Amdrup and
Jensen2 and Johnston and Wilkinson3
independently introduced the operation
of parietal cell, highly selective or prox
imal gastric vagotomy without drainage.
This operation has gradually been ac
cepted in many countries; in many parts
of the United Kingdom and Scandinavia
it is now regarded as the operation of Side Effects
choice for chronic uncomplicated
The objective when proximal gastric
duodenal ulcer. The results, in terms of
eliminating side effects, have been
excellent4 but over the long term, recur
rence rates of about 20% have been
Table 1—Clinical Results of
reported.5’6
Proximal Gastric Vagotomy
P atients and Findings

Visick
grade
1
II
III
IV

No. of patients

(n > 242)
141
48
17
36

Success A ->
(failure), %

78.1
I performed my first proximal gastric
vagotomy in 1969 and in my unit this
(21.9)
operation has now been performed by
various surgeons in 512 patients, with one
VOLUME 27, NO. 4, JU LY 1984 / THE CANADIAN JOURNAL OF SURGERY

f

L i

vagotomy was introduced was to elim
inate troublesome side effects — namely
dumping, bile reflux and vomiting and,
*..► in particular, postvagotomy diarrhea. The
number of side effects is shown in Table
► II; in only one patient were the symptoms
sufficiently severe to warrant a Visick
► ^grading other than II, which indicates
. qualified success. Of the seven who had
^ diarrhea, this symptom followed chole^ cystectomy in two; the combination of
cholecystectomy and vagotomy is known
». to be diarrheogenic. It should be
remembered that many healthy patients
>-with neither ulcer nor operation ex
perience similar symptoms from time to
*• time.4

' v Failures

The failures are analysed in Table III.
y *.The absolute failures (Visick grade IV) in
clude the 32 patients with recurrence
► already noted and 2 patients with
duodenitis but no ulceration. Two other
* * patients had gastric retention in the early
postoperative period and required draink age; they subsequently did well.
A i The qualified failures (Visick grade III)
I were a heterogeneous group. In seven
k there was abdominal pain but no en
doscopic or other evidence of recurrence.
Some of these patients as well as the two
with duodenitis may ultimately be found
■to have a recurrent ulcer. One patient had
moderate diarrhea, but it was probably
* due to the irritable bowel syndrome. The
most important problem has been eso
phageal reflux. It is scarcely surprising
y that hiatus hernia or reflux may occur
after the manipulation required to bare
>

at least 5 cm of esophagus. It is tempting,
and indeed easy, to add a Nissen fundoplication8 but we found three instances
of lesser curvature necrosis, in patients
operated on after this series was com
pleted, when proximal gastric vagotomy
and fundoplication were combined.9
This may have been due to the “ bloat syn
drome” and could perhaps have been
avoided by ensuring that the wrap around
was “ floppy” . Another alternative is the
Hill procedure as modified by Oster and
colleagues.10
Comments
W hat can be done for the failures?
Most experienced surgeons recognize that
dumping, diarrhea and bile reflux can be
extremely difficult to treat, but in this
series the major problem was the manage
ment of recurrent ulcer. We have had on
ly limited success with cimetidine and
ranitidine and more than half of our pa
tients have eventually required a second
operation. The Nashville school11 has
shown that vagotomy with antrectomy as
a primary procedure has a very low recur
rence rate so it is rational to treat recur
rent ulcer by repeat vagotomy and
antrectomy.12 We used this procedure in
104 patients after all types of vagotomy;
there was one operative death, in an
emergency procedure, and only two fur
ther recurrences. Thus, recurrent ulcer
can be well controlled by adequate fur
ther surgery. After correction of the
failures by medical or surgical treatment,
the ultimate clinical grading shows a 90%
success rate (Table IV).
The somewhat high recurrence rate that

*-

r

Table II—Late Side Effects after
Proximal Gastric Vagotomy in 242 Patients
Followed up for 5 to 13 Years

►

r

y

r

Side effect

No. (%)

Dumping
Diarrhea
Bile reflux

1 (0.4)
7* (2.9)
6 (2.5)

*Two followed cholecystectomy.

Table IV—Corrected Clinical Grading
(after Treatment of Failures),
5- to 13-Year Follow-up
Success
(failure), %

Visick
grade

No. of
patients

I
II
III
IV

162
55

i
J

90

21
4

1
J

(10)

r ►
Table Ill-Causes of Failure

r

Visick grade

y ►
r

s ^

i
d

>

Cause
Unexplained abdominal pain
Esophageal reflux
Diarrhea
Psychogenic
Recurrent ulcer
Duodenitis
Retention
*2 with Zollinger-Ellison syndrome.

)

Ill
(n - 17)
7
8
1
1
—
-

-

IV
In - 36)
-

32*
2
2

we have experienced leads us to ask
whether there are any technical modifica
tions that should be applied. We did not
employ intraoperative tests o f com
pleteness of vagotomy, although evidence
supporting the use of Burge13 or Grassi
tests14 appears convincing.
We have not used proximal gastric
vagotomy for gastric ulcer and perforated
or bleeding ulcer often enough to make
any worthwhile comment. For pyloric
stenosis, we initially added pyloroplasty
but we have now combined proximal
gastric vagotomy with duodenoplasty15
in 44 patients; in 5 of these, the ulcer
ultimately recurred but only 1 had further
obstructive symptoms.
From this experience we conclude that
proximal gastric vagotomy is a safe pro
cedure and the undesirable side effects of
truncal vagotomy with drainage are vir
tually eliminated. Esophageal reflux may
be a problem and its management is still
not clearly defined. The great problem is
recurrent ulcer but this can be controlled
by either medical or surgical treatment so
that the ultimate failure rate is only 10%.
Proximal gastric vagotomy is surely here
to stay.
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NEW VIVON EX* TEN.
TO TAL ENTERAL N U TR ITIO N

“
« 4

Introducing a new formula for patients who
need more than maintenance nutrition.
Vivonex T .E .N . is total nutrition via the
enteral route. It reverses catabolism by
producing a positive nitrogen balance to
aid wound repair...restore lean
body mass...speed recovery...
and shorten hospital stay.
New Vivonex T .E .N . is the
only enteral formula that
combines:

Enhanced Nitrogen Utilization
A high essential: nonessential
amino acid and branched-chain
amino acid content, together
with a calorie: nitrogen ratio
of 175:1 provide enhanced
nitrogen utilization.

Improved G l Tolerance
4
An osmolality comparable to that of peptide - ,
diets provides better G l tolerance. As for
fat content, the low (but adequate) fat
|
level does not alter gastric empty" 4
ing, thereby reducing the danger of aspiration, and making feeding
through a small bore tube possible.
^

t

4

Complete N utrition
^
Vivonex T.E .N . provides complete
nutrition including trace
!
elements in an elemental form,
a
Th is means there is little or
„
no digestion required by the
already stressed patient.
•*

.,

k

VIVONEX T.E.N.
Total Enteral Nutrition.
To reverse catabolism
speed recovery
shorten hospital stay.
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Arterial Injuries
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f
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►The authors review arterial injuries in 68
patients treated at Maisonneuvey ^Rosemont Hospital in Montreal between
1975 and 1982. Penetrating trauma
^ caused 54.4% of these injuries, which
consisted of either laceration or intimal
tear with thrombosis. Arterial injuries of
k the extremities were predominant
(58.8% ). Associated injuries were fre4 *quent. Surgical repair was effected in 60
l
patients. End-to-end anastomosis,
* angioplasty and venous or prosthetic
bypass grafting were the techniques
used. Postoperative complications occur. _ red in 37% of the patients. Overall mor
tality was 19% and was related mainly
►to aortic injury. The amputation rate for
arterial injuries of the extremities was
b *15% . Prompt recognition and treatment
of arterial injuries are important in order
* to achieve the best results.
Durant la periode de 1975 h 1982, 68
^ patients furent traites pour traumatisme
arteriel a I'hopital Maisonneuve, tftosemont. Les plaies penetrantes
causerent 54.4% de ces traumatismes.
v La laceration partielle ou complete et la
rupture intimale avec thrombose furent
y r les deux types de lesions rencontrees. La
proportion de traumatisme arteriel des
^extremites fut de 58.8% . Les
^traumatismes associes furent frequents.
Une correction chirurgicale fut pratiquee
r chez 60 patients. Les techniques
utilisees furent: I'anastomose termino- * terminate, I'angioplastie et le bypass
veineux ou synthetique. Le taux de com
y

plications postoperatives fut de 37% . La
mortality .totale fut de 19% et en relation
avec les traumatismes aortiques. Le taux
d'amputation pour les traumatismes
arteriels des extremites fut de 15% . Le
diagnostic e» le traitement des
traumatismes arteriels doivent etre des
plus precoces si I'on veut obtenir des
rgsultats favorables.

This study reviews 68 cases of arterial
trauma treated at the MaisonneuveRosemont Hospital in Montreal from
1975 to 1982. Most patients were less than
50 years old. The anatomical distribution
of the injuries is illustrated in Fig. 1.
Arterial injuries of the extremities were
predominant (58.8%) followed by those
of the abdomen, neck and thorax.
The two main types of arterial injury
encountered were partial or complete
laceration (64.7%) and intimal tear with
thrombosis (33.8%). Penetrating injuries
resulting from gunshot and stab wounds
and motor vehicle accidents were respon
sible for 54.4% of the cases.
Hypovolemic shock was frequently
present. Injuries to the central nervous
system, abdominal contents and bones
were common. The clinical presentation
was acute in all patients but one who had
a chronic pseudoaneurysm of the right il

iac artery caused by blunt abdominal
trauma. Trauma to arteries of the trunk
was characterized by hypovolemic shock
associated with multiple organ injuries.
Varying degrees of acute ischemia and
hemorrhage were the two classic accom
paniments of arterial injuries to the
extremities.
Surgical repair was carried out in 60 pa
tients; in the other 8, the clinical situation
precluded any arterial reconstruction. The
surgical techniques used were debride
ment and end-to-end anastomosis (16 pa
tients), angioplasty (8), saphenous bypass
grafting (16), prosthetic bypass grafting
(13), ligation (3), nephrectomy (2) and ex
ploration (2). All arterial injuries in the
limbs were treated with the first two
techniques. Prosthetic material was usual
ly required to repair aortic injuries.
There were 25 (37%) postoperative
complications and 13 deaths (19%) (Table
I). These high rates well reflect the severi
ty and the magnitude of these injuries.
The mortality of 19% was related main
ly to aortic injuries. Arterial injuries of
the extremities were associated with a
15% amputation rate.
To some extent, each anatomical region
had its own features, and accordingly they
will be reviewed separately.1

Carotid Arteries
A direct blow to the neck and severe
hyperextension of the cervical spine were

Table 1—Complications and Mortality
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FIG. 1—Anatomical distribution of arterial
injuries.

Complication/death

No.

Death
Neurologic sequelae
Central
Peripheral
Major amputation
Compartment syndrome
Causalgia
Crush syndrome
Pulmonary embolism
Pancreatic fistula

13
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6
3
2
1
1
1

343

responsible for carotid (common and in
ternal) artery injuries in eight patients.
These injuries produced intimal tears with
secondary thrombosis. When first seen,
the majority o f these patients already had
a neurologic deficit, indicating the
presence o f the lesion. In the presence of
a recent deficit, surgery was carried out
only in one patient with a circumferen
tial intimal tear of the carotid bifurcation
and partial thrombosis. One patient had a
stab wound o f the common carotid
artery. Surgical treatment in this case in
cluded lateral suture of the carotid artery.
Important neurologic sequelae ensued in
three patients (33%).
Thoracic Aorta
In a group of seven patients with
deceleration injury, four who were in
stable condition with contained rupture
o f the thoracic aorta had a successful
operation. In contrast, three patients with
free aortic rupture died o f hypovolemic
shock despite aggressive resuscitation and
attempted surgical repair. Early diagnosis
and treatment are most important if this
situation is to be avoided. Surgical treat
ment included grafting the defect; a tem
porary shunt was used in most patients.
One patient with a stab wound o f the aor
tic arch is also reported.
Abdominal Arteries
Penetrating injuries predominated
(56.5%) in these 11 patients with ab
dominal arterial trauma. Associated in
juries occurred in all cases and involved
the majority o f intra-abdominal organs.
Hypovolemic shock was frequent (63.6%).
Surgical treatment included aortic repair
in two patients, nephrectomy in two and
angioplasty in one patient. Iliac artery
bypass was performed in three patients.
Two patients with gunshot wounds o f the
aorta died during the operation. Mortality
was 45.4% and was related to prolonged
and severe preoperative shock associated
with aortoiliac injuries.
Arterial Injuries to the Extremities
The mechanism of injury and the types
o f arterial trauma were identical in the up
per and lower extremities in 40 patients.
Arterial laceration occurred in 66.7% of
the cases and intimal injury with throm
bosis in 33.3%. A high incidence of frac
tures and soft-tissue trauma was noted in
association with arterial injuries o f the
extremities.2 This combination had a
negative impact on the outcome in these
patients. Soft-tissue injury and associated
fractures carried, respectively, 23.5% and
33% amputation rates while in isolated
arterial trauma the amputation rate was
only 11%. Surgical treatment consisted of
344

debridement and either end-to-end
anastomosis or saphenous vein grafting.
Peripheral nerve injuries occurred in 40%
o f the patients with arterial injuries of the
upper extremities leading to chronic
disability in 26% o f them.
Angiography was done in 48.5% of the
patients. Acute ischemia and signs of
vascular involvement were the usual in
dications. The overall accuracy o f the
technique was 97%. Indications for
angiography are relative as in patients
with a single injury and acute arterial in
sufficiency. In contrast, the indication is
strong in multiple injuries o f one limb
combined with arterial insufficiency and
in patients with preexisting atherosclerotic
disease and possible arterial injury.
Suspected thoracic aortic rupture is an ab
solute indication for angiography and a
positive angiogram is essential before em
barking on a thoracotomy. Angiography
may be detrimental to those patients with
active bleeding and obvious arterial
injury.
Peripheral arterial injury associated
with limb fractures has been a subject of
controversy in regard to which injury
should be treated first. Eleven such cases
occurred in our series. In five patients, the
vascular repair was carried out before and
in six patients after the orthopedic pro
cedure. Complication and amputation
rates were comparable. The amputation
rate was 20% in patients whose vascular
injury was repaired first and 33% in the
others; this is not statistically significant.
Despite the small numbers, these results
tend to support the concept that the order
of repair must be chosen for each in
dividual case. The duration of ischemia
remains the important factor in this selec
tion. In the first 2 hours after arterial
trauma, the orthopedic procedure can be
carried out first, but after 4 to 5 hours
o f ischemic time, revascularization
becomes imperative to avoid the sequelae
and complications o f prolonged acute
ischemia. Close cooperation between the
orthopedic and vascular teams is essen
tial to achieve the best results. The Roger
Anderson or the Hoffman device was us
ed in all these patients.3
Associated peripheral nerve injuries
were found in 40% o f patients with
arterial trauma to the upper extremities
and in 12% with arterial injury in the
lower extremities. Long-term neurologic

sequelae were present in at least 12.5%
o f the patients with arterial injuries to the
lim bs.4 Treatment o f these injuries
should be carried out at the same time if
feasible. Proximal nerve injuries usually ^
carry a poor prognosis, while distal le
sions offer the best chance o f recovery..« ^
O f 40 patients with arterial injuries of
the limbs, 6 had associated venous in- -4
juries with a predilection for the popliteal
segment. Repair was carried out in four
<
patients and extensive damage precluded
any reconstruction in the other two pa
tients. The amputation rate for this group ^
o f six patients was 33%. In one patient,
who was in the ligation group, the am- .,
putation was directly related to venous
outflow occlusion and massive edema. < <
Although these numbers are too small to
draw any firm conclusion, major vein *
ligation seems to carry a substantial am
putation rate. Venous repair is probably-* 'f
as important as arterial repair at least in
critical locations such as the popliteal ^
area.
Crushing injuries, more than 6 hours
o f ischemia and associated venous injuries *
are the usual indications for fasciotomy
at the time o f the arterial repair. Three4 *
patients were in this category. In four
others without these predisposing factors, *
a compartment syndrome developed
within 48 hours of revascularization.
i
Fasciotomy through small skin in cisions_^
offers good decompression and has a
minimal effect on soft tissues, which are <
often severely traumatized. Fibulectomy,
although theoretically sound, may be ill-' advised in these circumstances.
The overall amputation rate in arterial 4
injury o f the limbs was 15%. The lower
limbs were involved in all but one am- * r
putation. Analysis o f the causes o f am- ^
putation underlines some important fac
tors such as delay in diagnosis, wound,* ,
sepsis and graft failure (Table II). Delay
in diagnosis occurred twice and led to a m --*
putation in both cases. These two patients
were transferred to our institution 3 days ' 4
and 22 hours, respectively, after injury.
|
Wound sepsis was usually secondary to
severe soft-tissue trauma associated with^ ^
multiple fractures. Due to heavy con
tamination, local edema and devitalized
tissues, infection supervened. This
necessitated amputation in two patients. < 1
Graft failure was responsible for one
j
amputation despite early re-exploration4

T a b le I I — C a u s e s o f M a jo r A m p u ta tio n
S ite
A x illa r y

No.

Cause

1

D e l a y in d i a g n o s i s ( 3 d )

F e m o ra l

1

E x t e n s iv e d a m a g e p r e c lu d in g r e p a ir , p r im a r y a m p u t a t io n

P o p lite a l

4

C ru s h s y n d ro m e
W o u n d s e p s is
D e l a y in d i a g n o s i s , v e n o u s i n j u r y , w o u n d s e p s is
G r a f t f a i l u r e , w o u n d s e p s is
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of the arterial repair. One of the most dif
ficult decisions and one that requires experience is when to amputate rather than
revascularize the limb,5 particularly in
► the case of extensively injured limbs with
loss of soft tissue and skin and with
’ v neurovascular damage. When in doubt,
^ a primary reconstruction should be at
tempted. Amputation may be done as a
h. secondary procedure if necessary.

J.F. S y m e s ,

The treatment of vascular trauma con
tinues to be an exciting challenge and re
quires much ingenuity. Application of the
modern principles of treatment has great
ly reduced the morbidity and mortality
associated with this condition.
References
1.

LlM RC JR, MILLER SE: Management o f acute civilian

m d , fr c s ic j ;

A.M. G r a h a m ,

md;

vascular injuries. Surg Clin N orth A m 1982; 62: 113-9
2. FLINT LM, R ic h a r d so n JD: Arterial injuries with lower
extremity fracture. Surgery 1983; 93: 5-8
3. RICH NM , METZ CW JR, HUTTON JE JR, BAUGH JH ,
HUGHES CW: Internal versus external fixation o f fractures
with concomitant vascular injuries in Vietnam. J Traum a
1971; 11: 463-73
4. VlSSER P A , HERMRECK A S , PIERCE GE, THOMAS JH ,
H a r d in CA: Prognosis o f nerve injuries incurred during
acute trauma to peripheral arteries. A m J Surg 1980; 140:
596-9
5. Bo le PV , P u rd y RT, M u n d a RT, M o a l l e m S,
DEVANESAN J, CLAUSS RH: Civilian arterial injuries.
A n n Surg 1976; 183: 13-23

M. M o u s s e a u ,

rn

\ Doppler Waveform Analysis versus Segmental Pressure and
> .Pulse-Volume Recording: Assessment of Occlusive Disease
►
in the Lower Extremity
k

In a prospective study, the accuracy of
A 4 combined segmental pressure
1j measurements and pulse-volume recor
dings was compared with Doppler
waveform analysis in evaluating
peripheral arterial occlusive disease.
r-Before arteriography, 50 patients (100
limbs) underwent vascular assessment
► which included measurement of the
segmental pressure and pulse volume at
' ’ the thigh, calf and ankle. Analogue
Doppler waveform tracings were
obtained from the femoral, popliteal and
tibial arteries and used to calculate the
y r
pulsatility index and inverse damping
, r factor. Results of each method were
assessed by independent observers and
r .compared with the arteriographic data.
No appreciable difference was
y
demonstrated between the two methods,
both giving an overall accuracy in the
r 9 0 % to 9 5 % range. Both accurately
predicted the severity of iliac and super
ficial femoral artery obstruction and
„ ^distinguished iliac from proximal disease
of the superficial femoral artery. Outflow
*- disease (tibial arteries) was better
assessed by measurement of segmental
f
pressures than by Doppler waveform
analysis or pulse-volume recording alone.
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Dans une etude prospective, la precision
obtenue en associant la mesure de la
pression segmentaire et I'enregistrement
du volume systolique a ete comparee a
celle de I'analyse des ondes Doppler
comme methode d evaluation des oblite
rations des arteres peripheriques.
Avant I'arteriographie, 50 patients
(100 membres) ont ete soumis a une
evaluation du systeme vasculaire comprenant la mesure de la pression seg
mentaire et du volume systolique au
niveau de la cuisse, du mollet et de la
cheville. Les traces correspondants des
ondes Doppler obtenus des arteres femorales, poplitees et tibiales ont ete utilisees pour calculer I'indice de pulsatilite
et le facteur de modulation inverse. Les
resultats de chaque methode ont ete
apprgcies par un observateur indepen
dant qui les a compares aux donnees
arteriographiques.
La precision globale rattachee a I'une
ou I'autre des deux methodes variait de
9 0 % a 9 5 % et ne differait pas de facon
appreciable. Les deux methodes sont
capables de predire avec precision la gravite des obliterations des arteres iliaques
et femorales superficielles et de distinguer entre les foyers iliaques et femoraux superficiels d'obstruction. L'obstruction de I'artere tibiale s'evalue mieux
par la mesure de la pression segmentaire
que par I'analyse des ondes Doppler ou
de I'enregistrement du volume systolique
seul.

Noninvasive evaluation has recently
assumed an increasing role in the manage
ment of patients with peripheral vascular
disease. In the 20 years since the advent
of the first Doppler velocity detector,

many types of equipment for noninvasive
investigation of vascular problems have
been developed. If the vascular surgeon
is to utilize data obtained from these in
struments to make critical clinical deci
sions, it is essential that he know the limits
of their reliability. The combination of
segmental pressure measurements and
pulse-volume recordings is perhaps the
most common approach used at present
to evaluate the arterial circulation to the
lower limbs. Various authors13 have
reported excellent results with this tech
nique. Others, 4’5 using frequency analysis
of Doppler signals, have also claimed
that the method will reliably assess arte
rial occlusive disease in the peripheral
vessels.
We have recently concluded a prospec
tive study, comparing the accuracy of
segmental pressure and pulse-volume
recording with that of Doppler waveform
analysis in a group of patients who sub
sequently underw ent an g io graphic
evaluation.
Methods
Before arteriography, 50 patients (100
limbs) underwent assessment in the
vascular laboratory. The assessment con
sisted of: (a) measurement of the segmen
tal pressures and pulse volume at the
thigh, calf and ankle, using a Life
Sciences pulse-volume recorder (Life
Sciences Inc., Greenwich, Conn.), and an
exercise test; (b) Doppler waveform
analysis of the femoral, popliteal and
tibial arteries using a Bach-Simpson
DFA-10 frequency analyser (Bach-Simp
son Ltd., London, Ont.). Single-plane
arteriography was then performed using
standard methods.
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The interpretations of the segmental
pressure and pulse-volume recordings and
Doppler waveform analysis were carried
out by different individuals independent
ly, who had no knowledge of the results
of the other procedure. The findings
were then compared to those from
arteriography with respect to specificity,
sensitivity and accuracy.
Segmental Pressure Measurement
Segmental pressures were recorded con
ventionally with a Doppler flow probe at
the ankle and appropriate cuffs at the
brachial, thigh, calf and ankle levels.
After 1 minute of treadmill exercise, the
ankle pressure measurements were re
peated at 1-minute intervals until baseline
pressures were restored. Our criterion for
the presence o f significant stenosis was a
pressure gradient of 20 mm Hg between
segments or an ankle-brachial index less
than 0.8. An ankle-brachial index less
than 0.5 was considered indicative of
multisegm ent disease. Postexercise
recovery time at the ankle level was also
used to indicate the degree of ischemia
present.

outflow (tibial arteries) segments of the
arteriograms were classified as (a) no
significant stenosis, (b) less than 50%
stenosis, (c) 50% to 99% stenosis and (d)
occlusion.
The result of the combined segmental
pressure and pulse-volume recordings and
that of the Doppler waveform data for
each segment were analysed and com
pared with the arteriographic findings for
specificity, sensitivity and accuracy.
Specificity was defined as the number of
negative noninvasive tests divided by the
number of arteriograms that appeared
normal or showed less than 50% stenosis.
Sensitivity was defined as the number of
positive noninvasive tests divided by the
number of arteriograms showing 50% to

100% stenosis. Accuracy was defined as
the total number of positives plus
negatives divided by the total number of 4
limbs examined.

*

Pulse- Volume Recordings
The criteria for the presence of oc
clusive disease with this technique are
related to waveform contour and ampli
tude. The presence of notable proximal
obstruction is signalled by flattening of
the anacrotic limb, rounding of the crest
and loss of the dicrotic notch or a
decrease in amplitude, or both. Further,
the fact that the calf pulse-volume record
ing has a greater amplitude than that of
the thigh, except in the presence of super
ficial femoral obstruction, was used to
distinguish iliac from proximal disease of
the superficial femoral artery.

FIG. I—Isolated iliac artery occlusion. Typical segmental pressure and pulse-volume
recording.

Doppler Waveform Analysis
Criteria for the presence of occlusive
disease by this method were based on the
waveform contour, the pulsatility index
and the inverse damping factor (D F 1).
As with pulse-volume recording, the
velocity waveform will have a lower, flat
tened peak, a decreased upstroke and no
reversed flow over a diseased vessel. A
pulsatility index of 6 or more at the
femoral level was considered indicative of
a normal iliac segment, while a value less
than 5 implied substantial iliac stenosis.
A DF’1 of less than 1 was considered in
dicative of significant disease in that seg
ment (superficial femoral or tibial).
Specificity, Sensitivity, Accuracy
The iliac, superficial femoral and
346

<

The patient illustrated in Figs. 1 to 3
with an isolated unilateral iliac lesion is ’
cited as an example of the findings on
segmental pressure and pulse-volume
recording and on Doppler waveform
analysis. Fig. 1 demonstrates an impor
tant segmental pressure gradient at the-i a
thigh level and the pulse-volume record
ing shows the typical changes of an oc- ■»
elusive iliac lesion (decreased amplitude
and abnormal contour of the thigh and <

FIG. 2—Doppler waveform analysis on same patient as Fig. 1.
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calf tracings, calf showing greater
amplitude than thigh). Fig. 2 demon
strates the Doppler waveform changes in
the same patient. The waveform is
► markedly altered, compared with the
other leg, the pulsatility index is dimin
\ V ished at the femoral level while the DF"1
distally is normal (greater than 1).
►
The results in the 100 limbs we ana
lysed are summarized in Table I. They in
dicate that both techniques are accurate
in identifying obstructive lesions greater
than 50% when compared to our “ gold
stan d ard ” o f arteriography. Both
methods reliably distinguished iliac
disease from superficial disease. In fact,
the lower specificity at the iliac level may
imply the detection of so-called occult il
iac stenosis not adequately seen on single
plane angiograms. We did find that Dop
pler waveform analysis was not as ac' curate in assessing the outflow but the dif
ferences were not significant.
Discussion
•.

Over the past 6 years we have used the
combination o f segmental pressure
* * measurements and pulse-volume record
ings to evaluate arterial occlusive disease
4 in the lower limb. With the advent of

FIG. 3—Arteriogram of same patient, with
unilateral iliac artery occlusion. Distal vessels
(not shown) were patent.

Doppler waveform analysis as an alter
native method, we elected to evaluate pro
spectively both approaches and thus
determine the limits of reliability o f each
and whether or not one was superior to
the other in delineating the presence of
obstruction of the iliac, superficial
femoral and tibial vessels.
The criteria and methods for measur
ing segmental pressure and pulse volume
have been well documented. However,
the terminology of pulsatility index and
inverse damping factor (D F 1) deserves
further clarification. Waveform analysis
is the best method for processing Doppler
signals. A normal Doppler waveform is
triphasic (forward flow, reversed flow
and then again forward flow). If an oc
clusive lesion is present, then the
waveform distal to it will be diminished.
In order to eliminate variations of the
waveform caused by technical factors,
several investigators4-6 have devised the
pulsatility index to quantify the Doppler
waveform. The pulsatility index is the
peak height of a wave divided by the
mean height. The DFA-10 frequency
analyser calculates these numbers
automatically and prints them as the
waveforms are recorded. Hemodynamically important stenosis at the femoral
level is indicated if the pulsatility index
is 5.0 or less. Normally, the index in
creases with progression distally in the leg.
This has been quantified by a second
numerical index, the damping factor,
which is the proximal pulsatility index
divided by the distal pulsatility index.7
To conform to the convention o f decreas
ing indices with increasing disease severi
ty, the term is expressed as the inverse
damping factor (DF-1). If the D F'1is less
than 1, then disease is present in that
arterial segment. Therefore, with Doppler
waveform analysis, the diagnosis of oc
clusive vascular disease can be ascertain
ed by inspecting the analogue waveform
at the femoral, popliteal and tibial vessels
and by calculating the pulsatility index
and D F 1. In this study, all procedures

t

►

T a b le 1— R e s u lts O b ta in e d w ith C om bined S e g m e n ta l P re s s u re and
P u ls e -V o lu m e R ec ording (S P /P V R ) and D o p p le r W a v e fo rm A n a ly s is (D W A )
C o m p a re d w ith th e A rte rio g ra p h ic D a ta fo r E a c h S e g m e n t
S egm ent
Iliac
S e n s itiv ity
S p e c ific ity
A c c u ra c y
S u p e rfic ia l fe m o ra l a rte ry
S e n s itiv ity
S p e c ific ity

-A

4
*>

t

4

A c c u ra c y
O u tflo w
S e n s itiv ity
S p e c ific ity
A c c u ra c y

S P /P V R , %

DW A, %

9 5 .1
8 3 .3
9 1 .5

9 4 .9
8 8 .8
9 2 .9

9 3 .3
8 5 .2

9 2 .8
9 6 .2
9 4 .4

8 9 .5
1 0 0 .0
6 6 .0
9 6 .4

8 0 .0
5 0 .0
7 8 .8

were carried out by the same tecbnician
on each patient at the same examination.
The data were then interpreted indepen
dently by different evaluators before the
angiograms were studied for comparison.
The results o f the study clearly
demonstrate that both approaches offer
a high degree o f accuracy at the iliac and
superficial femoral levels. Both pulsevolume recording and Doppler waveform
analysis distinguished accurately iliac
from proximal obstruction of the super
ficial femoral artery even when both were
present in the same limb. Evaluation of
the tibial outflow segment appeared bet
ter with segmental pressure and pulsevolume recording, primarily because
severe proximal disease tended to damp
both the pulse-volume recording and
Doppler waveform tracings alone whereas
segmental pressure measurements could
still show a gradient between the calf and
ankle, and an ankle-brachial index below
0.3 generally indicated poor outflow
below the knee.
In most instances, single-plane films
only were taken and only occasionally
were oblique films used to assess the il
iac vessels. The lim itatio n s o f
arteriography in assessing aortoiliac
disease have been documented and many
surgeons believe that stenoses in these
segments are routinely underestimated. In
1971, Moore and Hall8 outlined some of
the physiologic problems in interpreting
aortoiliac disease from arteriography.
Despite these limitations, we still rely on
arteriography in planning the therapeutic
approach and because it is the current
“ gold standard” , we felt justified in us
ing it for comparison with our data. Some
of the false-positive results obtained from
both methods at the iliac level may in fact
reflect a greater sensitivity of these noninvasive tests to so-called occult iliac
disease.
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Ventricular Function following Mitral Valve Surgery:
Assessment Using Radionuclide Ventriculography

r r>

The effects of mitral valve replacement
or commissurotomy on cardiac function
^ ^ were studied using radionuclide ventri
culography in 13 patients with chronic
x
mitral stenosis and in 8 with chronic
mitral regurgitation, before and after
4 mitral valve surgery. The stenosis
resulted from rheumatic heart disease in
* * all instances while regurgitation was due
^ to mitral valve prolapse in three patients
and rheumatic heart disease in five.
Fourteen patients had a CarpentierEdwards valve inserted and 4 a Lillehei» Raster disc valve. Three patients with
mitral stenosis had an open
«- commissurotomy.
All patients underwent supine-rest and
*■ * symptom-limited exercise radionuclide
ventriculography shortly before and 6 to
*
12 months after operation. The data ob
tained showed that left ventricular func**
tion remained unchanged postoperatively
,. in patients with mitral stenosis but
deteriorated in those with mitral
►t *■ regurgitation. Right ventricular function
improved postoperatively in those with
V- •'mitral stenosis but remained unchanged
in patients who had regurgitation.

Les effets sur la fonction cardiaque d'un
remplacement de valvule mitrale ou
t y d'une commissurotomie ont ete etudies
chez 13 patients souffrant de stenose
r »mitrale chronique et chez 8 patients
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ayant une regurgitation mitrale chronique
au moyen d'une ventriculographie
isotopique pratiquee avant et aprfes
chirurgie valvulaire. La stenose etait le
resultat d'une cardite rhumatismale dans
tous les cas alors que les regurgitations
6taient dues £ un prolapsus de la valvule
mitrale dans trois cas et a une cardite
rhumatismale dans cinq cas. Quatorze
patients ont recu une proth&se
Carpentier-Edwards et 4 une valvule &
disque Lillehei-Kaster. Trois patients
porteurs d'une stenose mitrale ont subi
une commissurotomie ouverte.
Tous les patients ont subi une ven
triculographie isotopique au repos, en
position couchee, et & I'effort limits par
les symptomes, avant, et de 6 & 12 mois
apres I'operation. Les resultats obtenus
montrent que la fonction ventriculaire
gauche est demeuree inchangee en
postoperatoire chez les patients qui
avaient une stenose mitrale alors qu'elle
s'est deterioree chez ceux qui avaient
une regurgitation mitrale. La fonction
ventriculaire droite s'est amelior6e en
postoperatoire chez ceux qui avaient une
stenose mais elle est demeuree in
changee chez les patients souffrant de
regurgitation.

The left ventricular ejection fraction at
rest may be either normal or decreased in
the presence of mitral stenosis.1-8 Studies
examining exercise left ventricular func
tion usually demonstrate hemodynamic
abnormalities.9-12 Whether reduced left
ventricular function is due to a decrease
in diastolic filling or to intrinsic myocar
dial dysfunction has not been firmly
established.2-4’6’8’13-17 Left ventricular
ejection fraction at rest is usually main
tained in mitral regurgitation due to ad
justments in left ventricular and left atrial
mechanics18-22 so that a depressed value
in such patients indicates a markedly ab
normal ventricle. Mitral valve replace
ment at this stage may be associated with
further deterioration in left ventricular

function or a decrease in operative
survival.7’23-26 Right ventricular function
has not been extensively evaluated for
either mitral stenosis or regurgitation.
The purpose of this study was to com
pare the effects of mitral valve replace
ment or commissurotomy in patients with
mitral stenosis and those with mitral
regurgitation. Equilibrium radionuclide
ventriculography provides an excellent
noninvasive tool to examine rest and max
imal exercise biventricular function.27-28
Patients and Methods
Included in the study were 21 patients,
13 (11 women, 2 men, group 1) in whom
mitral stenosis was the predominant
valvular lesion and 8 (4 women, 4 men,
group 2) in whom mitral regurgitation
was predominant. The mean age for
group 1 patients was 58 years (range from
40 to 73 years) and for group 2, 54 years
(range from 39 to 68 years).
The cause of the condition was
established in all patients by cardiac
catheterization and M-mode or twodimensional echocardiography. The
mitral stenosis in all group 1 patients was
due to rheumatic cardiac disease. The
mitral regurgitation in group 2 patients
was due to rheumatic cardiac disease in
five patients and to mitral valve prolapse
in three.
In both groups the patients’ hemo
dynamic condition was severe — luminal
diameter of 1 cm2 or less in all group 1
patients as determined by the Gorlin
method and regurgitation demonstrated
angiographically in group 2. No patient
had significant coronary artery disease
(25% or more narrowing of one or more
coronary arteries).
In group 1, 10 patients received new
m itral valves (C arp en tier-E d w ard s
bioprosthetic porcine valve in 8, LilleheiKaster eccentric monocuspid disc valve in
2) and 3 patients had an open mitral com
missurotomy. In group 2, all patients
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underwent m itral valve replacement
(Carpentier-Edwards in six and LilleheiKaster in two).
Mitral valve disease had been present
in all patients for at least 5 years and in
most for many years. Patients underwent
preoperative assessment within the 3
months before operation. Postoperative
assessment was conducted 6 to 12 months
after the surgical procedure. Diuretic
therapy was reduced at the time of
postoperative assessment in 10 of 13 pa
tients with mitral stenosis and 4 of 8 with
mitral regurgitation. All patients were re
quired to undergo at least one 3-minute
stage of supine bicycle exercise at a
workload of 25 watts.
Twenty-eight healthy men with a mean
age of 54 years (range from 34 to 65 years)
served as controls. No one was taking
regular medication. In all, the findings of
functional inquiry, physical examination,
exercise stress electrocardiogram and
thallium-201 scintigraphy were normal.
Wall motion was normal during exercise
radionuclide ventriculography.
In all group 1 patients, the left ven
tricular ejection fraction, derived from a
single right anterior oblique projection at
the time of cardiac catheterization, was
more than 50%; it was less than 50% in
four group 2 patients, as determined at
the time of ventriculography.
Radionuclide Ventriculography
Electrocardiographically multigated
equilibrium radionuclide ventriculogra
phy was carried out with the patient
supine at rest and during symptomlimited exercise. After in-vivo labelling of
erythrocytes with 20 mCi of technetium-99m pertechnetate, cardiac scinti
graphy was performed in the left anterior
oblique position that best isolated the left

ventricle. All images were collected for 2
minutes using a conventional Anger scin
tillation camera equipped with a highsensitivity parallel-hole collimator inter
faced to a dedicated medical computer
system (Ohio Nuclear model 460; Technicare International, Cleveland, Ohio).29
Data were collected in a continuous elec
trocardiographic synchronized mode with
16 frames spanning the cardiac cycle. Pa
tients began supine exercise with an in
itial workload of 25 W, which was in
creased by 25 W every 3 minutes until
symptoms were produced. Data were
analysed using a mobile medical com
puter (Ohio Nuclear model 550). As
previously described,30 the left ven
tricular ejection fraction was derived by
first identifying a background region of
interest, approximately 50 to 100 pixels
along the inferolateral left ventricular free
wall of the end-systolic frame. After
smoothing and background subtraction,
a region of interest was then drawn
manually around the left ventricle at endsystole and end-diastole (previously iden
tified from the left ventricular timeactivity curve), using an endless-loop cine
display to improve edge detection. This
was performed on three separate occa
sions and an average of the three counts
for each of the frames was used to
calculate the ejection fraction.
Determination of the right ventricular
ejection fraction was based on a previous
ly described technique.28 After subtrac
tion of background activity previously
identified along the left ventricular free
wall, right ventricular end-systolic and
end-diastolic regions of interest were
manually outlined. The superior right
ventricular edge was considered to border
on a parallel line drawn from the mitral
valve plane in both diastole and systole.
Analysis of variance shows that for the

left ventricle a change in ejection fraction
of 5% (absolute value! or more was
significant. For the right ventricle, a
change of 11 % (absolute value) or more
in ejection fraction was considered
significant.
The percentage change in radioactive .
counts from rest to exercise at end-systole
and end-diastole was used to determine-*
changes in cardiac volume.31
Statistical Analysis
Student’s /-test for paired and unpaired '
samples was used to determine significant
changes in hemodynamic parameters. *
Two-way analysis of variance was used
to determine intraobserver and in
terobserver variance for left and right
ventricular ejection fractions from 25
previously obtained resting studies in pa- ■
tients with coronary artery disease.
Variance was defined as the error due to i
observer bias plus the random error of the
method. The largest variance obtained
from intraobserver and interobserver
sampling was used to define a significant
change upon introduction of an interven- ,
tion. Probability of 5% or less was con
sidered significant.
■*
Results
Atrial fibrillation was present in 9 of
the 13 group 1 patients preoperatively and
it developed postoperatively in 2 others.
In group 2, six of the eight patients had
atrial fibrillation preoperatively and there
was no change postoperatively.
All patients were taking digoxin at the
time of preoperative assessment. Post
operatively, all but two patients were tak
ing digoxin. No patient was taking a 13receptor blocking agent.
■*

FIG. 1—Mitral stenosis. Rest (R) and exercise (Ex) left ventricular
ejection fraction (EF) and percentage change (%A) in end-systolic
volume (ESV) and end-diastolic volume (EDV) with exercise. Compared
with normal (triangles) increase (p < 0.001), exercise EF failed to rise
preoperatively (open circles) or postoperatively (closed circles) owing
to decrease (p < 0.01) in exercise EDV. Values are mean ± standard
error. NS = not significant.
350

FIG. 2—Mitral stenosis. Rest and exercise right ventricular ejection
fractions increased (p < 0.05) postoperatively (closed circles). Com
pared with normal (triangles) increase (p < 0.001), exercise EF failed ,
to rise preoperatively (open circles) or postoperatively owing to increase
(p < 0.001) in exercise ESV.
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creased ejection fraction postoperatively,
at rest, while five had a substantial
decrease (5% or more). Likewise, the
significant (p < 0.001) rise in right ven
tricular ejection fraction from rest to ex
ercise in healthy subjects did not occur in
those with mitral stenosis.

Group 1 (Figs. 1 and 2)
^

Preoperatively, all patients with mitral
stenosis were in New York Heart Associay tion class III for dyspnea or fatigue. At
the time of follow-up, 11 patients were
► in class I and 2 in class II. Rest and exer
cise heart rate and systolic blood pressure
► *■were unchanged postoperatively from
preoperative values (Table I). Changes
from rest to exercise were significant
^ (p < 0.001) and no differences occurred
postoperatively.
y. K The results for left and right ventricular
function are set forth in Tables II and III
k >respectively. The significant (p < 0.001)
rise from rest to exercise of the left venr tricular ejection fraction in healthy peo
ple did not occur in patients with mitral
K stenosis preoperatively or postoperativey ly, although three patients did have an in

None of the patients had evidence of
mitral stenosis at follow-up.
Group 2 (Figs. 3 and 4)

Discussion
All patients in this group were in New
York Heart Association class III for
dyspnea or fatigue preoperatively. At
follow-up, five patients were class I and
three were class II. Rest and exercise heart
rates and systolic blood pressures post
operatively did not differ substantially
from the preoperative values (Table I).

y y
Table 1-Preoperative and Postoperative Heart Rate and
Systolic Blood Pressure at Rest and Exercise in Groups 1 and 2 *

k-A

■4

Heart rate, beatslmin

I
A

Group

A

A

Control
1, mitral stenosis
Preop
Postop
2, mitral regurgitation
Preop
Postop

A

Systolic blood pressure, mm Hg

Rest

Exercise

Rest

Exercise

65 ± 11

129 ± 20

129 ± 16

198 ± 28

78 ± 14
76 ± 12

131 ± 36
130 + 42

114 ± 12
117 ± 17

141 ± 17
153 ± 24

85 ± 15
80 ± 14

129 ± 30
130 ± 31

124 ± 11
137 ± 26

155 ± 27
176 ± 24

'Values are mean ± standard deviation.

*- >
Table II— Group 1, Mitral Stenosis. Left Ventricular Function Pre- and Postoperatively
Ejection fraction, %
Rest
Control

67 ±

76 ±

6

t
Y- *

Preop

56 + 11 n

55 ± 17
NS

Postop

y y

End-systolic
volume, % '

Exercise

5 i

55 ± 15 J

J

- 1 6 ± 24
*

J

End-diastolic
volume, % '
+ 1 0 ± 18
NS

- 1 9 ± 24

1 NS
52 ± 15 J

“1
1t

-1 1 ± 2 0

1 NS
+ 2 ± 28 J

§
NS

J

- 8 ± 10

'Percentage change in volume with exercise from resting value,
tp < 0.01.
4p < 0.001.
§p < 0.05.

r *

Table Ill-Group 1, Mitral Stenosis. Right Ventricular Function Pre- and Postoperatively
Ejection fraction, %
-----------------------------------------__________ Rest___________ Exercise

k

Control

51 ±

8

64 ± 11
J t

S

Preop

37 ± 15

Postop

]
48 ± 10 J

A

4

*

32 ± 15

t
45 ± 12

.
End-systolic
volume, % *

End-diastolic
volume, % *

-21 ± 28

I*
1t

All changes from rest to exercise were
significant (p < 0.001).
Tables IV and V show the results of left
and right ventricular function at rest and
after exercise. As in group 1, there was
no significant change in either left or right
ventricular ejection fraction from rest to
exercise pre- or postoperatively. Four pa
tients had a decrease and three patients
an increase in rest ejection fraction (5%
or more).

+ 5 ± 19
NS

]*
+ 15 ± 30

4
I

ns

+ 24 ± 2 8

'Percentage change in volume with exercise from resting value,
tp < 0.05.
4p < 0.001.

J

+ 9 ± 33
NS
+ 1 2 + 35

J

Left Ventricular Function
The etiology of the impaired response
of the left ventricular ejection fraction in
patients with mitral stenosis surprisingly
remains controversial. Gash and asso
ciates8 found that of five patients with a
left ventricular ejection fraction of less
than 50%, four had normal intrinsic mus
cle function. Reduced systolic function
was the result of an increased afterload
without adequate Frank-Starling com
pensation. In contrast, other studies have
suggested that impaired muscle function,
which may have been due to chronic
rheumatic myocarditis, results in a re
duction in ejection fraction.2'6,9'1417
Others32'33 have suggested that the
presence of right ventricular dysfunction
may depress left ventricular function.
Although the mechanism of left ven
tricular dysfunction at rest was not ex
amined in this study, both systolic and
diastolic left ventricular impairment could
have contributed to the diminished ejec
tion fraction. Lack of improvement post
operatively in the left ventricular ejection
fraction at rest suggested that impaired
diastolic filling from mitral valve stenosis
was not the sole cause of the reduced ejec
tion fraction. Due to chronic rheumatic
fibrosis, preoperative systolic function
may have been impaired and so con
tributed to the decreased ejection fraction
at rest. It is possible that the ejection frac
tion was falsely depressed by the use of
equilibrium radionuclide ventriculography
in the presence of atrial fibrillation. But
this is unlikely since the value of ra
dionuclide ventriculography in this situa
tion has been either documented or com
mended by others.34,35
By determining volume changes with
mitral stenosis, we were able to assess
ejection fraction responses to exercise in
greater detail. Preoperatively, a signifi
cant decrease occurred in exercise enddiastolic volume. Coupled with a normal
decrease in end-systolic volume, the left
ventricular ejection fraction failed to rise,
suggesting that impaired diastolic filling
was responsible for the abnormal ejection
fraction response to exercise. Since the
heart rate did not increase beyond the
normal exercise heart rate, reduced
diastolic filling time was not responsible.
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Postoperatively, impaired diastolic filling
persisted. Moreover, there was a slight
rise in end-systolic volume. Thus, mitral
valve surgery did not improve exercise left
ventricular function as measured by these
parameters. Possibly, diastolic filling re
mained abnormal because of prosthetic
valve narrowing, a consistent finding
following mitral valve replacement.36 In
addition, the presence postoperatively of
atrial fibrillation may have reduced enddiastolic filling. The slight rise in endsystolic volume indicates a reduction in
exercise systolic function. This may have
occurred during the perioperative period
but more likely paradoxical septal motion
contributed to this finding.37
In contrast to mitral stenosis, mitral
regurgitation is associated with major
hemodynamic left ventricular stress. The
left ventricle compensates by several
mechanisms. Wall thickness increases in
relation to the increase in chamber size
and the chamber becomes spherical.22
Major increases in left ventricular and left
atrial compliance permit a reduction in
end-diastolic pressure.18'22 The enlarged
left atrium can accept very large volumes
of blood at the onset of systole and in do
ing so, markedly reduces resistance to left
ventricular outflow. These adaptive
mechanisms permit mitral regurgitation
to be present for prolonged periods
without a reduction in left ventricular
ejection fraction. In this study, a slight
reduction in left ventricular ejection frac
tion postoperatively at rest and a signifi
cant decline in exercise ejection fraction
suggest that mitral valve replacement may
have been undertaken relatively late in the
course of the disease. Normally, a decline
in regurgitant volume combined with an
increase in afterload (obstruction to the
low impedance leak) results in a decrease
in end-diastolic volume, little change in
end-systolic volume and a slight fall in left
ventricular ejection fraction. In the
presence of preoperative left ventricular
dysfunction, a greater fall in ejection frac

tion is likely after mitral valve replace
ment.7,23'26
Right Ventricular Function
In this study, the right ventricular ejec
tion fraction preoperatively was depress
ed at rest with both mitral stenosis and
regurgitation. Winzelberg and asso
ciates38 noted a relation between
pulmonary artery pressure and right ven
tricular ejection fraction in patients with
aortic and mitral valve disease. The ejec
tion fraction was decreased in over half
the patients with right ventricular peak
systolic pressures greater than 50 mm Hg.
However, this decrease may not relate to

Table IV—Group 2, Mitral Regurgitation. Left Ventricular Function Pre- and
Ejection fraction, %
End-systolic
Rest
Exercise
volume, %*
+10
Control
67 ± 5-1
76 ± 6 n
-1 6 ± 24 -]
t
NS
+
57 ± 9 ,
- 9 ± 19
Preop
54 ± 11
§ - 4
NS
It
1 t
0
49 ± 12 J
46 ± 8 J
+11 + 37 J
Postop
"Percentage change in volume with exercise from resting value,
tp < 0.05.
fp < 0.001.
§p < 0.01.

Postoperatively

Table V—Group 2, Mitral Regurgitation. Right Ventricular Function Pre- and
Ejection fraction, %
End-systolic
Rest
Exercise
volume, %*
Control
51 ± 8 i
64 ± 11
-2 1 ± 28
+ 5
. t
+
Preop
30 ± 17
24 ± 17
+29 ± 14
4 + 19
NS
NS
NS
J
Postop
38 ± 15 J
31 ± 17
+ 39 ± 38
+ 19
"Percentage change in volume with exercise from resting value,
tp < 0.01.
tp < 0.001.

Postoperatively

J

FIG. 3—Mitral regurgitation. Exercise EF decreased (p < 0.05)
postoperatively (closed circles). Compared with normal (triangles) in
crease (p < 0.001), exercise EF failed to rise postoperatively owing to
increase (p < 0.01) in exercise ESV. Open circles = preoperative values.
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a decline in intrinsic muscle function.
Wroblewski and associates39 found that
in the presence of moderate pulmonary
hypertension, removal of pulmonary -i '
artery pressure from the calculation of
right ventricular performance showed 1
that contractility was not impaired. In
deed, in patients with mitral stenosis,
1
right ventricular ejection fraction improv-^
ed postoperatively in the present study,
probably owing to a reduction in _.
pulmonary artery pressure.
During exercise, pulmonary artery -*
pressure may increase further because in
creased forward flow is obstructed.9 "
Thus, as our preoperative study^,
demonstrated with mitral stenosis and ^
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FIG. 4—Mitral regurgitation. Compared with normal (triangles) in- *
crease (p < 0.001), exercise EF failed to rise preoperatively (open circles)
or postoperatively (closed circles) owing to increase (p < 0.001) in ex-* *ercise ESV.
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mitral regurgitation, exercise may be
associated with an abnormal response of
the right ventricular ejection fraction.
Surprisingly, right ventricular ejection
fraction also declined postoperatively.
* Although the exercise ejection fraction
*
improved significantly in patients with
*
mitral stenosis compared with the
► ►preoperative value, it failed to increase
from the rest value because o f a rise in
- c end-systolic volume. Similarly, the exer
cise ejection fraction failed to rise from
*■ rest in patients with mitral regurgitation
owing to an increase in end-systolic
" volume. These hemodynamic alterations,
. k comparable in magnitude to those found
preoperatively, implied depressed systolic
r y function. Exercise systolic function may
have been impaired postoperatively for
v several reasons. First, a significant gra
dient across the prosthetic mitral valve
•*" v during exercise could cause an increase in
right ventricular afterload. Although prosy * thetic valves vary in their flow gradients,
k k a mild gradient usually exists.36 Second,
irreversible damage to the right ven4 tricular myocardium may have occurred
i
because o f the hemodynamic stress o f a
► k chronically elevated pulmonary artery
pressure. Improvement in contractility
* * postoperatively would be unexpected.
Third, tissue may have been damaged
during the perioperative period. Con
ceivably, gradual improvement in
myocardial function with an increase in
w ejection fraction could occur beyond our
follow-up of 6 to 12 months.
y »In summary, left ventricular ejection
fraction remained unchanged after opera► > tion for mitral stenosis but was reduced
after operation for mitral regurgitation.
► ' Right ventricular function improved after
operation for mitral stenosis; it remain
ed unchanged after opr-ation for mitral
regurgitation.
y

y

■
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Transluminal Dilatation for Takayasu’s Arteritis

^ ^

Les syndrdmes medicaux des attaques
transitoires de I’ischemie cerebrale, la
claudication des extremites sup6rieures,
la defaillance renale et I'angine intestinale ont ete corrigees par la technique
de la dilatation des arteres.
Cette technique a ete suggeree comme
une alternative e la revascularisation
chirurgicale chez les sujets choisis atteints de l'arterite de Takayasu.

Takayasu's arteritis, pulseless disease or
occlusive thromboaortopathy, is a proy
►gressive disease usually of young
women. Early morbidity and death result
f *■ from ischemia of vital organs. The
results of surgical revascularization have
*"
been disappointing.
Two women with Takayasu's arteritis
are reported. They underwent
y transluminal dilatation of serious symp
tomatic stenoses of the origins of the
k
left carotid, left subclavian, renal and
superior mesenteric arteries. Four repeat
4
dilatations were required. There was one
complication.
*
Clinical syndromes of transient cerebral
^ k ischemia, upper limb claudication, renal
failure and intestinal angina have been
reversed by transluminal dilatation.
Percutaneous transluminal dilatation is
.. a suggested alternative to surgical
revascularization in selected patients
y
with Takayasu's arteritis.
'

L'arterite de Takayasu est une maladie
qui se distingue par I'absence de pouls
r * ou par ('obliteration de I’aorte et de ses
branches. La maladie progressive affecte
r
d'une mani&re prddominante les jeunes
femmes. La morbidity precoce et la mort
peuvent etre les consequences causees
> r par I'ischemie des organes vitaux. Les
resultats de la revascularisation
v- + chirurgicale ont ete decourageants.
La dilatation des arteres par la techniv *
que de I'entree d'un catheter a ete faite
aux endroits ou les symptdmes de la
stenose etaient les plus considerables,
r Y c'est-e-dire a I'origine de la carotide
gauche, sous-claviere gauche, renale et
r
► I'artere mesenterique superieure. Le proced6 a du etre repete quatre fois; une
>- '
complication s'est presentee.

r '
►

r
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Takayasu’s arteritis is a progressive in
flammatory arteriopathy whose cause is
unknown. It results in thickening of the
arterial wall, leading to constriction or oc
clusion, occasionally aneurysmal dilata
tion and, rarely, thrombus formation in
the aorta and its major branches.1
The clinical history o f Takayasu’s
arteritis is often one o f slow progression
interspersed with acute morbid episodes
due to inadequate blood supply to vital
organs such as brain, kidneys or
intestine.2
The success o f percutaneous translu
minal angioplasty as a new therapeutic
modality for atherosclerotic obstructive
disease has prompted its use for the treat
ment o f Takayasu’s arteritis. This report
is to update our experience3 and docu
ment further expansion o f the technique
to include stenoses o f the renal4 and
superior mesenteric artery origins involv
ed in Takayasu’s arteritis.

advanced over it. Four balloon inflations were
accomplished without complication. Follow
ing dilatation, there was marked improvement
in the left arm pulse and diminution of the
systolic gradient across the stenosis from 90
mm Fig to 10 mm Hg. Postdilatation aor
tography showed angiographic improvement
as well as antegrade opacification of the left
vertebral artery.
Over the next 2 days, the patient experienc
ed quite marked hyperesthesia of the left arm,
thought to be due to the increased blood flow
to that arm.
Eight days later a retrograde left carotid
angioplasty was performed through a left com
mon carotid arteriotomy. A no. 7 French
Gruntzig balloon catheter with guide was in
serted through the arteriotomy and advanced
under fluoroscopic control across the left com
mon carotid ostial stenosis. Three dilatations
were performed. Following each deflation of
the balloon, blood was allowed through the
arteriotomy. No embolic debris was seen. An
increase in systolic pressure o f 40 mm Hg was
recorded distally after dilatation.
In tra o p e ra tiv e a rte rio g ra p h y show ed
satisfactory dilatation. The patient recovered
without complication.
Fifteen months later, repeat arteriography
showed increased stenosis of the origins of the
left subclavian (gradient 60 mm Hg) and left
carotid (gradient 65 mm Hg) arteries. Repeat
percutaneous transluminal dilatation was per
formed. Gradients were reduced to 25 mm Hg
at the origin of the left subclavian artery and
20 mm Hg at the origin o f the left carotid

Case Reports
Case 1
A 34-year-old woman had a history of severe
left-sided headaches, episodes o f blindness of
the left eye lasting up to 3 minutes, vertigo and
weakness of the left arm manifested by an in
ability to hang up cups or wash dishes.
No blood pressure could be recorded in the
left arm, which was markedly cooler than the
right and showed slow capillary filling. Bruits
were heard over the entire anterior precordium
including the left infraclavicular region.
Arch aortography demonstrated typical fin
dings of Takayasu’s arteritis with severe
stenoses at the origins of the left common
carotid and subclavian arteries (Fig. 1). There
was retrograde filling of the left vertebral artery
in later phases of the injection.
Transluminal dilatation was undertaken. A
guide wire was passed across the left subclavian
ostial stenoses and a no. 7 French dilatation
catheter with a balloon 6 mm in diameter was

FIG. 1—Case 1. Arch aortogram
demonstrates stenoses at origins of left subcla
vian and left carotid arteries (arrows). Systolic
pressures were 140 mm Hg proximally and 50
mm Hg distally.
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Table I—Case 1. Systolic Pressure Gradients (mm Hg) before and after Percutaneous*
Transluminal Angioplasty
Date of angioplasty
Oct.1981

Feb. 1983

Apr. 1983

June 1983

Pressure gradient

Pre

Post

Pre

Post

Pre

Post

Pre

Aorta to left carotid artery
Aorta to left
subclavian artery
Aorta to superior
mesenteric artery

80

40*

65

20

—

—

-

20

90

10

60

25

-

—

—

—

10

-

-

—

130

75

105

35

30

—

Post Sept. I

'First dilatation through left common carotid arteriotomy.

artery. Repeat pressure studies done 6 months
later demonstrated no change in the degree of
stenosis (Table I) (Fig. 2).
During the patient’s period o f observation,
she began to complain of postprandial midab
dominal colicky pain. No diarrhea or weight
loss was noted. The only new physical finding
was a loud midabdominal bruit.
Biplane arteriography documented a com
plex stenosis of the celiac axis not suitable for
dilatation. A severe stenosis of the superior
mesenteric artery (gradient 130 mm Hg) was
found (Fig. 3). Transluminal dilatation of this
vessel was accomplished successfully to a
residual gradient of 75 mm Hg.
Symptoms and increased stenosis (gradient
105 mm Hg) of the superior mesenteric artery
occurred within 3 months. Repeat transluminal
dilatation reduced the gradient to 35 mm Hg
(Fig. 4). This gradient has remained stable for
6 months (Table I).

APR
PRE

Case 2
A 34-year-old woman was admitted with
severe nausea, vomiting and azotemia. Her
serum creatinine level was 707 /tmol/L.
Twelve years previously, she had been in
vestigated for severe hypertension, and
Takayasu’s arteritis type II (Kimoto variety)
had been diagnosed.5 Aortography docu-

FIG. 2—Case 1. Follow-up aortogram after
15 months. Origins of left subclavian and left
carotid arteries well dilated. 110, 120, 130 =
systolic blood pressures in mm Hg.
356

mented severe left renal ostial stenosis, celiac
and superior mesenteric artery occlusions and
stenosis of the left common iliac artery. Aortorenal and aortosuperior mesenteric artery
bypasses were performed. The renal bypass
failed early and left nephrectomy was done to
control recurrent hypertension.
Repeat aortography 3 years later docu
mented occlusion of the superior mesenteric
artery graft and 95% ostial stenosis of the re
maining right renal artery. Further surgery was
not considered because the previous grafts had
failed to remain patent. Hypertension recur
red and was difficult to control despite ag
gressive medical management.
Renal failure occurred 8 years later, resulting
in the present admission. Rehydration and tem-

porary transvenous dialysis were undertaken.
She rem ained anuric. A ngiography
docum ented a 161 mm Hg g radient
(165/90-4/4 mm Hg) across the ostial stenosis
^ ,
o f the right renal artery (Fig. 5). Retrograde
transluminal dilatation using a no. 7 French
^
Gruntzig catheter successfully reduced the
arterial gradient to 45 mm Hg (Fig. 6). Urine ^ .
production resumed and the serum creatinine
”
level stabilized at 159.6 /rmol/L.
A ^
Over a 9-month period, hypertension
became severe and repeat aortography
.
documented recurrent stenosis with a gradient
of 170 mm Hg. A repeat dilatation was only
^
partially successful. A 95 mm Hg gradient re
mained and dissection of the distal renal artery ^ ^
was seen. Over the next 48 hours renal failure
recurred. Repeat aortography documented a ^ A
thrombus in the right renal artery. Strep
tokinase therapy at 15 000 U /h was given. „
Dissolution did not result and the clot was
thought to be subintimal. Repeat dilatation of
,,
the area of the subintimal hemorrhage suc
cessfully re-established adequate renal blood v
flow (resulting in a residual gradient of 60 mm
’
Hg) and renal function returned. Her serum
creatinine level remained stable at 159.6 to
212 jitmol/L over an 8-month period but her K M
hypertension persisted.
\

Discussion

^
4 4

The course of the individual afflicted
with Takayasu’s arteritis is difficult to 4 *
predict. An initial delay in diagnosis is
common.2 Of those with documented
\

11 ' 8 3
PTA

20

FIG. 3—Case 1. Lateral abdominal aor
togram shows stenosis of celiac axis (left ar
row) and superior mesenteric artery (right ar
row). Numbers indicate systolic pressures in
mm Hg proximally and distally to superior
mesenteric artery stenosis. Gradient is 130 mm
Hg.

FIG. 5—Case 2. Abdominal aortogram. Arrow shows ostial stenosis of right renal artery.
Systolic blood pressures are 165 mm Hg proximal and 4 mm Hg distal to stenosis.

FIG. 4—Case 1. Lateral aortogram follow
ing second transluminal dilatation. Arrow =
site of previous stenosis of superior mesenteric
artery; 120 is systolic pressure in mm Hg distal
to previous stenosis.

FTG. 6—Case 2. Abdominal aortogram
following successful transluminal angioplasty
of right renal artery. Systolic pressure gradient *■
is now 45 mm Hg.
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disease, morbidity is usually related to
unrelieved renovascular hypertension, or
visual and cerebral events thought to be
■-»- secondary to ischemic episodes.
Medical therapy, particularly during
► the active phase o f the disease, is directed
towards preventing progression of the
r * underlying inflammatory process of the
^ ^arterial wall.
Revascularization is undertaken to prevent ischemic damage to end organs
whose arterial supply is severely compromised by the disease, or to correct
renovascular hypertension.
y *Surgical revascularization, however,
has a higher morbidity and mortality in
v “Takayasu’s arteritis than in equivalent
obstructive arteriopathy due to athero
sclerosis.6,7 In a review o f the literature
y by Ishikawa,6 26.9% o f the surgically
treated patients died. Lupi-Herrera and
r y associates8 reported that four of five
aortorenal grafts occluded in patients
► 'with Takayasu’s arteritis and they have
abandoned the procedure. Graft occluf 4 sion or anastomotic failure is thought to
^ be related to active disease at the site o f
arterial anastomosis.
A„
The use o f percutaneous transluminal
d ilatation as the in itial form o f

revascularization in Takayasu’s arteritis
has been reported.9
During our first attempt at dilatation
at the origin o f the left carotid artery, we
used left common carotid arteriotomy
through the neck10 to prevent emboliza
tion. Cerebral blood flow was interrupted
at the time o f dilatation and blood and
possible embolic debris were allowed
through the arteriotomy. N o debris was
seen. As a result, subsequent per
cutaneous transluminal dilatation was
performed using the femoral approach.
Castaneda-Zuniga and associates4
have stressed the need to repeat trans
luminal dilatation should clinical signs or
follow-up angiography document recur
rent stenosis. Our experience with two pa
tients requiring nine dilatations of four
major vascular lesions supports the ef
ficacy o f repeated dilatation should it be
required. Close follow-up, including the
use o f the noninvasive techniques and
repeat angiography, have been useful in
documenting recurrent stenosis before
end-organ ischemia occurs.
While the long-term results o f this form
o f therapy remain uncertain, percutane
ous transluminal angioplasty appears to
be a safe and logical initial technique for

revascularizing severely stenotic arteries
in patients with Takayasu’s arteritis.
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Percutaneous Transluminal Angioplasty of Iliac Arteries:
the Importance of Functional Studies

Results of percutaneous transluminal
>- angioplasty of 60 Iliac arteries are
presented, with a follow-up of 3 to 12
* *" months. The patency rate at 1 year was
95% using the thigh-brachial index as
4 the criterion and 86% with the ankle^ brachial index. Study of the patients
with an exercise test component im4
4,
proved the sensitivity of the evaluation,
demonstrating that both indices tend to
* *• underestimate the functional improve
ment. The authors propose a simple,
cost-effective way for practitioners to
follow-up their patients after per'
cutaneous transluminal angioplasty.
Les auteurs presentent une sdrie de 60
angioplasties transluminaies percutanees
de I'art&re iliaque avec une postr » observation de 3 S 12 mois. Le taux de
succes a 1 an est 95% en utilisant
»- I'index cuisse-bras comme crit&re et
86% avec I'index cheville-bras. En plus
r de ces mesures au repos, ils ont inclus
une composante fonctionnelle dans
v
revaluation par le laboratoire vasculaire
^ y ex ont ainsi amdliore la sensibilite de
leurs evaluation, demontrant que les in. y dices ont tendance 6 sous-estimer
■'amelioration apres la dilatation par
r angioplastie. Les auteurs proposent aux
praticiens une methode simple et peu
* coOteuse de suivre leurs patients apres
angioplastie percutande.
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The introduction of noninvasive vascular
testing has made it possible to document
accurately the natural history of disease
and to assess and compare the results of
treatment.1 In many centres, noninvasive
evaluation has now become an essential
component of the clinical assessment of
patients with known or suspected vascular
disease before and after treatment.2 We
have followed up a group of patients with
iliac artery disease before and after per
cutaneous transluminal angioplasty by
measuring their performance at rest and
after exercise with resting segmental
pressure studies and functional evalua
tion. These studies were used to document
the success of angioplasty, comparing the
results of resting segmental studies with
the functional evaluation during the
follow-up period.
Patients and Methods

From October 1980 to April 1983, 142
percutaneous transluminal angioplasties
were performed in our institution. Eightyone involved the iliac arteries; in 60 of
tnese the patients were followed up for
3 to 12 months and are included in this
study. All angioplasties were performed
by the same radiologist (M.H.) and
evaluated by the same vascular laboratory
technician (D.L.). All lesions were
segmental (less than 4 cm long) and in
completely occluded.3
The following angioplasty technique
was used: after local intraderm al
anesthesia with lidocaine 2% , a per
cutaneous puncture ipsilateral to the
stenosis was performed at the level of the
common femoral artery (few patients
underwent contralateral puncture) and
catheterization was carried out through
the stenosis, using a leading guide wire.
A balloon-tip catheter was then inserted
over the guide wire (the balloon size was
chosen according to the vessel diameter
measured directly on the angiogram) and
the ballon was manually inflated with a

10-mL syringe filled with Renografin-30.
The balloon was inflated to full capacity
and the dilatation repeated as necessary
to increase the vessel diameter to normal
size. Before inflation of the balloon, 5000
U of heparin were injected through the
catheter. After removing the catheter and
applying hand pressure, we applied a
pressure dressing. All patients were nurs
ed flat in bed overnight.
Evaluations were made before angio
plasty, on the following day and at 3 and
12 months after. Each assessment includ
ed measurements of the ankle-brachial
pressure index before and after exercise
and the thigh-brachial pressure index,
and an exercise tolerance test. The exer
cise tolerance test consisted of the walk
ing time performance on a treadmill set
at 2.4 kph with a 10° grade.4 The exer
cise test was concluded after 5 minutes of
walking or at the appearance of claudica
tion when the time was noted and the
ankle-brachial pressure measured. The
walking distance is calculated by multiply
ing the walking time by the treadmill
speed.
To assess the reproducibility of our
results, the mean contralateral anklebrachial pressure index was calculated
before and after angioplasty. No signifi-
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FIG. 1—Mean (± SEM) ankle-brachial
pressure index (A /B ) before and after
angioplasty in contralateral limb.
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cant difference was found (p > 0.05, Stu
dent’s 7-test), indicating that our method
of measuring the indices is reliable
(Fig. 1).
We define patency as any improvement
over the preangioplasty index; our paten
cy rates at 1 year were 95% (thighbrachial) and 86% (ankle-brachial).
Results
Table I represents the group’s perfor
mance in terms of indices. The results of
the exercise tolerance test are expressed
in Table II. To compare the sensitivity of
each category of measurements, we ex
pressed our data as percent improvement
(Figs. 2 and 3).

Twelve months after angioplasty (Fig.
4).—In this group, 37 procedures were
performed; 23 patients had examinations
and 14 were lost to follow-up. There was
a significant difference between the im
provement in the thigh-brachial index
and exercise tolerance (p < 0.05) and in
the thigh-brachial index and postexercise
ankle-brachial index (p < 0.01), as well
as in the pre- and postexercise anklebrachial indices (p < 0.02). However,
there was no significant difference be
tween the ankle-brachial pressure index
and the results of the exercise tolerance
test (0.1 > p > 0.05).
Using the vascular laboratory data and
the recurrence of symptoms as criteria, we

had eight failures in our series of common
iliac artery angioplasties. One procedure
involved a dilatation of a distal anasto- ^
mosis of an aortoiliac graft (the only pro
cedure on a graft in our series). Three
were performed on patients with disease
of the superficial femoral artery and tibial tartery, two on patients with tibial artery
1
disease alone and two patients with n o -4 ^
distal disease. Looking at the successful
group, 1 year after angioplasty, we found
that all but one had two- or three-vessel M
run-off.
◄

Discussion
•*

<

Our patency rates (95% with thigh-

Improvement after Angioplasty
Immediately after angioplasty (Fig.
2) .—There was no significant difference
between the improvement in the anklebrachial pressure index and that for the
thigh-brachial index. However, the dif
ferences in improvement between the
an k le-b rach ial index and exercise
tolerance and between the thigh-brachial
index and exercise tolerance were signifi
cant (p < 0.001). There was no signifi
cant difference between the postexercise
ankle-brachial index and the exercise
tolerance test results.
Three months after angioplasty (Fig.
3) .—This group includes 60 procedures;
55 patients were tested and 5 were lost to
follow-up. There was a significant (p <
0.01) difference after angioplasty between
the improvement in the ankle-brachial
pressure index and in exercise tolerance
and the thigh-brachial index and exercise
tolerance. As before, improvement of the
postexercise ankle-brachial index and ex
ercise tolerance did not differ signifi
cantly.

FIG. 2—Mean ( ± SEM) percent improve
ment of indices after angioplasty. A /B =
ankle-brachial pressure index, T /B = thighbrachial pressure index, PEI = postexercise
ankle-brachial pressure index, ET = exercise
tolerance test.

FIG. 3—Mean (+ SEM) percent improve
ment of indices at 3 months after angioplasty.

Table 1—Indices before and after Percutaneous Transluminal Angioplasty'
Before
Day after
Index
angioplasty
angioplasty
3 mo
12 mo
Ankle-brachial pressure
0.56 ± 0.02
0.73 ± 0.0 3 t
0.78 ± 0.02t 0.82 ± 0 .0 3 t
Thigh-brachial pressure
0.62 ± 0.02
0.83 ± 0 .0 2 t
0.83 ± 0.02t 0.87 ± 0.14 t
Postexercise ankle-brachial
pressure
0.43 ± 0.04
0.62 ± 0.094
0.79 ± 0.03t 0.78 ± 0 .0 5 t
'Figures are mean ± standard error,
tp < 0.001.
+p - 0.05.

Table II—Exercise Tolerance Test: Improvement before and after Angioplasty'
Day after
Before
Exercise
angioplasty
angioplasty
3 mo
12 mo
Time, min
1.72 ± 0.22
2.83 ± 0 .5 8 t
3.90 ± 0.254
4.33 ± 0.204
Distance, m
74.7 ± 15.3
45.3 ± 5.7
102.9 + 6.6
114.3 ± 5 . 1
'Figures are mean ± standard error.
tp < 0.05.
4p < 0.001
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FIG. 4—Mean ( ± SEM) percent improve
ment of indices at 12 months after angioplasty.
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brachial and 86% with ankle-brachial
pressure measurements) were comparable
to those noted by Neiman and associates5
->- in their review of more than 4000 cases
of peripheral vascular disease treated by
percutaneous transluminal angioplasty.
We found no significant difference be^ * tween the improvement in ankle-brachial
i ^.and thigh-brachial indices immediately
after angioplasty, probably because most
, w of our patients had two- and three-vessel
run-off in the calf. Incorporating an ex► ercise tolerance test increased the sensitivi
ty of our evaluation, indicating that
thigh-brach ial and an k le-b rach ial
^pressure m easurem ents tend to
underestimate the functional improveu_ ment in these patients. This is also true
at 3 months; however, at 12 months, the
y difference between the ankle-brachial
pressure index and results of the exercise
f y tolerance test was not statistically signifi
cant (0.1 > p > 0.05). We think that this
r is due to a smaller sample number (23
procedures). Still, the exercise tolerance
‘
test seems to be a more sensitive indicator
, of patient performance.
Our early results suggest that perk k cutaneous transluminal angioplasty offers
results comparable to those of aortoiliac
*

bypass grafting6 if patients are carefully
selected.3,7' 10 None of our patients had
complete obstruction and all lesions in
volved short segments (less than 4 cm).
Four of the eight failures had severe distal
disease, including occlusion of the super
ficial femoral artery and poor run-off.
One patient had a distal graft dilated. On
ly one successful patient had poor run
off in the calf, emphasizing the impor
tance of patient selection for angioplas
ty. As noted in 1975 by Malone and
associates6 in the case of aortofemoral
bypass grafting, the postoperative symp
toms of patients after angioplasty cor
relate well with patency.
Conclusions
This study indicates that with proper
patient selection and technique, trans
luminal angioplasty of the iliac arteries is
an effective treatment, with patency rates
comparable to those of bypass pro
cedures. The inclusion of a functional
component in follow-up evaluations more
closely mimics clinical conditions and is
more sensitive than resting studies alone.
Thus, the referring doctor can successful
ly follow up patients after angioplasty by

noting the walking distance and time
before the onset of claudication in addi
tion to routine physical examination.
Deterioration of symptoms or signs is an
indication for vascular laboratory testing
and, if necessary, angiographic reap
praisal.
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crural 57 ATP concernent I'iliaque
primitive (36) et I'iliaque externe (21). A
I'etage sous-crural 43 ATP concernent
I'artere poplitee haute (9) et I'art6re
femorale superficielle (34). L'ATP de la
lesion iliaque primitive est dominante
avant I'age de 60 ans par rapport a
I'ATP femoro-poplitee (p < 0 .0 5 ). A
I'etage iliaque 89% des patients ont un
stade de claudication severe; e I'etage
femoro-poplite les troubles trophiques
sont retrouves dans 39% des cas. Le
caractdre "dominant" ou "accessoire"
de la lesion n'intervient pas de facon differente dans ('indication selon le niveau.
La thrombose segmentaire repermeabilisee represente 44 .2% des indications
d'ATP femoro-poplite contre 7% a
I'etage iliaque (p < 0.04). Le taux
d'echec est moindre a I'etage iliaque que
femoro-poplite. La surveillance des suites

therapeutiques concerne 8 6 .6 % des
patients avec un recul de 22 mois en
moyenne. Les indices systoliques de la
cuisse apres ATP iliaque et de la cheville
apres ATP femoro-poplite sont majores
de facon significative (p < 0.0 1 ). A
I'etage femoro-poplite, dans 74% des
cas, le patient est totalement asymptomatique. Un seul 6chec est note
(3.8% ); amputation de cuisse au 12e
mois apres ATP. A I'etage iliaque. dans
91% des cas, une amelioration est
observee et 7 0 % des patients sont
asymptomatiques. Globalement, le taux
de succes (permeabilite et amelioration
clinique) actuariel est de 9 2 % ± 0 .0 9 % .
The authors compared the anatomoradiologic data from a series of 100 con
secutive percutaneous transluminal
angioplasties (PTA), as well as the im-
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mediate and long-term results as a func
tion of the level of the lesion — iliac or
femoropopliteal. Proximal to the thigh,
there were 57 PTAs, 36 of the common
iliac and 21 of the external iliac. In the
lower thigh, there were 43 PTAs, 9 of
the upper part of the popliteal artery and
34 of the external femoral artery. Per
cutaneous transluminal angioplasty of
the common iliac lesion was dominant in
patients under 60 years of age (p <
0.05). At the iliac level, 89% of the pa
tients had severe claudication; at the
femoropopliteal level. 39% had trophic
problems. The "dominant” or "ac
cessory" character of the lesion did not
modify the indication for the procedure,
regardless of the level. Segmental throm
bosis accounted for 44.2% of the
femoropopliteal PTA indications, com
pared with 7% at the iliac level (p <
0.04). The failure rate was less at the
iliac than at the femoropopliteal level.
Follow-up was available for 86.6% of the
patients for an average of 22 months.
The systolic indices at the thigh after
iliac PTA and at the ankle after
femoropopliteal PTA were significantly
increased (p < 0.01). At the
femoropopliteal level, 74% of the pa
tients were totally asymptomatic. There
was one failure (3.8%); amputation at
thigh level was carried out 12 months
after the PTA. At the iliac level, improve
ment was observed in 91% of the pa
tients and 70% became asymptomatic.
The overall success rate (clinical patency
and improvement) was 92% ± 0.09% ,
based on the life-table method.

Depuis le rapport preliminaire sur l’angioplastie translum inale percutanee
(APT) de Dotter et Judkins,1 cette tech
nique, standardisee par Gruntzig et
H opff2 et Gruntzig et Kumpe,3 peut etre
consideree comme l’une des plus importantes acquisitions de l’angiographie therapeutique. Elegante car peu agressive,
elle permet sans geste chirurgical direct
une recanalisation ou dilatation des
thromboses et stenoses arterielles segmentaires; l’elargissement endoluminal est le
fruit d’une fragmentation avec clivage de
la plaque atheromateuse intimale, la
media et l’adventice se laissant distendre
du fait de leur elasticite.4 Nous mettons
en correlation les indications anatomocliniques et les resultats des ATP a l’etage
sus-crural et femoro-poplite.
Etude de la serie

De 1979 a 1983 nous avons etudie 100
ATP consecutives. C ’est apres un bilan
fonctionnel clinique, des explorations vasculaires debimetriques non penetrantes et
une analyse des lesions radiologiques que
les indications des ATP ont ete posees au
terme de reunions conjointes entre mede362

cins angiologiques, radiologues et chirurgiens vasculaires. Les ATP ont ete reali
s e s par les radiologues vasculaires. Les
comparaisons statistiques ont utilise les
tests du chi carre, de l’ecart type, du t de
Student ainsi que les calculs actuariels de
succes.
Repartition topographiques des A TP

A 1’etage sous-crural 43 ATP se repartissent en deux groupes — 9 ATP poplites hautes et 34 ATP de l’artere femorale
superficielle. Nous n ’avons pas pose d e 
dication d’ATP des arteres femorales profondes ou poplitees basses.
A 1’etage sus-crural 57 ATP se repartissent en 36 cas concernant l’artere iliaque primitive et 21 cas de l’artere iliaque
externe. Nous n’avons pas retrouve de cas
d’ATP de 1’hypogastrique.
Age et sexe des patients (fig. 1)
Reflet de l’epidemiologie de la maladie
atherosclereuse, la preponderance des

ATP est au sexe masculin (3:1). La femme
est touchee par l’atherome, et par conse
quent justiciable d’ATP, a un age significativement plus eleve que 1’homme (69
ans contre 58.4 annees en moyenne). La
comparaison du niveau cfe l’ATP en fonction de Page des patients (tableau I) montre qu’au dela de 60 ans, 1’ATP femoropoplitee est le plus frequemment rencon-^
tree. L’axe de l’artere iliaque externe est
concerne de fa?on identique quelle que
soit Page; par contre l’ATP d ’une lesion
cible de l’artere iliaque primitive est dominante avant 60 ans (p < 0.001).

-t

*

<

Globalement, 74% des patients sont au
stade de claudication intermittente severe
et 3% des patients ont une lesion asymptomatique dilatee en complement de
lesions plus importantes. Les ATP pour -< ,
sauvetage de membre concernent 23% des
;*
cas: douleurs de decubitus (15%) ou trou-4 r
bles trophiques (8%). La correlation des
I
stades cliniques en fonction du niveau de x '
l’ATP (tableau II) montre qu’a l’etage A

Age, ans
< 60
ATP femoropoplitee
7
ATP iliaque externe
9
ATP iliaque primitive
26
Total
42
X2 - 29.26, degres de liberte - 2, p < 0.01.

*
*

Stade clinique

Tableau 1—Niveau de I'ATP et age
Niveau

4-

>60
33
8
6
47

Tableau II—Niveau de I'ATP et stade clinique
Niveau
Stade clinique
Iliaque
Femoro-poplite
Troubles trophiques ou douleurs de decubitus
6
17
Claudication intermittente
51
26
Total
57
43
Ecart reduit - 3.4, p < 0.001.

Total
40
17
32
89

Total
23
77
100
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iiiaque, dans 89% des cas (51 sur 57), l’indication est motivee par un stade de clau
dication intermittente severe. Par contre,
*■ dans 11% (6 sur 57) seulement des cas,
il existe un stade de sauvetage de mem* bre. A l’etage femoro-poplite on constate
^ ^ une dominance significative (p < 0.001)
de l’indication de 1’ATP pour sauvetage
K39.5%) (17 sur 43) par rapport a l’ATP
iiiaque.
Resultats
Lesions anatomiques
V

►

La lesion cible concernee par l’ATP
peut s’integrer dans un tableau d’atteinte
etagee polystenosante; elle est alors accesy soire (38%) ou bien dominante, determinante dans la symptomatologie fonctioY r nelle (59%). Dans ce dernier cas l’ATP
^se veut curative. II apparait que ce caracf tere “ accessoire” ou “ dominant” n ’inA tervient pas dans l’indication selon le
niveau sus- ou sous-crural; la lesion est
t determinante dans 64.3% (27 sur 42) des
ATP femoro-poplitees et dans 58.2% (32
* *> sur 55) des ATP iliaques. A l’etage
femoro-poplite, les thromboses segmen* k taires a repermeabiliser representent
44.2% (19 sur 43) des indications contre
7% (4 sur 57) a l’etage iiiaque (p < 0.04);
1’indication des ATP sus-crurales est dans
plus de 9 cas sur 10 une stenose. Ces donv nees anatomiques correspondent a l’observation faite cliniquement de lesions
j- - femoro-poplitees dilatees a un stade de
sauvetage de membre. La longueur
^ r moyenne des thromboses repermeabilisees
,

FIG. 2—Evaluation hemodynamique des 14
ATP iliaques (indice systolique a la cuisse).
Recul moyen de 13.3 mois (extremes: 1 a 28
' mois). Ecart type de la moyenne. Difference
moyenne (7X) = 0.223 ± 0.14, t de Student
' 7 (t) = 5.9, degres de liberty (ddl) = 13, p <

est de 3.5 ± 2.5 cm (ecart type) et celles
des stenoses de 1.8 ± 1.5 cm. La longueur
moyenne de la thrombose est significativement plus importante que celle de la ste
nose (p < 0.01). II n ’existe pas de diffe
rence significative entre les longueurs
moyennes des thromboses repermeabili
sees selon le niveau sus- ou sous-crural de
meme qu’entre les stenoses a ces niveaux.
Resultats immediats des A TP
selon le niveau sus- ou sous-crural
Le taux d ’echec radio-clinique lie a la
methode est de 18% (18 sur 100); la comparaison des echecs radio-cliniques selon
le niveau iiiaque (14%) (8 sur 59) et
femoro-poplite (23%) (10 sur 43) est en
faveur d ’un moindre taux a l’etage iiia
que a la limite de la signification statistique (p < 0.06). L’analyse des 10 echecs
d’ATP sous-crurales montre que sur huit
lesions de l’artere femorale superficielle
la lesion n ’a pu etre franchie dans cinq
cas (quatre thromboses segmentaires et
une stenose pre-occlusive); dans les trois
autres cas, la dilatation n’a pas ete suffisante (absence d ’amelioration clinique
dans un cas et thrombose secondaires
dans les autres suivies d’une amputation
de cuisse pour l’une et d’une sympathectomie lombaire pour l’autre). Les deux
echecs d’ATP poplitee pour des lesions
pre-occlusives et thrombotiques ont
entraine une amputation et une sympathectomie lombaire.
Au niveau sus-crural, les echecs (huit
cas) sont le fait de lesions non franchies,
pre-occlusives deux fois et non dilatables
trois fois. Dans trois cas, malgre une dila
tation radiologique correcte de lesions
“ accessoires” , il existe un echec clinique.
La morbidite liee a l’abord percutane
femoral est la meme quelque soit le niveau
de l’ATP: sept hematomes au point de
ponction, non chirurgicaux.

Resultats tardifs compares
entre A TP iliaques et f&morales
La surveillance des suites therapeutiques, d ’une duree moyenne de 22 mois (3
a 38 mois), concerne 86.6% des ATP
reussies. Les indices systoliques a la cuisse
apres ATP iiiaque sont significativement
majores: l’indice moyen avant ATP,
de 0.88% ± 0.03%, est augmente a
1.1% ± 0.04% (p < 0.001). Les memes
constatations sont faites au niveau de la
cheville apres ATP femoro-poplitee:
de 0.71% ± 0.03% l’indice passe a
0.90% ± 0.04% (p < 0.001) (figs. 2 et 3).
Sur le plan fonctionnel a l’etage
femoro-poplite, sur 27 ATP suivies, une
amelioration est acquise dans 96.3% (26
sur 27) des cas et, dans 74% (20 sur 27)
des cas, le patient est totalement asymptomatique (fig. 4a). Le cas d ’am putation
de cuisse observe (3.8%) a ete secondaire
a une gangrene que l’ATP a stabilise pen
dant 12 mois. La lesion etait pre-occlusive
et “ accessoire” .
A l’etage iiiaque, 44 patients soumis a
une ATP ont ete suivis. Dans 70% (31 sur
44) des cas, les patients sont asymptomatiques et dans 91% (40 sur 44) des cas une
amelioration est observee. Quatre patients
ont ete operes pour stenose recidivante,
soit sur la zone anterieurement dilatee
(trois fois a 10 et 12 mois), soit dans un
segment arteriel sus-jacent a l’ATP (fig.
4b).
Globalement, sur 71 patients suivis
apres ATP, le taux de succes actuariel
(asymptomatique ou perimetre de marche
augmente) a 3 ans est de 92% ± 0.09%.
Discussion
Sur un plan technique, l’ATP a toujours ete realisee sous heparinate de
sodium intraveineux. L’anticoagulation a

A

0.001.

FIG. 3—Evaluation hemodynamique des 10
ATP femoro-poplitees (indice systolique jambier). Recul moyen de 12 mois (extremes: 1 a
30 mois). S = 0.191 ± 0.09, (t) = 6.6, ddl
= 9, p < 0.001.

FIG. 4—Comparaison des resultats fonctionnels tardifs selon le niveau de I’ATP. (a)
27 femoro-poplitee suivies, (b) 44 iliaques
suivies.
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ete poursuivie pendant 48 heures avec
relais aux anti-aggregants plaquettaires
(dipyridamole-Aspirine). L’appreciation
de l’efficacite hemodynamique de la dila
tation ou de la recanalisation a ete faite
par les mesures des gradients transstenotiques. Ceux-ci sont plus fiables a
l’etage iliaque que femoro-poplite du fait
de la taille des arteres.
Les verification anatomo-pathologiques4 ont permis de visualiser l’indeformabilite de la plaque d’atherome; sous
l’effet de la pression, elle se rompt sur la
media et l’adventice qui, par leur elasti
city, se pretent sans rupture a la dilata
tion. La cicatrisation intimale secondaire
se fait sans retraction fibreuse ce qui
explique la persistance du “ recalibrage”
La cicatrice retractile explique peut-etre
les recidives observees. Dans un quart des
cas, apres ATP, il persiste un aspect
radiologique de dissection s’expliquant
par ces ruptures sous-intimales. En aucun
cas la realisation d’une ATP n ’a entrave
secondairement un geste de chirurgie. Les
complications chirurgicales sont appreciees a 3.5% par Roberts et Ring,5 dominees dans 1% a 2% des cas par des
hemorragies au point de ponction et, dans
1% des cas, par une migration embolique
deteriorant le lit d’aval. Dans un cas (1%)
de notre serie, une desobstruction par
catheter de Fogarty a ete necessaire.
Schneider et collaborateurs6 rapportent,
sur 882 cas d ’ATP, un taux de complica
tions chirurgicales de 2.5% (2% de sutu
res arterielles et 0.5% d’emboles). Le taux
d ’echecs de notre serie lie directement a
la methode est de 10%; il s’agit soit d ’une
stenose franchie non dilatee ou d ’une
thrombose secondaire. Le taux d’echec de
l’etude collective rapportee par Zeitler et
collaborateurs7 sur 2942 cas d ’ATP est
aussi de 10%. Schneider et collabora
teurs6 evaluent le taux de succes initial
entre 93% pour les ATP iliaques et 88.3%
pour les atteintes femoro^poplitees.
Levade et collaborateurs8 rapportant les
resultats de l’etude multicentriques franfaise sur 647 cas d ’ATP, observent 6%
de complications (dont 2% chirurgicales)
et un taux de succes de 96% a l’etage
iliaque et 92% a l’etage sous-crural.
Rieger et collaborateurs,9 sur 306 steno
ses iliaques, observent 88.3% de succes
immediat.
Tardivement 1’evaluation des resultats
repose sur l’amelioration clinique et
hemodynamique ainsi que sur d’eventuels
controles radiologiques. La mesure des
indices systoliques a la cuisse et a la cheville permet d ’authentifier un bon resultat ainsi que les epreuves de marche avec
etude de la recuperation des valeurs de
repos.10,11 Samson et collaborateurs12
decrivent une possible dissociation anatomoclinique: dans 9 cas sur 12 d ’ATP
iliaques et 3 sur 12 ATP femoro-poplitees
sans amelioration objective des chiffres
hemodynamiques malgre un succes radio
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logique, les membres ont ete sauves. Anatomiquement, le controle est possible par
les methodes semi-effractives que sont les
angiographies intraveineuses photographiques avec soustraction13 ou les angio
graphies veineuses digitalisees.14
La fiabilite a long terme de l’ATP est
grande. Schneider et collaborateurs6
retrouvent un taux actuariel de permea
bility a 1 et 5 ans de 89.4% et 84.6% a
l’etage iliaque et de 74% a 68% au niveau
sous-crural. Sur 5000 cas recenses par
Zeitler et collaborateurs,7 le taux de per
meability a 3 ans a l’etage iliaque est de
84% et, a 5 ans a l’etage femoro-poplite,
de 69%. Rieger et collaborateurs9 ont
retrouve un taux de permeability a 6 ans
de 80% sur 164 stenoses iliaques controlees.
Ainsi Tindication ideale de l’ATP estelle representee par le stenose courte, concentrique et non calcifiee de 1’artere ilia
que primitive ou de 1’artere iliaque
externe.5’15 A Petage femoral c’est surtout 1’artere femorale superficielle qui est
l’objet de la dilatation. Ces indications
sont elargies aux arteres iliaques internes,
femorales profondes et au stenoses
anastomotiques.5
Conclusions
Le taux important de succes initial et
a long terme de cette technique peu agressive et non chirurgicale lui reserve une
place de choix dans le traitement de cette
maladie chronique qu’est l’arteriopathie
des membes inferieurs. Les limites tech
niques de l’ATP, progressivement reculees, permettent d’elargir les indications.
Loin d ’etre une therapeutique concurentielle de la chirurgie, l’ATP en est un com
plement. Peut-etre la decennie a venir
elargira-t-elle les possibility de l’angiographie therapeutique par l’application
du rayon laser sur la plaque d ’atherome.
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Duodenal Obstruction Secondary to Congenital Web
in an Adult
-

'Congenital duodenal web, although rare,
may be more common than presently apr predated. The possibility of this condi
tion should be considered in the differen
tial diagnosis of duodenal obstruction in
y the adult. It should be treated
surgically either by duodenotomy with
► excision of the web or by duodenoje
junostomy. The results are excellent, as
*- illustrated by the authors in their report
of a 58-year-old man with this condition,
* who was treated by duodenojejunostomy.
x
Bien que rare, la presence d'un
diaphragme duodenal congenital est
peut-etre plus frequente qu'on ne le croit
presentement. Cette possibility doit etre
, y envisagee chaque fois que I'on procede
au diagnostic differential d'une obstruc► tion duodenale chez I'adulte. Cette affec
tion est une indication de chirurgie.
r L'operation consiste en une duodenotomie avec incision de la membrane ou
*en une duodeno-jejunostomie. Les
resultats sont excellents comme I'illustre
le cas decrit par les auteurs d'un homme
de 58 ans qui a ete traite par duodenojejunostomie.

^Congenital duodenal diaphragm or web
is a rare anomaly, reported to occur in 1
► in 9000 to 40 000 births.1 The majority
become apparent in infancy. Its occurr rence in adults has been considered a rari
ty, but recent reports suggest that this eny tity may be more common than previous
ly appreciated.13 Appropriate investiga
tions include plain films of the abdomen,
► upper gastrointestinal series and
gastroduodenoscopy. Once the diagnosis
r is made, operation is indicated.
We report a case of congenital web
►which presented with acute duodenal
obstruction in an adult and was diagnos-

ed preoperatively. Excellent results were
obtained with a duodenojejunostomy.

Case Report
A 16-hour history of progressive abdominal
distension, epigastric fullness and one episode
of vomiting led to the admission o f a 58-yearold man. He denied a history o f peptic ulcer
disease, weight loss or malaise. He admitted
that he had suffered intermittently for many
years from epigastric fullness and mild discom
fort following the ingestion of high residue
foods, particularly raw fruits and vegetables,
but because this occurred infrequently he had
never sought medical attention. He was a wellnourished, mildly obese, afebrile man who
complained of mild discomfort and had mark
ed upper abdominal distension. There were no
signs of peritoneal irritation and bowel sounds
were norm al. His hemoglobin, serum elec
trolyte and blood urea nitrogen levels were nor
mal. The leukocyte count was slightly elevated.
Abdominal films showed a markedly distended
stomach (Fig. 1). Following insertion of a
nasogastric tube, 1.5 L of bile-stained fluid
were aspirated.
Roentgenography after barium meal show
ed that the first and second portions of the
duodenum were distended (Fig. 2a) and there
was partial obstruction at the third portion
(Fig. 2b). A septum was outlined at the point
of obstruction, with the contrast medium trick
ling through a centrally located aperture.

_ f From the Department o f Surgery,
St. Joseph’s Health Centre and University
K o f Toronto, Toronto, Ont.
Accepted fo r publication Dec. 22, 1983
^ Reprint requests to: Dr. M. Deitel,
St. Joseph’s Health Centre Research
\ dFoundation, 30 The Queensway, Toronto,
Ont. M6R 1B5

FIG. 1—Plain film shows stomach distend
ed with fluid.

Ultrasonography revealed a normal gallblad
der, biliary tree and pancreas.
Endoscopy, using the 11-mm Q-gastroscope,
revealed a normal esophagus, a large stomach
containing bile-stained material, a dilated
pylorus and first, second and proximal third
parts of the duodenum. There was no duodenal
ulcer. At the proximal third part of the
duodenum, approximately 7 cm beyond the
ampulla of Vater, was a circumferential, soft,
mucosa-lined diaphragm with a central open
ing. The endoscope could be passed wrlh dif
ficulty through the centrally located aperture,
the margins of which hugged the instrument.
At laparotomy on the day of admission, a

Fig. 2b
FIG. 2—(a) Markedly distended first and se
cond portions of duodenum, (b) Almost com
plete obstruction of proximal third part of
duodenum due to septum with tiny central
opening.
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cause. We believe this explains the de
velopment of obstruction in our patient.
The diagnosis of duodenal web in an
adult requires an awareness of the enti
ty, in order to distinguish it from the
other uncommon causes of high smallbowel obstruction, such as superior
mesenteric artery syndrome7,8 and an
nular pancreas.9 Plain abdominal roent
genograms may show dilated stomach
and proximal duodenum. The upper
gastrointestinal series will demonstrate the
dilated stomach and duodenum proximal
to the web and may show a windsock
shaped obstruction (Fig. 2b). Gastroscopy
was used in seven other cases,1-3,10 but
Discussion
was carried through the duodenum far
enough to give the diagnosis preoperativeF o rty -th ree cases o f congenital ly in only three; the diagnosis was con
duodenal web presenting in adults have firmed by gastroduodenoscopy in our
been reported,1 5 in the past 2 years.2,3 patient.
Some patients had moderate to severe
Intraoperatively, the presence of a
symptoms of upper gastrointestinal tract slight circumferential indentation of the
obstruction intermittently for several duodenum externally indicated the site of
months to a few years. Outlet obstruction the web. Histologically, the web consists
attributed directly to peptic ulcer disease of a lining of thickened mucosa, including
was the most common preoperative muscularis mucosae, on both sides of a
diagnosis in these cases.1-4 In the three normal submucosa.5 Of these duodenal
patients described by Cooperman and webs, 75% are within 2 cm of the ampulla
associates1 and in two of three patients of V ater;1,5 approximately 60% are
reported by Killebrew and Kukora,3 con located proximal to the ampulla.3
servative therapy resulted in marked pro
Initial therapy consists of gastric de
longation of obstructive symptoms with compression with a nasogastric tube and
resulting malnutrition.
replacement of fluid and electrolytes. The
The embryologic defect producing the surgical procedures that have been per
duodenal web is probably best explained formed include duodenotomy with exci
by Tandler’s theory, proposed in 1900.5 sion of the web and duodenoplasty,1,3,6,10
Tandler examined the developing gut in duodenojejunostomy,8 gastrojejunosto
embryos and found that during its my3,6 and duodenoduodenostomy.2,11
development the intestinal lumen is fill Most patients have been treated by duo
ed with proliferating epithelium. A pro denotomy with excision of the web and
cess of vacuolization results in a lumen. suturing the mucosal edges together, with
If vacuolization is incomplete, a duodenal either a transverse or longitudinal closure
web may result. Atresia of the intestinal of the duodenotomy or Finney pyloro
lumen also occurs as a result of in plasty.1-3,6,10 This gives excellent results.
complete vacuolization. A complete web Gastrojejunostomy may be inadequate,
becomes manifest in the neonate. When as it fails to relieve the duodenal obstruc
apertures are present, they may be single tion and symptoms often persist postor multiple. One patient, reported by operatively.4 Furthermore, bile gastritis
Bilton and Yap,6 had a single 2-mm may recur subsequently. We preferred
aperture that did not become clinically ap duodenojejunostomy in our patient, be
parent until age 61.
cause the web was approximately 7 cm
It is not clearly understood why pa beyond the ampulla and quite close to the
tients with small apertures may live for superior mesenteric artery. Technically,
many years asymptomatically, in a nor this was easily performed.
Our patient differed in that he had a
mal nutritional state, and then the con
dition may progress to obstruction. In at brief history of obstructive symptoms.
least six reported cases the obstruction oc The normal electrolyte levels, fluid
curred concomitantly with pyloroduo- balance and nutritional status of the pa
denal ulceration. Subsequent medical tient support this. However, the fact that
ulcer therapy resulted in only temporary he had a markedly distended stomach and
relief of the obstruction.1-3 Mucosal duodenum and yet had vomited only once
edema associated with the ulcer with and was not in severe distress indicated
resultant narrowing of the aperture distal- that there was a degree of chronic
ly may have caused the condition to pro obstruction.
gress to obstruction in these patients. In
The congenital duodenal web, although
termittent partial duodenal obstruction by rare, is likely more common than has
debris following high-residue meals and been appreciated, with three papers be
mucosal edema are likely an important ing published recently, reporting on eight
normal gallbladder and pancreas were noted.
The first, second and proximal part o f the third
portions o f the duodenum were dilated and
mobilized by the Kocher maneuver. There was
no evidence o f compression o f the duodenum
by the superior mesenteric artery, the obstruc
tion being to the right o f this vessel. The
duodenum was marked externally by a slight
ring-like constriction at the site o f obstruction.
A side-to-side antecolic duodenojejunostomy
was performed. The postoperative recovery
was uncomplicated. At the 6-month follow-up,
the patient was asymptomatic, experiencing no
epigastric fullness or discomfort with highresidue foods. An upper gastrointestinal series
showed that the duodenojejunostomy emptied
promptly.
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adult patients.1-3 This entity should be
considered in the differential diagnosis of
subacute or acute duodenal obstruction
in the adult. Once the diagnosis is made, Tsurgical correction either by duodeno
tomy with excision of the web or a *
duodenojejunostomy provides excellent.results.
4

A
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The recommended initial treatm ent dose in good risk patients is 14
mg/m2.
Efficacy
Efficacy data are available on 349 patients with locally advanced or
metastatic breast carcinoma. Results are dependent on many predispos
ing factors including prior chemotherapy and/or radiotherapy, the health
o f the patients, sites of metastases, and dose of the agent employed. In a
European multi-centre first- line single-agent trial using an initial dose
o f 14 m g/m 2. the overall response rate was 39% . which compared
favourably to doxorubicin therapy at a dose o f 60-75 m g/m 2when given
to patients with similar stage disease. In an ongoing study o f a direct
comparison with doxorubicin, given as second-line therapy to breast
cancer patients who failed a standard first-line combination, response
rates are 27% for NOVANTRONE* and 23% for doxorubicin. The mean
duration of response observed after NOVANTRONE* was greater than
those reported after doxorubicin. Responses have been seen in all major
sites o f metastases including lymph nodes, lung, bone, skin and viscera, in
patients both with and without prior hormonal therapy. Available data

suggest that NOVANTRONE* is comparable in efficacy with doxorubicin
in the treatment o f advanced breast cancer. Myelosuppression with 2 1-day
treatment intervals is comparable with that observed with doxorubicin.
Multiple courses o f single-agent NOVANTRONE* therapy, in some cases
for longer than twelve cycles, have been administered with excellent
tolerance and a good response. NOVANTRONE* showed incomplete crossresistance with doxorubicin since responses have been observed in pa
tients in whom doxorubicin had failed or who relapsed after response to
that drug. A continuing large-scale clinical trials program with combi
nation therapy also demonstrated early positive results for efficacy and
safety. In seven studies, over 100 cycles o f combination therapy have
been given to 77 patients.
Safety
Data on the overall safety profile of NOVANTRONE* (based on 989 patients)
demonstrated advantages o f NOVANTRONE* compared to the anthracy
clines with respect to both the quality o f life and tne long-term safety of
patients. The majority o f side effects with NOVANTRONE* are mild in
nature. Removal o f patients from NOVANTRONE* treatment for reasons
o f toxicity has been rare in clinical studies. A number o f patients have
reported no side effects at all. In addition, the relatively low risk of
serious side effects has permitted treatment o f patients on an out-patient
basis. The most common acute effects were nausea and/or vomiting
(only 3.5% severe or very severe with NOVANTRONE*. compared to
10-15% reported with doxorubicin), stomatitis/mucositis (only 0.3%
severe or very severe with NOVANTRONE*) and alopecia (only 0.9%
severe or very severe, and 15% overall with NOVANlRONE* compared
with 85% severe o r very severe and 100% overall reported with
doxorubicin). Serious local reactions have not been reported following
extravasation o f NOVANTRONE* at the infusion site.
With respect to myelosuppression, initial NOVANTRONE* doses o f 14
mg/m2 every three weeks are well-tolerated in good-risk patients. Se
vere degrees o f myelosuppression have been rare. The median white
cell nadir in a European second-line study was 2 .5 x l0 3; in a European
first-line study only 4.8% (2/42) o f patients experienced a nadir o f less
than 1.000. The nadir usually occurs around day 10 or 11 and returns to
normal baseline value by day 21, in time for the next course of treatment.
After multiple courses o f NOVANTRONE*. white blood cell and platelet
nadirs show no further decrease beyond those observed in the first few
cycles, indicating no cumulative or permanent effects of NOVANTRONE*
on marrow reserves.
Cardiotoxicity
Adverse cardiac experiences have been infrequent. In contrast, doxoru
bicin has been reported to produce chronic cardiomyopathy and irre
versible congestive heart failure in up to 11 % o f patients given nine or
more courses o f that drug at the usual dose schedule (60 mg/m2 every
three weeks). Whether or not related to NOVANTRONE*. only 119 cardiacrelated episodes have been reported from a total data-base o f more than
3,200 treated patients, including only 29 (0.9% ) reports o f clinical con
gestive heart failure, o f which only one had no other known predispos
ing factors. The risk o f cardiotoxicity is increased with prior antineoplastic drug or radiation therapy. In patients without predisposing
factors, development o f congestive heart failure with NOVANTRONE*
therapy is rare.
Clinical experience suggests there is no need to lower the dose for pa
tients with existing renal o r hepatic disease.
In summary, NOVANTRONE* is well tolerated and provides a better
quality of life for patients with breast cancer, compared with doxorubicin
and yet shows comparable efficacy.
NOVANTRONE* has been used alone or in combination in patients with
or without prior chemotherapy, as well as in those who have received
prior adjuvant therapy. It is less cardiotoxic than anthracyclines such as
doxorubicin and thus represents a clear therapeutic advance over cur
rently available compounds.
SYM PTOM S AND TR EA TM EN T O F OVERDOSAGE
There is no known specific antidote for NOVANTRONE. As would be
expected from the pharmacological actions of the drug, haematopoietic,
gastrointestinal, hepatic and renal toxicity may be seen, depending on
the dosage given and the physical condition o f the patient. The manage
ment of overdosage is symptomatic and supportive and patients should
be monitored closely. (See also the sections “ WARNINGS” , “ PRE
CAUTIONS” and “ ADVERSE REACTIONS")
DOSAGE
The recommended initial dosage for use as a single agent is 14 mg/m2of
body surface area, given as a single intravenous dose, which may be
repeated at 2 1-day intervals. A lower initial dose (12 mg/m2 or less) is
recommended in patients with inadequate marrow reserves due to prior
therapy or poor general condition.
Dosage modification and timing o f subsequent dosing should be deter
mined by clinical judgement depending on the degree and duration of
myelosuppression. If 2 1 day white blood cell and platelet counts have
returned to adequate levels, prior doses can usually be repeated. The
following Table indicates a guide todosing based on myelosuppression.

WBC AND
PLATELET NADIR
IF WBC NADIR
>1 500
AND
PLATELET NADIR
>50 000
IF WBC NADIR
>1 500
AND
PLATELET NADIR
>50 000
IF WBC NADIR
<1 500
OR
PLATELET NADIR
<50 000
IF WBC NADIR
<1 000
OR
PLATELET NADIR
<25 000

TIME TO
RECOVERY
RECOVERY
<21 DAYS

SUBSEQUENT
DOSING
REPEAT PRIOR DOSE OR
INCREASE BY 2mq/m! IF
MYELOSUPPRESSION NOT
CONSIDERED ADEQUATE.

RECOVERY
>21 DAYS

WITHHOLD UNTIL
RECOVERY THEN
REPEAT PRIOR DOSE.

ANY DURATION DECREASE BY 2mq/m2
FROM PRIOR DOSE AFTER
RECOVERY.
ANY DURATION DECREASE BY 4 mg/m2
FROM PRIOR DOSE AFTER
RECOVERY.

While no unforeseen problems have been encountered when NOVAN
TRONE* is used in combination with other antineoplastic therapy, data
are limited; therefore, NOVANTRONE* in combination therapy should
be used with caution until wider experience is obtained.
As a guide, when used in combination chemotherapy with another
myelosuppressive agent, the initial dose o f NOVANTRONE* should be
reduced by 2-4 m g/m2 below the doses recommended above for single
agent usage; subsequent dosing, as outlined above, depends on the de
gree and duration of myelosuppression.

AD M IN ISTRA TIO N O F SOLUTION
NOVANTRONE* solution should be diluted to at least 50 mL with either
Sodium Chloride for Injection (U.S.P.) or 5% Dextrose for Injection
(U.S. P.). This solution should be introduced slowly into the tubing of a
freely-running intravenous infusion o f Sodium Chloride for Injection
(U.S.P.) or 5% Dextrose for Injection (U.S.P.) administered over not
less than three to five minutes intravenously. If extravasation occurs,
the administration should be stopped immediately and restarted in an
other vein. However, serious local reactions have not been reported
following extravasation.
NOVANTRONE* should be administered by individuals experiencedig,
the use o f antineoplastic therapy.
Caution in the handling and preparation of NOVANTRONE* solutions
must be exercised and the use o f protective eyeglasses, gloves and adttr^
protective clothing is recommended. (See "SA FE HANDLING BY
HOSPITAL PERSONNEL" section).
STO RA G E DIRECTION S
4
<
NOVANTRONE* should be stored at room tem perature — DO NOT
FREEZE. With recommended storage. NOVANTRONE* remains stable
for two (2) years.
-i
Following preparation o f the infusion, the diluted solution should be
stored at room temperature and used within 24 hours. Any original
solution which remains in the vial should be discarded. NOTE: LIKE
THE ORIGINAL SOLUTIONS, THE DILUTIONS SHOULD ALSO
NOT BE FROZEN.
DRUG CO M PATIBILITY
^ *•
Until specific compatibility data are available, it is recommended that
NOVANTRONE* not be mixed in the same infusion with other drugs. .
G U IDELINES FO R SAFE USE BY H O SPITAL PE R SO N N E L ^
Handling:
1. Preparation o f antineoplastic solutions should be done in a v e rn a l laminar flow hood (Biological Safety Cabinet — Class II).
2. Personnel preparing NOVANTRONE* solutions should w ear PVC
gloves, safety glasses and protective clothing such as disposable
gowns and masks.
3. Personnel regularly involved in the preparation and handling of
antineoplastics should have bi-annual blood examinations.
■* «,
Disposal:
1. Avoid contact with skin and inhalation of airborne particles by use
o f PVC gloves and disposable gowns and masks.
2. All needles, syringes, vials, ampoules and other materials which
have come in contact with NOVANTRONE* should be segregated in
plastic bags, sealed and marked as hazardous waste. I n c in e ra te d J
I000°C or higher. Sealed containers may explode if a tight seal
exists.
3. If incineration is not available, mitoxantrone hydrochloride may \fk
detoxified by adding 5.5 parts by weight of calcium hypochlorite to
each 1 part by weight of mitoxantrone hydrochloride in 13 parts by
weight o f water. + The calcium hypochlorite should be added GR*V*
DUALLY and the procedure carried out with adequate ventilation
since chlorine gas is liberated.
Vials:
* *
Prepare an adequate quantity of calcium hypochlorite solution (eg; Add
43.5 g calcium hypochlorite to 100 mL of w aterf). W ithdraw any
NOVANTRONE* remaining in the vial with the aid of a hypodermic syringe.
Add to the prepared calcium hypochlorite solution slowly, preferably in
chemical fume hood or biological safety cabinet — Class II. Add an
appropriate quantity o f the calcium hypochlorite solution to the vial to
detoxify any remaining drug. W ithdraw the solution and discard in the
sewer system with running water. Dispose of the detoxified vials in a
safe manner.
Needles, syringes, disposable and non-disposable equipment:
Rinse equipment with an appropriate quantity o f calcium hypochloci'e .
solution (43.5 g per 100 mL o f water*). Discard the solution in the
sewer system with running water and discard disposable equipment in a
safe manner. Thoroughly wash non-disposable equipment in soap^ind^
water.
Spillage /Contamination:
Wear gloves, mask, protective clothing. Place spilled material in sp
appropriate container (i.e. cardboard for broken glass) and then in a
polyethylene bag; absorb remains with gauze pads or towels; wash area
with water and absorb with gauze or towels again and place in bag;-scaj,
double bag and mark as a hazardous waste. Dispose o f waste by inciner
ation or by other methods approved for hazardous materials. Personnel
involved in cleanup should wash with soap and water.
^
t Appropriate safety equipment such as goggles and gloves should be
worn while working with calcium hypochlorite solution since it is
corrosive.
—r
AVAILABILITY
NOVANTRONE* mitoxantrone hydrochloride for injection is supplied as
a sterile aqueous solution at a concentration equivalent to 2 mg mitoxaif- '
trone free base per mL. and is available in the following vial sizes:
lOmL/vial (20mg) Product C o d e .............................................. 9393-34
12.5mL/vials (25mg) Product C o d e .......................................... 9393-7*
Identification:
Glass vials containing 10 and l2.5m L o f a clear, dark blue solutio^
CH EM ISTRY
Composition
NOVANTRONE* mitoxantrone hydrochloride, a synthetic anthracenedi^ne.'*
is a potent antineoplastic agent. Its molecular formula is C 22H 28N40 6
.2HC1 and its m olecular weight is 517.4. It is a hygroscopic dark blue
solid supplied as a sterile, aqueous solution containing mitoxantronf
hydrochloride equivalent to 2 mg/mL mitoxantrone free base, with so
dium chloride, sodium acetate, and acetic acid as inactive ingredients.
The product does not contain antibacterial preservatives. Its structural
formula appears below.
HO

O

HO

O

H
H
N C H .C H ,N C H ,C H jO H

N C H ,C H ,N C H ,C H ,O H
H
H

PAAB
CCPP
*T ra d e mark of American Cyanamid Company

Cyanamid Canada Inc.
Toronto

'* ■

molecular form ula: C 22H 2gN40 6.2HCI
molecular weight: 517.4.
Chemical Name
^ J
1 .4-Dihydroxy-5.8-bis[[2-[(2-hydroxyethyl)amino]ethyl] aminoj -9,10-anthracenedione dihydrochloridc

Product monograph available on request.
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The Prone Position for Transurethral Resection of
Anterior Bladder-Wall Tumours
Transurethral resection of tumours of the
. » anterior bladder wall may be technically
difficult. The resectoscope must be held
► with an awkward upside-down grip and
the surgeon assume an uncomfortable
' " position, particularly as the bladder fills
^nd causes the tumour to drift away
from the surgeon. There is a risk of int traperitoneal perforation as the surgeon
cuts more deeply to resect the tumour.
+ When the patient is in the prone position
the tumour is more accessible. This
» *■ allows it to be resected more easily,
more thoroughly and more comfortably.
4 *The technique may be used in men as
well as in women.
La resection transuretrale des tumeurs de
la paroi anterieure de la vessie peut
y presenter des difficultes techniques. La
prise du resectoscope est difficile et le
■ v chirurgien conserve une position inconfortable, particulierement quand la vessie
v *se remplit, poussant la tumeur hors de la
portee du chirurgien. Alors que le
T chirurgien doit sonder plus profond6ment
pour rSsequer la tumeur, il y a risque de
perforation intrap£ritoneale. La tumeur
r , est plus facilement accessible quand le
patient est couch6 sur le ventre. Ceci
v- vpermet une resection plus facile, plus
complete et plus confortable. La techniy que s'applique aussi bien chez I'homme
que chez la femme.
r

y Transurethral resection is an excellent
method of treating patients with the comKnon, superficial stage 0, A or B1 car
cinoma of the bladder and as palliation
->- for some patients with stage C or D
tumours (Jewett classification1 with the
*• Marshall modification2). The procedure
is technically simple, the morbidity and
*" mortality are low and bladder function is
^ ^preserved. These benefits are related, to
some extent, to the experience of the
.
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surgeon and to the fact that most blad
der cancers are found near the ureteral
orifices. Melicow3 noted that, in 70% of
patients, the carcinomas are found on the
posterior and lateral wall near the ureteral
orifices, 20% are found on the trigone
and in only 10% of patients do the
tumours occur on the dome of the blad
der. Cox and associates4 reported that
44% of carcinomas are found on the
lateral wall, 26% at the base of the blad
der and only 13% are located on the
dome. In 17% of the patients the lesions
were multiple.4 Greene and associates5
noted that more than 80% of carcinomas
of the bladder are related anatomically to
the ureteral orifice and only 9% are found
on the anterior bladder wall (Table I).
The tum ours, which are found
anteriorly near the 12 o ’clock position,
are often silent and thus more advanced
when the diagnosis is made. A few are
high-grade adenocarcinomas reflecting a
urachal origin. Anterior bladder-wall
tumours are technically more difficult to
handle with a resectoscope because the in
strument must be held in an awkward up
side-down grip. Moreover, the surgeon
often needs to assume an uncomfortable
position and, as the bladder fills, the
tumour drifts away from the resectionist,
forcing him to “ reach” to continue to
resect the tumour. In some cases, an assis
tant must apply suprapubic pressure.
There is the added risk of intraperitoneal
perforation of the bladder as the surgeon
resects more deeply to remove all the
carcinoma.
Some years ago, the senior author
(R.A .H .), faced with the problem of a
carcinoma in the anterior wall of the blad
der in a woman, suggested that the

T a b le 1— L o c a tio n of B la d d e r T u m o u rs 3
L o c a tio n

No.

%

P o s te ro la te ra l to u re te ra l o rific e s

55

46

L a te ra l w a ll

26

22

B ase

14

12

T rig o n e
D om e, a n te rio r w a ll

3

2

11

9

V e s ic a l n e ck

7

5

P o s te rio r w a ll

5

4

tumour could be resected more thorough
ly, more easily and more comfortably
with the patient in the prone position.6
In this position, the anterior wall of the
bladder has the same relation to the resec
tionist as the trigone and posterior wall
of the bladder have in the lithotomy
position.
We would like to draw attention to this
suggestion and extend its applicability to
men. In men, an external perineal
urethrotomy is needed with the urethro
tomy as proximal in the perineal urethra
as possible, so there will be a “ straight
shot” through the prostatic urethra into
the bladder.
Surgical Technique
The procedure may be done with the
patient under general or spinal anesthesia.
The patient is in the usual lithotomy
position when the diagnostic cystoscopic
examination is made. The resectoscope
sheath is passed through the urethra in
women or the urethrotomy in men. The
foot section of the operating table,
lowered for the cystoscopic examination,
is elevated into place and the patient’s legs
are lowered onto the foot section. The pa
tient, with the resectoscope sheath in situ,
is turned to the prone position, with the
legs straight and together so that the
resectoscope sheath is supported by the
medial aspect of the thighs. The resec
toscope sheath may be wrapped with a
sterile towel and held by the surgeon. The
patient is placed so that the abdomen lies
on the middle section o f the table,
pushing the anterior bladder wall into a
flattened and more accessible position for
the resectionist. An arm board is secured
to each side of the middle section o f the
surgical table in a slightly abducted posi
tion and the legs are strapped to the arm
boards. The foot section of the table is
lowered completely to provide room for
the resectionist. The operative site is
prepared once more.
When the anterior lobe o f the prostate
is enlarged, a certain effort must be made
to elevate the ocular end of the resec
toscope so that the loop may bite deeply
into the tumour. Sometimes the anterior
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lobe o f the prostate must be resected.
When the procedure is completed, a no.
24 French Foley catheter is left in the
bladder for 6 days. In men, the Foley
catheter is introduced with the patient
supine and traverses the entire urethra.
The perineal incision is packed with
iodoform gauze to control bleeding.
Several catgut sutures in the skin hold the
packing in place for 4 days.
Comment
The benefits of the prone position are
several. The resectionist can use the resectoscope in a comfortable and familiar
fashion. The tumour does not drift away
from the resectionist as the bladder fills.
These advantages allow a more careful
and thorough resection.
There is concern about implantation of

malignant cells in the tract of the exter
nal perineal urethrostomy. We have not
seen this. Experience in similar situations,
transperineal or transrectal needle biop
sy of the carcinomatous prostate,7 tran
surethral resection of carcinoma of the
prostate by way of an external perineal
urethrostomy8 and transurethral resec
tion of the prostate and bladder car
cinoma at the same sitting,9 suggests that
seeding is rare. We believe that the abili
ty to resect tumours of the anterior blad
der wall easily and thoroughly when the
patient is in the prone position far
outweighs the risk of planting carcinoma
in the surgical tract.
We have found use of the prone posi
tion an excellent modification when resec
ting the sometimes difficult or almost
impossible-to-reach tumours of the
anterior bladder wall.
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Human Atrial Trabeculae: an Experimental Preparation f o r . .
Studying Myocardial Response to Perioperative Manipulations
Trabeculae taken from discarded human
right atrial specimens during cardiac
surgery provide a useful preparation for
studies in myocardial physiology and
pharmacology. Three extrinsic
measurements that have a marked effect
on contraction of this preparation are
temperature, stimulation frequency and
calcium ion (Ca2 + ) concentration. There
is a large decline in developed force
below 30°C . The optimal stimulation fre
quency (temperature 34 °C , Ca2+ con
centration 2 .5 mM) is 1 Hz. The Ca2 +
level required to give half maximal force
development is 2.0 mM. In a series of
46 atrial trabeculae (approximately 1 mm
in diameter) from 33 patients, the
authors found a mean contraction ten
sion of 1.37 ± 0.0 9 g/mm2 (± standard
error) (temperature 34 °C , stimulation
frequency 1 Hz, pH 7.4, Ca2+ concen
tration 2.5 mM) at maximum force. The
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preparation appears to have great poten
tial for the study of perioperative
manipulation on myocardial function.
Les colonnes charnues prelevees sur les
pieces d'oreillette humaine retirees au
cours d'une chirurgie cardiaque offrent
une preparation utile pour l'6tude de la
physiologie et de la pharmacologie du
myocarde. Trois facteurs extrinseques
qui exercent un effet notable sur la con
traction de cette preparation sont la
temperature, la frequence de contraction
et la concentration des ions calciques
(Ca2 + ). On constate une baisse importante de la tension dgveloppee sous les
30°C . La frequence optimale de stimula
tion (£ 3 4 °C et a une concentration de
Ca2+ de 2.5 mM) est de 1 Hz. Le taux
de Ca2+ necessaire pour assurer la
moitie de la force maximale de
developpement est de 2.0 mM. Dans
une serie de 46 colonnes charnues
auriculaires (d'environ 1 mm de
diam&tre) provenant de 33 patients, les
auteurs ont trouv§ une tension de con
traction de 1.37 ± 0.0 9 g/mm2 (± I'erreur type) (S 34 °C , frequence de
stimulation de 1 Hz, pH de 7.4, concen
tration de Ca2+ de 2.5 mM) & force
maximum. Cette preparation semble offrir de grandes possibilites pour I'etude
des manipulations perioperatoires sur la
fonction myocardique.

Myocardial tissue from human atria is
f
available on a regular basis in centre^ ■* ■
where open-heart surgery is performed.
t
This tissue is potentially valuable for'" y
studying the mechanics of human
myocardium. Further, it may be used to ’ '
study the effects of myocardial intervenj
tions, including cardioactive drugs,
without the need to extrapolate from , 1
animal models.
j
The effects of drugs on human atria!.
tissue have been reported in the
j
literature,1-9 but it is not easy to compare -*
and evaluate the results. The difficulty
i
arises because preparations lack uniformity and the extrinsic variables such as
\
stimulation rate and temperature differ.
Variations in the state of the preparations^ ,
are perhaps an even more serious problem
j
and this clearly should be evaluated in ,
each preparation. To do this, some stanj
dardized measure of contractile perfor- <
mance is required to provide a criterion
|
for comparing and screening prepara- •" '
tions. A reasonable number of measure
ments under standardized conditions are'* 4
needed so that acceptable limits may be ,
defined.
We have developed a standardized pro- >
cedure for obtaining reasonably uniform
preparations from human atria. In this ♦ J
report we examine 46 such preparations.
Maximum contraction tension is evalu- ^ r
ated under a defined set of conditions and
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the effects of the main extrinsic deter
minants of myocardial contraction (tem
perature, stimulation frequency, pH and
calcium ion concentration) are surveyed.
Methods
Samples of right atrial appendages were
yObtained from consenting patients at the
time of cardiac surgery. Immediately after
removal from the patient, the samples
were immersed in oxygenated blood at
4°C and transported to the laboratory.
The endocardial surface was examin
ed for trabeculae approximately 1 mm in
^diameter and 5 mm to 10 mm long. Two
suitable trabeculae could usually be found
in most atrial samples. The trabeculae
were removed and held vertically. The
lower end was held by a fixed plexiglass
clip. The upper end was attached to a
force transducer (model UC 2; Gould
Inc., Oxnard, Calif.) through a second
vclip. The position of the force transducer
was measured by a Mercer micrometer
gauge (model 252; St. Albans, England),
with the zero reference length taken from
the point at which the muscle clips
touched.
The preparation was then immersed in
T a b le 1 - D a t a f r o m H u m a n R ig n i m i . a l
T r a b e c u la e (n = 4 6 )
V a lu e

V a r ia b le
W e ig h t , m g

6 .4 2 ±

0 .3 5

L e n g t h a t L mal, m m

7 .1 8

±

0 .2 4

C r o s s - s e c t io n a l a re a , m m 2

0 .8 7

±

0 .0 4

R e s t in g

0 .4 3

±

0 .0 6

D e v e lo p e d

1 .2 5

±

0 .0 8

0 .0 6

F o rce , g

T e n s io n , g / m m 2
R e s t in g

0 .4 7

±

D e v e lo p e d

1 .3 7

±

0 .0 9

sta n d a rd

e r ro r .

V a lu e s p r e s e n t e d

as m ean

±

A ll m e a s u r e d a t 3 4 ° C , 1 H z , C a 2 ’ 2 . 5 m M a n d
pH 7 .4 .

a buffered Tyrode’s solution (mM: NaCl
117, KC1 3.4, MgS04 3.1, KH2P 0 4 1.2,
NaHC03 28, glucose 11 and CaCl2 2.5)
in a 120 mL water-jacketed bath at 34°C.
The bath was continuously aerated with
a mixture of 95% oxygen and 5% carbon
dioxide (pH 7.4).
Field stimulation was used to excite the
preparation through platinum plate elec
trodes on either side of the muscle.
Stimulus pulses (5 ms) were generated by
a Grass S88 stimulator through a Grass
SIU-5 stimulus isolation unit (Grass In
strument Co., Quincy, Mass.). Stimulus
voltage was adjusted to a level 50% above
the maximum response. Contractions
were monitored on a Grass model 7 direct
writing recorder from the force trans
ducer.
After mounting, the trabeculae were
allowed to equilibrate at 34°C for 20
minutes at a stimulus frequency of 0.1 Hz
with a light (0.2 g) preload. Stimulus fre
quency was then increased to 1 Hz and
length was increased until maximum force
(Lraax) was developed. Muscles were
allowed to stabilize for a further 20
minutes and basal resting and active
forces were measured.
This second equilibration period was
used to screen out unacceptable prepara
tions — those with contraction anomalies
such as multiple peak contractions, those
with spontaneous electrical activity and
those with low contractile force. An ar
bitrary cut-off value of 0.7 g was adopted
on the basis of preliminary experiments.
About half of the preparations were re
jected, mainly because of spontaneous ac
tivity; 46 trabeculae remained. These
preparations were taken from 33 patients
(26 men, 7 women), between 20 and 68
years of age. The operative diagnoses
were coronary artery disease in 27,
valvular disease in 4 and congenital heart
disease in 2 patients.

The effect of one variable was studied
in each of four groups of preparations.
In group 1 (n = 14), five different
stimulation frequencies were used (0.5,
1.0, 1.5, 2.0 and 2.5 Hz). In group 2 (n
= 8), force was monitored at three pH
levels (6.7, 7.4 and 7.9). The pH of the
Tyrode’s solution was adjusted to these
values by titration with 0.1 M sodium
hydroxide or 0.1 M hydrochloric acid.
Group 3 (n = 12) was used to study the
effect of different temperatures (20°, 25°,
30°, 35° and 40°C). In group 4 (n = 12),
different Ca2+ concentrations were used
(1.5, 2.0, 2.5, 3.0, 3.5 and 4.0 mM). In
all of the above interventions, changes
were made in random order and after
each change a stabilization period of 5 to
15 minutes was allowed before the
response was measured. Preliminary ex
periments showed that the effects of
changes in temperature, pH and frequen
cy were reversible but that some residual
effects remained after changes in Ca2+
concentration. To overcome this pro
blem, the preparation was returned to a
Ca2+ level of 2.5 mM after each change,
and force with each concentration was ex
pressed as a percentage of that in 2.5 mM
Ca2+ immediately before each random
change.
For comparative purposes the tension
(g/mm2) was calculated by dividing the
measured force (g) by the cross-sectional
area (mm2). At the end of each experi
ment, the trabecula between the two clips
was removed, blotted dry, and weighed
on a Roller-Smith torsion balance
(Bethlehem, Penn.). The cross-sectional
area (mm2) was then calculated by first
converting the weight (mg) of the
preparation into volume (mm3) with a
density of 1.065 and then dividing the
volume by the length (mm) of the muscle
at Lmax, assuming the trabecula to be
cylindrical.
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FIG. 1—Frequency-force relation; mean contractile force (circles)
and standard error (vertical lines) for 14 trabeculae; pH 7.4, 34°C,
Ca2+ concentration 2.5 mM.

Temperature - °C
FIG. 2—Temperature-force relation; mean contractile force (circles)
and standard error (vertical lines) for 12 trabeculae; pH 7.4, frequency
1 Hz, Ca2+ concentration 2.5 mM.
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Results
During the first equilibrium period,
while the muscle was stimulated at 0.1
Hz, force increased slowly. It increased
further when the rate changed to 1.0 Hz.
A t Lmax, resting force was about one
third of developed force (Table I). At
greater lengths, resting force increased
rapidly and developed force declined.
Group 1
The effect of stimulation frequency on
developed force was examined over the
range 0.5 to 2.5 Hz (pH 7.4, 34°C, Ca2+
concentration 2.5 mM). Maximum con
tractile force was developed at a frequen
cy o f 1 Hz (Fig. 1) with a steady fall as
frequency increased.
Group 2
When the effect of pH on developed
force (1 Hz, 34°C, Ca2+ concentration
2.5 mM) was measured, maximum force
was found to develop at pH 7.4 (1.04 ±
0.18 g [ ± SEJ). At the other two pH levels
used, force was smaller although the dif
ference was not great (0.88 ± 0.26 g at
pH 6.7 and 0.94 ± 0.18 g at pH 7.9).
Group 3
Below 30° C there was a notable and
consistent decline in force (Fig. 2). The
response at 35°C was greater than at
either 30°C or 40°C but the variation was
not large over this range.
Group 4
A fairly large increase in force was evi
dent over the range of Ca2+ levels from
1.5 to 3.0 mM, half maximum force be
ing reached at about 2.0 mM. Above 3.0
mM a plateau was reached (Fig. 3) that
approached a value about 25°7o higher
than that in 2.5 mM Ca2+
Discussion
W ith the procedure described and the
selection criteria outlined, it is possible to
obtain reasonably consistent contractile
responses from isolated human atrial
trabeculae. It is not easy to compare the
values we obtained with those of others
using human myocardial tissue because a
standardized procedure and standardiz
ed measurement of contractile force are
lacking. Only one study of human myo
cardium out of 11 reports we surveyed ex
pressed developed tension in normalized
units (g/m m 2) . 10 Sonnenblick and
colleagues10 had a value of 1.81 ± 1.19
g/m m 2 (± SD) for human papillary
muscle, which is about 30% higher than
374

the value we obtained for atrial muscle.
Studies using human atria generally in
volve large atrial samples1,2 or atrial
strip s.8 In such preparations the
myocytes would not be parallel and align
ed with the axis of force measurement so
that maximum developed force would not
be reached. Wagner and associates8 us
ed atrial strips about 1 mm in diameter
and reported values of 233 ± 30 g/g dry
weight, which would correspond to about
150 m g/mm2. Large atrial preparations,
such as those used by Levy,1,2 with
weights up to 160 mg appear to give mus
cle forces of up to 2 g, which would corre
spond to very low tensions expressed
either on a g/g basis or as tension per unit
area. Gristwood and associates7 used
atrial trabeculae 1.0 ± 0.1 mm in
diameter. They did not tabulate results
but their figures indicated muscle forces
of 0.3 to 1.0 g which are comparable,
although lower, than those we measured.
Most of our samples were taken from
patients with coronary artery disease. It
is not possible to tell to what extent this
might have affected the preparations, but
we found no clear difference between
these preparations and those taken from
patients with other heart defects. The
specimens seem preferable to those taken
soon after death of noncardiac origin.
Abraltis and Stropus11 took atrial strips,
which varied in diameter from 1 to 2 mm
post mortem. Their recordings indicated
a developed force of about 100 mg which
would correspond to about 4% of the ten
sion we observed and are certainly much
smaller than contractions observed with
similar atrial strips taken during
operation.8
It is not yet possible to define any
theoretical expected value for normalized
tension development of the myocardial
contractile elements although Fabiato12
obtained a maximum value for “ skin
ned” rabbit myocytes fully saturated with
calcium of 11.67 g/mm2. As he pointed
out, only about 20% of this force may be
mobilized in a single twitch, which is nor
mally limited by both the Ca2+ concen
tration and the duration of the twitch.
The contractile force we recorded is thus
at least of the order of magnitude ex
pected from Fabiato’s observations.
We have found an optimal frequency
of 1 Hz under the conditions used. This
could, of course, be different with dif
ferent external conditions (temperature
Ca2+ concentration). The optimal fre
quency appears similar to that observed
by Levy,1 although he did not give a
systematic tabulation of results.
The acute effect of pH changes over the
range of 6.7 to 7.9 is relatively small.
Possibly, the effects of metabolic acidosis
would be greater over a longer period
since the myocardium has a large in
tracellular buffering capacity,13 so it

would require some time for an ex
tracellular change to be converted into an
intracellular pH shift.
The sharp decline in force at tem
peratures below 30°C has not been
reported previously. It seems surprising
since we have not seen a similar fall in
developed force in other species. This
perhaps warrants further investigation. <
The increase in contractile force with
increasing Ca2+ concentration is typical
of the myocardial response seen in other
species, such as the dog14 and rat.15 As in
the case of dog myocardium, it appears
that maximum contractile force is only
developed at higher Ca2+ levels than are,
normally found in plasma. Rat heart, on
the other hand, has a lower Ca2+ re
quirement with half maximum activation
at about 0.4 mM Ca2+ compared with
2.0 mM found for human atrial muscle
under the conditions described in these
experiments.
The conditions we chose for the second
equilibration period (34°C, 1 Hz, pH 7.4,
Ca2+ concentration 2.5 mM), on which
normalized values are based, are close to
those required for maximum force
development, although a further ex
ponential type of increase would be given
by raising Ca2+ to a still higher level.
Isolated trabeculae from discarded
surgical specimens appear to provide a
useful preparation for study. Under the
conditions described here, the expected
range of tension development is 1.37 ±
0.09 g/m m 2. The small size of the
trabecular preparation has the additional
advantage that diffusion distances are
small so that the time required f o r '
equilibrating the extracellular space with
agents such as cardioactive drugs would
be minimal. The preparation has great
potential for the study of the myocardial
response to perioperative events such as ,
perfusion, cardioplegia and p h ar
macologic manipulations.
*
We acknowledge the technical assistance of
Mrs. R. Ravindra and Mrs. D. Ayres.

FIG. 3—Calcium concentration-force rela
tion (force at 2.5 mM Ca2+ = 100%) and ^
standard error (vertical lines) for 12 trabeculae;
pH 7.4, frequency 1 Hz, 34°C.
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AN IMPORTANT INNOVATION
IN HOSPITAL ANTIBIOTIC THERAPY
Prescribing Information
CEFOBID*
(cefoperazone sodium)

For Intravenous or Intramuscular Injection

Antibiotic
ACTION
In vitro studies indicate that the bactericidal action of CEFOBID (cefoperazone sodium) results from the
inhibition of bacterial cell wall synthesis.
INDICATIONS AND CLINICAL USES
CEFOBID (cefoperazone sodium) may be indicated for the treatment of the following infections when
caused by susceptible strains of the designated microorganisms:
LOWER RESPIRATORY TRACT INFECTIONS caused by Streptococcus pneumoniae, Haemophilus in
fluenzae. Staphylococcus aureus, Streptococcus pyogenes, Klebsiella species (including Klebsiella
pneumoniae), Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis, indole-positive Proteus
species and Enterobacter species.
URINARY TRACT INFECTIONS caused by Escherichia coli, Pseudomonas aeruginosa, Enterobacter
species, Klebsiella species, Enterococcus, Proteus mirabilis, Staphylococcus aureus, Staphylococ
cus epidermidis and indole-positive Proteus species
Due to the nature of the underlying conditions which usually predispose patients to Pseudomonas
infections of the lower respiratory and urinary tracts, a good clinical response accompanied by
bacterial eradication may not be achieved despite evidence of in vitro sensitivity.
ACUTE BILIARY TRACT INFECTIONS ASSOCIATED WITH CHOLECYSTITIS OR CHOLANGITIS caused
by Escherichia coli.
SEPTICEMIA caused by Staphylococcus aureus. Streptococcus pneumoniae, Streptococcus agalactiae, Escherichia coli and Klebsiella species.
WOUND INFECTIONS (SURGICAL AND TRAUMATIC) caused by Staphylococcus aureus, Streptococ
cus pyogenes and Pseudomonas aeruginosa.
GYNECOLOGICAL INFECTIONS (SUCH AS PELVIC INFLAMMATORY DISEASE AND ENDOMETRITIS)
caused by Streptococcus agalactiae, Neisseria gonorrhoeae, Escherichia coli, Bacteroides species
(including Bacteroides fragilis), Peptococcus species and Peptostreptococcus species.
Specimens for bacteriologic culture should be obtained prior to therapy in order to identify the causative
organism and to determine its susceptibility to CEFOBID (cefoperazone sodium). Therapy may be in
stituted before results of susceptibility testing are known , however, modification of the treatment may be
required once these results become available.
CONTRAINDICATIONS: CEFOBID (cefoperazone sodium) is contraindicated in patients with known
allergy to the cephalosporin class of antibiotics.
WARNINGS: Before therapy with CEFOBID (cefoperazone sodium) is instituted, careful inquiry should be
made to determine whether the patient has had previous hypersensitivity reactions to cephalosporins,
penicillins or other drugs. CEFOBID (cefoperazone sodium) should be administered with caution to
penicillin-sensitive patients or to any patient who has demonstrated some form of allergy, particularly to
drugs. If an allergic reaction to CEFOBID (cefoperazone sodium) occurs, discontinue administration of
the drug and treat the patient with the usual agents (e g. epinephrine, antihistamines, pressor amines or
corticosteroids).
Pseudomembranous colitis has been reported to be associated with the use of CEFOBID (cefoperazone
sodium). Therefore, in those patients administered CEFOBID (cefoperazone sodium) who develop diar
rhea, it is important to consider such a diagnosis.
Treatment with broad-spectrum antibiotics, including CEFOBID (cefoperazone sodium), alters the
normal flora of the colon and may permit overgrowth of Clostridia. Studies indicate that a toxin produced
by Clostridium difficile is one primary cause of antibiotic-associated colitis
Mild cases of colitis may respond to drug discontinuance alone. Moderate to severe cases should be
managed with fluid, electrolyte, and protein supplementation as indicated. When the colitis is not reliev
ed by the discontinuance of CEFOBID (cefoperazone sodium) or when it is severe, consideration should
be given to the administration of oral vancomycin
PRECAUTIONS
General: The concomitant administration of aminoglycosides and some cephalosporins has caused
nephrotoxicity. Although transient elevations of BUN and serum creatinine have been observed, there is
no evidence that CEFOBID (cefoperazone sodium) when administered alone causes significant
nephrotoxicity. However, the effect of administering CEFOBID (cefoperazone sodium) concomitantly
with aminoglycosides is not known
CEFOBID (cefoperazone sodium) is excreted in both the bile and urine. In normal volunteers, 19 to
41 % of the dose is excreted in the urine, the remainder being excreted by the hepato-biliary system. The
serum half-life of CEFOBID (cefoperazone sodium) is usually prolonged and urinary excretion of the drug
increased in patients with hepatic disease and/or biliary obstruction. Serum concentrations of
cefoperazone should be monitored in these patients treated with doses in excess of 2 grams daily and
dosage should be adjusted as necessary.
Because renal excretion is not the main route of elimination of cefoperazone, adult patients with renal
failure usually require no adjustment in dosage when daily doses of 2 to 4 grams (1 to 2 grams every 12
hours) are administered If higher doses of CEFOBID (cefoperazone sodium) are used, serum concentra
tions of cefoperazone should be monitored. If there is evidence of accumulation, dosage should be
decreased accordingly
In one study in patients with chronic renal failure, the half-life of CEFOBID (cefoperazone sodium) was
reduced from 4.17 to 1.67 hours during hemodialysis. Thus, dosing should be scheduled to follow a
dialysis period.
In patients with both hepatic dysfunction and renal impairment, the initial dosage of CEFOBID
(cefoperazone sodium) should not exceed 1 to 2 grams daily and serum concentrations of cefoperazone
should be monitored closely.
Vitamin K deficiency has occurred in a few patients treated with CEFOBID (cefoperazone sodium). The
mechanism is most probably related to the suppression of gut flora which normally synthesizes this
vitamin. Those at risk include patients with poor diet or malabsorption states (e g. cystic fibrosis) and
patients on prolonged intravenous alimentation regimens. Prothrombin time should be monitored in
these patients and exogenous vitamin K administered as indicated
A reaction characterized by flushing, sweating, headache, and tachycardia has been reported when
alcohol is ingested during and as late as the fifth day after CEFOBID (cefoperazone sodium) administra
tion. Patients should be cautioned concerning ingestion of alcoholic beverages in conjunction with ad
ministration of CEFOBID (cefoperazone sodium). For patients requiring artificial feeding orally or
parenterally, solutions containing ethanol should be avoided.
CEFOBID (cefoperazone sodium) should be administered with caution to individuals with a history of
gastrointestinal disease, particularly colitis.
Overgrowth of nonsusceptible organisms may occur during prolonged use of CEFOBID (cefoperazone
sodium). Patients should be observed carefully during treatment. If superinfection occurs, appropriate
measures should be taken

Drug Laboratory Test Interactions
A false-positive reaction for glucose in the urine may occur with Benedict's or Fehling’s solution. ^
Pregnancy: The safety of CEFOBID (cefoperazone sodium) in pregnancy has not been established. The
use of CEFOBID (cefoperazone sodium) in pregnant women requires that the likely benefit from the drug
be weighed against the possible risk to the mother and fetus
^
Reproduction studies have been performed in mice, rats and monkeys at doses up to 10 times the
human dose and have revealed no evidence of impaired fertility or teratogenic effects due to
cefoperazone sodium Animal reproduction studies, however, are not always predictive of humaf
response
Nursing Mothers: Cefoperazone is excreted in low concentration (0.4 to 0.9 /ig/m L) in human milk
Caution should be exercised when CEFOBID (cefoperazone sodium) is administered to a nursing mott^r.
Children: The safety and efficacy of CEFOBID (cefoperazone sodium) in children have not b e e n ^
established.
j
ADVERSE REACTIONS
*
Hypersensitivity: Macuiopapular rash, urticaria, pruritis, eosinophilia, drug fever
f
Hematology — Decreases in hemoglobin and/or hematocrit have occurred. Slight decreases in
neutrophil count have been reported, and reversible neutropenia may occur with prolonged administra A
tion. Transient eosinophilia has occurred. Hypoprothrombinemia has been observed. Some individuals
have developed positive direct Coombs' test during treatment.
Liver — Transient elevations in SGOT, SGPT and alkaline phosphatase levels have been noted. One p # *
tient with a history of liver disease developed significantly elevated liver function enzymes during
therapy with CEFOBID (cefoperazone sodium). Clinical signs and symptoms of nonspecific hepatitis ac- g
companied these increases After CEFOBID (cefoperazone sodium) therapy was discontinued, the fa - r
tient’s enzymes returned to pre-treatment levels and the symptomatology resolved
Kidney — Transient elevations of blood urea nitrogen and serum creatinine have been noted.
Gastrointestinal — Altered bowel habits (loose stools or diarrhea) have been reported. Most of these
events have been mild or moderate, but some have been severe. In all cases, these symptoms respond
ed to symptomatic therapy or ceased when cefoperazone therapy was stopped Nausea and vomiting^
have been reported rarely
Pseudomembranous colitis has been reported rarely in patients administered CEFOBID (cefoperazone
sodium). Symptoms of pseudomembranous colitis can appear during or for several weeks subsequent ta«
antibiotic therapy.
Disulfiram-like Reaction
Disulfiram-like reactions have been reported when alcohol was ingested during and as late as the fifttjr
day after CEFOBID (cefoperazone sodium) administration.
Central Nervous System — Headache and dizziness occur rarely
Local Reactions — CEFOBID (cefoperazone sodium) is well tolerated following intramuscular adminis^p- ^
tion. Occasionally, transient pain may follow administration by this route. When CEFOBID (cefoperazone
sodium) is administered by the intravenous route, some patients develop phlebitis at the site of ad
ministration.
.
Other — Diaphoresis/chills
1

.
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SYMPTOMS AND TREATMENT OF OVERDOSAGE
Since no case of overdosage has been reported to date with CEFOBID (cefoperazone sodium), no*
specific information on symptoms or treatment of overdosage is available. Treatment should be symp
tomatic.
Hemodialysis is not effective in the removal of cefoperazone.
^ '*
DOSAGE AND ADMINISTRATION
~r
DOSAGE
CEFOBID (cefoperazone sodium) may be administered intravenously or intramuscularly.
Dosage and route of administration should be determined by severity of infection, susceptibility of the*
causative organism, and condition of the patient.
Adult
The recommended daily dose of CEFOBID (cefoperazone sodium) is 2 to 9 grams administered in equal-4
ly divided doses every 8 to 12 hours (See table below). The usual duration of treatment is 7 to 14 days.
Adult Dosage
Type of Infection
Daily Dose
Frequency and Route-*
Mild to moderately severe
2 to 4 grams
1 to 2 grams
infections such as pneumonia,
every 12 hours
acute urinary tract infection,
I.M. or I V.
-4
wound infection
Severe infections or infections
4 to 8 grams
2 to 4 grams
caused by less sensitive
every 12 hours
*
organisms
IV .
Infections commonly requiring
9 grams
3 grams every
.
antibiotics in higher dosage
8 hours I.V.
(e.g. septicemia and lifethreatening infections)
j
The maximum adult daily dose should not exceed 9 grams
*
For infections caused by Streptococcus pyogenes, therapy should be continued for at least 10 days.
Impaired Renal Function
.
.
Because renal excretion is not the main route of elimination of cefoperazone, adult patients with renal
failure usually require no adjustment in dosage when daily doses of 2 to 4 grams (1 to 2 grams every 12
hours) of CEFOBID (cefoperazone sodium) are administered. If higher doses of CEFOBID (cefoperazone*
sodium) are used, serum concentrations of cefoperazone should be monitored If there is evidence of' '
accumulation, dosage should be decreased accordingly. For patients whose glomerular filtration rate is
less than 18 m L/m in or whose serum creatinine level is greater than 3.5 m g/dL, the maximum*
CEFOBID (cefoperazone sodium) dosage should be 4 grams per day
^
In patients undergoing hemodialysis, dosing should be scheduled to follow a dialysis period.
j
Hepatic Disease and Biliary Obstruction
j
The serum half-life of cefoperazone is increased 2 to 4 fold in patients with hepatic disease and/o*
biliary obstruction. Serum concentrations of cefoperazone should be monitored in patients treated with
doses in excess of 2 grams daily and dosage should be adjusted as necessary.
,
^
Hepatic Dysfunction and Renal Impairment
** f
In patients with both hepatic dysfunction and concomitant renal impairment, the initial dosage of
CEFOBID (cefoperazone sodium) should not exceed 1 to 2 grams daily and serum concentrations of
cefoperazone should be closely monitored.
Children
The safety and efficacy of CEFOBID (cefoperazone sodium) in children have not been established.

ADMINISTRATION
Intramuscular:
CEFOBID (cefoperazone sodium) should be administered by deep intramuscular injection into a large
muscle mass such as the gluteus maximus or anterior thigh. The maximum dose of CEFOBID
(cefoperazone sodium) should be two (2) grams.
Intravenous:
Direct Intravenous (bolus) Injection: The reconstituted solution should be injected slowly over a
period of no less than three (3) minutes. The maximum dose of CEFOBID (cefoperazone sodium)
should be two (2) grams.
Intermittent Intravenous Infusion The reconstituted solution may be infused over a period of 15
minutes to 1 hour through the tubing of an administration set while any of the intravenous solutions
(See Solutions for I.V. Infusion) are being infused. During infusion of the solution containing
CEFOBID (cefoperazone sodium), it is desirable to temporarily discontinue administration of the other
solution.
Continuous Intravenous Infusion: CEFOBID (cefoperazone sodium) may also be administered over a
longer period of time.
Note: If therapy with CEFOBID (cefoperazone sodium) is carried out in combination with an
aminoglycoside antibiotic, each should be administered at different sites because of a physical in
compatibility. An aminoglycoside should not be mixed with CEFOBID (cefoperazone sodium) in the
same container.
PHARMACEUTICAL INFORMATION
CHEMISTRY
Trade Name: CEFOBID
Proper Name: Cefoperazone sodium
Chemical Name:
Sodium (6R,7R)-7-[(R)-2-(4-ethyl-2,3-dioxo-1-piperazinecarboxamido)-2-(p-hydroxyphenyl)
acetamido)-3 [[(1 -methyl-1H-tetrazol-5-yl)thio]methyll-8-oxo-5-thia-1-azabicyclo[4.2.0]
oct-2-ene-2-carboxylate
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Molecular Formula: C25H2sNg0gS2Na Molecular Weight: 667.65
Description:
Cefoperazone sodium is a white powder, soluble in water, sparingly soluble in methanol, poorly soluble
in ethanol, and insoluble in ethyl ether, acetone, chloroform, or n-hexane.
Composition:
CEFOBID vials contain cefoperazone sodium (expressed in terms of free acid). The sodium content of
each gram of CEFOBID is approximately 34 mg (1.5 mEq sodium ion). The pH of a 25% (w /v) solution
is 4.5 to 6.5 and the solution is colorless to straw yellow depending on the concentration.
RECONSTITUTION
For Intramuscular Use:
Solution for Reconstitution
Sterile Water for Injection
or, if required
Bacteriostatic Water for Injection
0.5% Lidocaine Hydrochloride Injection
Reconstitute as follows:
Volume to be
Vial Size
Added to Vial
(mL)
(g)

E c k e l L , G r is t w o o d RW , N a w r a t h H , O w e n D A A ,
S a t t e r P : Ino tro p ic a n d electrophysiological effects o f
h istam ine on hum an ventricular heart m uscle. J Physiol
(Lond) 1982; 330: 111-23

7. G r is t w o o d R W , L in c o l n JC R , O w e n D A A , S m it h
IR : H istam ine release from hum an right a triu m . Br J
Pharmacol 1981; 74: 7 -9

Approximate
Available
Volume (mL)

Approximate
Average Concentration
(mg/mL)

1.0
3.5
4.0
250
2.0
7.0
8.0
250
Shake well until dissolved. Solutions should be allowed to stand after reconstitution to allow any foam
ing to dissipate in order to permit visual inspection for complete solubilization. Vigorous and prolonged
agitation may be necessary to solubilize CEFOBID (cefoperazone sodium).
For Intravenous Use:
Solutions for Reconstitution and Dilution
Sterile Water for Injection
or, if required
Bacteriostatic Water for Injection
Reconstitute as follows:
Volume to be
Approximate
Approximate
Vial Size
Added to Vial
Available
Average Concentration
(mL)
Volume (mL)
(mg/mL)
(g)
1
9.5
10.0
100
2
19.0
20.0
100
Shake well until dissolved. The prepared solution may be further diluted to the desired volume with any
of the solutions for I.V. infusion listed below.
For direct intravenous (bolus) injection: Reconstitute as directed above
For intermittent intravenous infusion: Reconstitute as directed above
For continuous intravenous infusion: Reconstitute with Sterile Water for Injection. The-reconstituted
solution may be added to an appropriate intravenous bottle/bag containing any of the solutions for I .V.
infusion listed below:
Solution for I.V. Infusion
5% Dextrose Injection (USP)
10% Dextrose Injection (USP)
5% Dextrose and Lactated Ringer's Injection
Lactated Ringer's Injection (USP)
5% Dextrose and 0.9% Sodium
0.9% Sodium Chloride Injection (USP)
Chloride Injection (USP)
Normosol® M and 5% Dextrose Injection
Normosol® R
5%Dextrose and 0.2% Sodium
Chloride Injection (USP)
Stability of Solutions
Storage:
Reconstituted solutions for intramuscular injection should be used within 24 hours if kept at room
temperature, or 72 hours if stored under refrigeration (5°C).
Reconstituted solutions for I.V. injection or infusion should be used within 24 hours if kept at room
temperature, or 72 hours if stored under refrigeration (5°C).
Incompatibility
CEFOBID (cefoperazone sodium) should not be added to blood products, protein hydrolyzates, or amino
acids. CEFOBID (cefoperazone sodium) should not be mixed together with an aminoglycoside.
DOSAGE FORMS
Availability:
CEFOBID (cefoperazone sodium) is available as a lyophilized powder
1,0g vial — cefoperazone 1 .0 g as sodium salt
2.0g vial — cefoperazone 2.0 g as sodium salt
Storage
CEFOBID (cefoperazone sodium) should be stored protected from light and refrigerated (2 to 8°C).
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A Case of “Trigger Toe”
"Triggering" of the toes, in which local
tendon hypertrophy prevents the smooth
movement of the tendon, has been
described as a problem more theoretical
than real and only three cases have been
reported.
The authors report a case of partial
tethering of the flexor hallucis longus
tendon just distal to the medial malleolus
in a 28-year-old jogger who had painful
triggering of the great toe on plantar
flexion of the ankle and great toe.
Division of the flexor hallucis longus
tendon pulley distal and posterior to the
medial malleolus cured the patient.
Le probleme des orteils a ressort a ete
juge comme un probleme plus thgorique
que reel. Le gros orteil est rarement
affects.
Les auteurs dScrivent un cas d'orteil a
ressort du a un blocage partiel du tendon
du long fISchisseur du gros orteil,
blocage distal 6 la mallSole interne. La
patiente est agSe de 28 ans. Elle fait de
la course a pied et souffre depuis 5 ans
de symptomes progressifs et douloureux
relics a I'orteil a ressort.
Une section chirurgicale de la poulie du
tendon du long flechisseur du gros orteil
distale et postSrieure a la mallSole in
terne a resolu le probl&me de ressort.

Localized te n d o n hypertrophy, usually o f
in flam m ato ry o r trau m a tic origin, can
o b stru ct the sm o o th gliding o f the tendon
th ro u g h its p u lley , p ro d u cin g a “ trig g er
in g ” sensation as the o b stru ctio n is o v er
c o m e. T ypically, the first a n n u la r co m 
p o n e n t of th e digital flexor sh eath in th e
h a n d is the site o f the o b stru c tio n . O nly
ra re ly has “ trig g erin g ” been re p o rte d in

th e f o o t.1'3 W e rep o rt here th e case o f a
patient with stenosing tenovaginitis o f the
sh eath o f th e flexor hallucis longus.

Case Report
A 28-year-old woman, who daily jogged 2
miles, noticed a painless snapping sensation in
the left great toe over a 5-year period. One year
previously she had sprained her left ankle while
skiing, and after this she had intermittent pain
distal and posterior to the medial malleolus
associated with a snapping sensation at the first
metatarsophalangeal joint. Persisting symp
toms, including inability to jog, led the patient
to seek medical advice 1 year after her skiing
injury.
On physical examination there was no defor
mity or tenderness, and passive movements of
the toes, foot and ankle were normal and
painless. Following active plantar flexion of the
ankle and great toe, attempted active dorsiflexion of the great toe caused a clawing deformi
ty with further interphalangeal joint flexion.
This deformity could be overcome actively and
produced an audible and palpable “ snapping”
as the interphalangeal joint returned to neutral.
The snapping could be felt along the course of
the flexor hallucis longus tendon both distal
to the medial malleolus and on the plantar
aspect of the great toe. We made the clinical
diagnosis of stenosing tenovaginitis of a pulley
of the flexor hallucis longus. This tendon
passes through two flexor sheaths, a proximal
sheath behind the talus and berfeath the susten
taculum tali and a distal one beneath the neck
and head of the first metatarsal4 (Fig. 1).
The flexor hallucis longus was explored
under local anesthesia to permit active trigger
ing during operation. There was no abnormali-
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FIG. 1—Path of flexor hallucis longus ten
don and position of proximal and distal flex
or tendon sheaths.

ty at the metatarsophalangeal level. Through'* <
a second incision, distal and posterior to the
medial malleolus, the proximal pulley was approached by reflecting anteriorly the posterior
tibial nerve while preserving its calcaneal bran- '*
ches. A fusiform thickening of the flexor
hallucis longus was observed just proximal to ' '
this pulley which was also very thick. There was
no dislocation or obvious laceration of the ten-'' ~y
don and the synovium was not hypertrophied.
Longitudinal sectioning of this flexor sheath 4
eliminated the triggering. Six months after
1
operation the patient was free of pain and *
symptoms.
A t

Discussion

* t

T he flexor hallucis longus muscle arises
fro m th e in ferio r tw o th ird s o f the
p o ste rio r surface o f the fib u la a n d fro m
:
th e interosseous m em b ran e.4 T h e posi- A
tio n o f its ten d o n is m ain tain ed by tw o
!
pulleys, a proxim al one b en eath th e *
susten tacu lu m tali an d a distal one
b en eath the first m e tatarsal. T h e m uscle 4 v
is p articu larly im p o rta n t fo r p u sh o ff in
ru n n in g an d has a fu n ctio n an alo g ous to 4
th e A chilles ten d o n fo r th e b allet dancer

en pointed
T he triggering p h en o m en o n is m ost A
co m m o n in th e h a n d at th e level o f the
m etacarp al head. It m ay be congenital or-,
related to in flam m ato ry disease, p a r
tic u la r ly rh e u m a to id te n o s y n o v itis . <
N onspecific tenosynovitis o r te n d o n in 
ju ry , o r p a rtia l ten d o n ru p tu re causing *
ten d o n irregularity as th e ru p tu re d fibres
|
re tra c t, m ay also p ro d u ce trig g erin g .6 4
W hile tendinitis o f th e flexor hallucis,, x
longus is well recognized, p artic u larly in
b allet dan cers, triggering is so rare th a t A
only th ree cases have been re p o rte d , tw o
o f them in ballet d ancers;1,3’5 Jah ss7 even -.
d o u b te d its existence.
j
T he site o f triggering in o u r p atien t *
could n o t be determ ined preoperatively
because th e triggering snap w as tra n sm it-4
ted along the w hole length o f th e ten d o n . ^
In retrospect, exploration o f th e m e tatar
sophalangeal pulley was unnecessary. The >
cause o f th e localized tendon enlargem ent
was n o t definitely id en tified , b u t since I
th ere w as n o synovitis, p a rtia l ru p tu re o f
cen tral fibres in th e ten d o n as described *■
by S am m arco an d M iller3 seem s likely.
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^ Amphojeloma: Antacid Impaction in a Critically III Patient
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Patients in the intensive care unit seldom
have mechanical small-bowel obstruction,
■ - and obstruction due to medication
bezoars is even less common. A 65-yearv r old woman, in the intensive care unit
because of septic shock and acute renal
failure, had a small-bowel obstruction
^ due to Amphojel concretions. Obstruc
tion from such a cause may be prei i vented by including non-constipating
antacids, stool softeners or sorbitol.
^ *■ Aggressive use of H2-antagonists to
prevent gastrointestinal bleeding in
septic patients will reduce the need for
orally administered antacids. When
obstruction occurs due to antacid concretions, it may be relieved by passing a
long intestinal tube, by giving enemas
v for colonic obstruction or by operation.
y-

►

II est peut frequent qu'un patient soit ac^ cueilli aux soins intensifs souffrant d'une
obstruction m6canique du grele, et une
► obstruction due d un bezoard d'origine
medicamenteuse est encore plus rare.
t - ► Une femme de 65 ans, admise aux soins
intensifs en choc septique et en insuf’’fisance renale aigue, a presente une
obstruction de I’intestin grele due a des
concretions d'Amphojel. Une obstruction
r de ce type peut etre prdvenue en donnant des anti-acides qui ne provoquent
r pas de constipation et en administrant
une substance capable d'amollir les
i- fselles ou du sorbitol. L'utilisation
systematique des antagonistes des
recepteurs H2 chez les patients septiques
dans le but de prevenir les hdmorragies
’ gastro-intestinales va rdduire le besoin
d'anti-acides oraux. On peut corriger une
obstruction intestinale due d des concrdy ^tions d'anti-acides en passant un long
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tube intestinal, en donnant des
lavements ou en procddant a une
intervention chirurgicale.

Acute renal failure is a common accom
paniment of multiple organ failure in
critically ill septic patients.1 These pa
tients are at risk o f a major gastroin
testinal hemorrhage for a number of
reasons, one o f which is believed to be
prolonged exposure o f the gastric mucosa
to unopposed gastric acidity.2 Aggressive
medical management o f the acute renal
failure and gastric acidity involves the use
of both H2-antagonists and antacids. In
this setting Amphojel, an aluminumcontaining antacid, is ideal because of its
high buffering capacity and phosphate
binding characteristics. There are scat
tered reports in the literature o f complica
tions resulting from the use o f aluminumcontaining antacids in critically ill
patients.3-6 We report a patient with
overwhelming sepsis and acute renal
failure who had a complete small-bowel
obstruction as a result o f hardened Am
phojel concretions.

Case Report
A 65-year-old woman was known to suffer
from alcoholism and long-standing insulindependent diabetes. Several operative pro
cedures had been performed including a
hysterectomy, bilateral oophorectomy and a
cholecystectomy several years before. For 1
year she had had chronic urinary tract
infections.
The patient initially presented to a local
hospital with a short history of fever, chills,
anorexia and drowsiness. She was noted to
have foul smelling urine. For 72 hours she had
refractory, elevated blood sugar levels and
episodes of hypotension and confusion. Fler
renal function progressively declined so she was
transferred to the Kingston General Hospital.
On admission, the patient was disoriented,
confused and unable to provide a history. She
was markedly obese and had extreme
tenderness in the right flank. Vital signs were

as follows: temperature 40°C, blood pressure
70/40 mm Hg, respiratory rate 24/min, heart
rate 120 beats/min. Her hemoglobin level was
70 g/L, leukocyte count 23 x 109/L , platelets
105 x 109/L , serum sodium 131 mmol/L,
potassium 6.3 mmol/L, chloride 100 mmol/L
and carbon dioxide 15 mmol/L. Renal failure
was present with a blood urea nitrogen level
of 73.19 mmol/L urea and a serum creatinine
level of 680 jimol/L. Arterial blood gas
measurements made on a partial intake of ox
ygen of 40% revealed a pH of 7.3, partial
pressure of oxygen of 87.2 mm Hg, of carbon
dioxide 27.9 mm Hg and a bicarbonate level
of 13 mmol/L. Gram staining of the urine
showed large numbers of leukocytes and gram
negative bacteria. Subsequent cultures grew
Escherichia coli from both urine and blood.
The patient was stabilized after hemodynamic
monitoring lines were placed and broad spec
trum antibiotics including tobramycin, clin
damycin and erythromycin were given.
Dopamine in the range of 4 to 6 /tg/kg was
given intravenously to support her blood
pressure. Computerized tomography disclos
ed an emphysematous right kidney. Hemodial
ysis was instituted. This was followed by ap
preciable upper gastrointestinal bleeding and
the patient’s hemoglobin level dropped by 30
g/L. Ulcerative esophagitis, antritis, gastritis
and a chronic pyloric channel ulcer were seen
at endoscopic examination, but no active
bleeding was noted. The patient was given
cimetidine 300 mg intravenously twice daily
and Amphojel 30 mL every hour as necessary
through the nasogastric tube to maintain a
gastric pH greater than 4.5.
A right radical nephrectomy was carried out
24 hours after admission. Microscopic ex
amination of the specimen disclosed acute
pyelonephritis with acute papillary necrosis and
diffuse glomerulosclerosis. Two days after
operation, the patient was returned to the
operating room because of continued bleeding
from the incision in the right flank. Frank
blood was noted in the peritoneal cavity and
a laparotomy was done. Three litres of blood
were found in the peritoneal cavity but no ab
dominal source of bleeding and no perforation
were seen in either the stomach or duodenum.
There were many dense adhesions and multi
ple putty-like concretions in the small bowel.
Due to the patient’s unstable condition these
concretions were not removed; preoperative
medications including Amphojel were
restarted.
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Over the following week the patient con
tinued to deteriorate. Her abdomen became
grossly distended and markedly tender in all
four quadrants. Clinically and radiologically,
a small-bowel obstruction was diagnosed. Sep
sis was also evident hemodynamically by de
creased systemic vascular resistance and in
creased cardiac output despite appropriate an
tibiotics. Oliguria remained and the patient re
quired frequent hemodialysis to control the
renal failure.
The patient continued to deteriorate; 18 days
after admission she was reexplored. There was
no focus of infection. However, the small
bowel from the ligament of Treitz to the
sigmoid colon was filled with rock-hard con
cretions. The small bowel was grossly dilated
in several areas with early ischemia adjacent
to the concretions. The adhesions were lysed
and through an ileotomy the concretions were
removed. An ileostomy and mucous fistula
were then formed. The concretions were rockhard balls of Amphojel mixed with bile. All
elements were removed from the bowel. The
spleen was incidentally traumatized during this
procedure and was removed.
The patient remained in septic shock with
an elevated leukocyte count despite adequate
antibiotic coverage with amphotericin B.
Cultures of the sputum, urine and spleen
revealed a pure growth of Torulopsis glabrata.
She continued to deteriorate and died 30 days
after admission of widely disseminated fungal
septicemia.

Discussion
Mechanical intestinal obstructions are
common in clinical surgical practice.
However, impaction of feces or, less com
monly, medications, accounts for only
1% to 2% of patients with mechanical in
testinal obstruction reviewed in large
series.7 In the intensive care unit,
paralytic ileus is more commonly seen due
to prolonged sepsis, major trauma or
drug administration. It is also recognized
that in these patients gastrointesti
nal hemorrhage can be a major con
cern.2 Aggressive medical management
with H2-antagonists such as cimetidine
and antacids has been reported to decrease
the incidence of gastrointestinal hemor
rhage.810 If the patient is also in renal
failure, the dosage of the Hr antagonists
is adjusted and the preferred ant
acid is one that contains aluminum.1
These antacids are, however, notoriously
constipating although they are effective
buffers and bind intestinal phosphates,
thus reducing the risk of hyperphos
phatemia in acute renal failure. Mag
nesium-containing antacids are general
ly not used because they may cause mag
nesium intoxication leading to serious
neurologic and cardiovascular effects.
Calcium carbonate is also avoided be
cause of the possibility of hypercal
cemia." Patients in the intensive care
unit receiving aluminum-containing an
tacids for control of gastric acidity and
380

having episodes of prolonged paralytic il
eus and major cardiovascular instability
are at risk of medication impaction in the
large bowel or, less frequently, the small
bowel.
Antacid impaction or medication bezoars have been reported in patients on
long-term renal dialysis and those who
have undergone renal transplantation.
The most complete review was by Welch
and associates6 in which 10 cases of col
onic impaction were recorded in 180
transplant patients and those with chronic
renal failure over a 6-year period. The im
pactions were always in the colon. Three
patients in their group died. Small-bowel
obstruction due to Amphojeloma is ex
ceedingly rare; only three cases have been
reported. The mortality for small-bowel
obstruction due to antacid impaction is
about 50% .
To avoid antacid impaction in critical
ly ill patients, there are several treatment
possibilities. First, antacid regimens may
be altered to include nonconstipating
agents such as magnesium hydroxide,
unless it is contraindicated. Second, the
use of stool softeners such as Colace and
the addition o f sorbitol may decrease the
constipating effect of aluminum antacids.
Gastric acidity may be controlled through
the aggressive intravenous administration
of Hr antagonists such as cimetidine;
this permits a reduction in the frequency
of oral antacid administration. The effec
tiveness of this therapy in preventing
gastrointestinal hemorrhages has been
debated.12 Lastly, proper hydration may
soften the mixture of Amphojel and
secretions within the small bowel.
When the bowel is obstructed by multi
ple small-bowel or colonic concretions
formed by antacids, several options are
available to relieve the obstruction. A
long intestinal tube may be used for
drainage as well as for the administration
of softeners and for cathartics. If the col
on is primarily involved, enemas may
relieve the impaction. These enemas con
tain various combinations of Colace,
olive oil, trypsin and soap suds. The use
of hyperosmolar enemas containing
Hypaque have been successful in reliev
ing colonic obstruction in a few patients
after transplantation. If all conservative
measures fail, operation may be required
to decompress the bowel and remove all
concretions. Anastomoses should be
avoided in the unprepared colon or in the
presence of contamination. The preferred
procedure is an ileostomy and mucous
fistula for right-sided or distal smallbowel impactions. The Hartmann pro
cedure is advocated for more distal im
pactions. If complications such as colonic
perforation occur, the prognosis is par
ticularly poor.
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POST-OPERATIVE
FAIN BEFORE YOU
LEAVE THE O.R.

MARCAINE* NERVE BLOCK OR INFILTRATION
BEFORE CLOSURE GIVES UP TO 15 HOURS OF
POST-OPERATIVE PAIN RELIEF1
POST-OPERATIVE STRESS can be
substantially reduced by preventing
post-operative pain in those critical
first hours after surgery2

Marcaine blocks this pain, giving an
easier, quicker recovery; often w ithout
the need for narcotic analgesics.3
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Marcaine*

(bupivacaine hydrochloride injection U.S.P.).
Indications:
Peripheral nerve block including retrobulbar block, infiltration, sympa
thetic blockade, caudal, epidural, and pudendal blocks.

Contraindications:
Bupivacaine is contraindicated in persons with known sensitivity to
local anesthetics of the amide type.
The use of bupivacaine is contraindicated in the presence of sepsis
near the site of proposed injection, in severe shock and in heart block.

Warnings:
Usage in Pregnancy: There are no adequate and well-controlled studies
in pregnant women of the effect of bupivacaine on the developing
fetus. Decreased pup survival in rats and an embryocidal effect in rab
bits have been observed when bupivacaine hydrochloride was adminis
tered to these species in doses comparable to nine and five times
respectively the maximum recommended daily human dose (400 mg).
Bupivacaine hydrochloride should be used during pregnancy only if the
potential benefit justifies the potential risk to the fetus. This does not
exclude the use of Marcaine 0.25% or 0.50% at term for obstetrical
anesthesia or analgesia.
Obstetrics: The highest (0.75%) concentration is not recommended for
obstetrical anesthesia. There have been reports of cardiac arrest with
difficult resuscitation or death following its use for epidural anesthesia
in obstetrical patients.
Due to the high risk to the fetus, paracervical block is no longer recom
mended.
The obstetrician is warned that severe persistent hypertension may
occur after administration of certain oxytocic drugs, if vasopressors
have already been used during labor (e.g. in the local anesthetic solu
tion or to correct hypotension).
Until further experience is gained in children younger than 12 years,
administration of bupivacaine in this age group is not recommended.

Precautions:
Marcaine (bupivacaine) should be used cautiously in persons with
known drug allergies or sensitivities, particularly to the amide-type local
anesthetics.
Caution is advised in administration of repeat doses of bupivacaine to
patients with severe liver disease.
The lowest dosage that gives effective anesthesia should be used, to
avoid high plasma levels and serious systemic side effects. Injection ol
repeated doses of bupivacaine may cause a significant increase in
blood levels due to accumulation of the drug or its metabolites or slow
metabolic degradation.
Tolerance varies with the status of the patient. Debilitated, elderly and
acutely ill patients may require reduced doses commensurate with age
and physical condition.
It should be remembered that solutions containing a vasopressor
agent, e.g. epinephrine, should be used with caution, if at all, in patients
who are receiving monoamine oxidase inhibitors or anti-depressants
of the triptyline or imipramme type, because severe, prolonged hyper
tension may result. Dose-related cardiac arrhythmias may occur if
preparations containing epinephrine are employed in patients during or
immediately following the administration of chloroform, halothane,
cyclopropane, trichloroethylene or other related agents. In deciding
whether to use these products concurrently in the same patient,
the combined action of both agents upon the myocardium, the concen
tration and volume of vasoconstrictor used, and the time since injec
tion, when applicable, should be taken into account.
The decision to use a local anesthetic containing a vasoconstrictor in
areas with a limited blood supply or in patients with peripheral vascular
disease, will depend on the physician’s appraisal of the relative advan
tages and risks.
Local anesthetics which contain preservatives, i.e. those supplied in mul
tiple dose vials, should not be used for caudal or epidural anesthesia.
Epidural Use: It is advised that a test dose, generally 2-3 mL of 0.5%
bupivacaine (or other amide anesthetic) containing 1:200,000 epine
phrine (10-15 micrograms) be administered to check that the spinal
canal or a blood vessel has not been entered while locating the epidural
needle or catheter.
In the event of spinal injection clinical signs of spinal block would
become evident in a few minutes.
In the event of intravascular injection a transient increase in pulse rate
and possibly momentary increase in systolic blood pressure are
usually detectable with a monitor. The other symptoms and signs of
“epinephrine response” are less dependable. The effects of other medi
cation the patient has received may modify this response.
When reinforcing doses are required the test dose should be used
again to check the catheter location.
Use in Ophthalmic Surgery: When Marcaine 0.75% is used for retrobulbar block, complete corneal anesthesia usually precedes onset of clini
cally acceptable external ocular muscle akinesia. Therefore, presence
of akinesia rather than anesthesia alone should determine readiness of
the patient for surgery.

nervous system and the cardiovascular system. The central nervous
system effects are characterized by excitation or depression. The first
manifestation may be nervousness, dizziness, blurred vision, or tre
mors, followed by drowsiness, convulsions, unconsciousness, and pos
sibly respiratory arrest. Since excitement may be transient or absent,
the first manifestation may be drowsiness, sometimes merging into
unconsciousness and respiratory arrest.
Other central nervous system effects may be nausea, vomiting, chills,
constriction of the pupils, or tinnitus. The cardiovascular manifesta
tions of excessive plasma levels may include depression of the myocardium, blood pressure changes (usually hypotension), and cardiac
arrest. Recent clinical reports and animal studies suggest this may be
more likely to occur with the long acting amide local anesthetics such
as bupivacaine.
Allergic reactions are characterized by cutaneous lesions (e.g. urticaria,
edema) and other manifestations of allergy.
Reactions following epidural or caudal anesthesia may include: high or
total spinal block, urinary retention; fecal incontinence, loss of perineal
sensation and sexual function; persistent analgesia, paresthesia, and
paralysis of the lower extremities; headache and backache; and slow
ing of labor and increased incidence of forceps delivery.
It should be noted that reactions due to systemic absorption may be
slow or rapid in onset. Those of rapid onset include respiratory depres
sion, cardiovascular collapse and cardiac arrest. This type of reaction
necessitates a high degree of preparedness since it can occur with little
warning.
In co-ordinated studies of 3200 procedures carried out by 15 investiga
tors, there were 2 severe systemic reactions. Both patients experienced
convulsions as a result of inadvertent vascular injection.
Fetal bradycardia has been observed with the use of bupivacaine. Most
cases, including a few fatalities, occurred when the paracervical route
was used (see “Warnings”).
In some subjects bupivacaine may produce marked peripheral vaso
constriction in unanesthetized areas which may last for several hours.

Treatment of Overdose and Severe Reactions:
Toxic effects of local anesthetics require symptomatic treatment; there
is no specific cure. The physician should be prepared to maintain an
airway and to support ventilation with oxygen and assisted or con
trolled respiration as required. Supportive treatment of the cardiovas
cular system includes intravenous fluids and, when appropriate, vaso
pressors (preferably those that stimulate the myocardium).
Convulsions may be controlled with oxygen and intravenous adminis
tration, in small increments, of a barbiturate or muscle relaxant, as
follows: preferably, an ultra short-acting barbiturate such as thiopental
or thiamylal; if this is not available, a short-acting barbiturate (e.g. seco
barbital or pentobarbital) or a short-acting muscle relaxant (succmylcholme). Intravenous muscle relaxants and barbiturates should only be
administered by those familiar with their use.

Dosage and Administration:
The duration of anesthesia with bupivacaine is such that, for most pro
cedures, a single dose is sufficient. Maximum dosage limit must be indi
vidualized in each case after evaluating the size and physical status of
the patient, as well as the usual rate of systemic absorption from a par
ticular injection site. Most experience to date is with single doses of
bupivacaine up to 225 mg with epinephrine 1:200,000, and 175 mg
without epinephrine; more or less drug may be used depending on indi
vidualization of each case.
At present there is insufficient clinical evidence with multiple dosage or
intermittent dose techniques to permit precise recommendations for
such procedures to be given. However, limited clinical experience in this
area of use indicates that bupivacaine may be repeated in 3 to 6 hours
up to a maximum dose of 400 mg in 24 hours. In most cases the dura
tion of anesthetic effect is prolonged by the addition of epinephrine.
The following doses have generally proved satisfactory for the average
adult. They may require adjustment in relation to age and the physical
condition of the patient.
Local infiltration: up to a maximum dosage of 0.25% solution.
Peripheral nerve block: 5 to 30 mL of 0.50% or 5 to 60 mL of 0.25%
solution.
Sympathetic: 20 to 50 mL of a 0.25% solution.
Epidural: 10 to 20 mL of a 0.25%, 0.50%, or 0.75%t solution.
Caudal: 15 to 30 mL of a 0.25% or 0.50% solution.
tO.75% not recommended for obstetric use.

Supplied:
Each 20 mL single dose vial contains: bupivacaine 0.25%, 0.50% or
0. 7 5 . with or without epinephrine 1:200,000. Boxes of 5 vials.
Each 50 mL multiple dose vial contains: bupivacaine 0.25% or 0.50%.
Boxes of 1 vial.
Note: Bupivacaine solutions without epinephrine may be autoclaved.
Product Monograph available on request.
References
1. Ocker, Glenn A.: Bupivacaine: A New Longer Lasting Local Anesthetic.
Journal of the American Podiatry Association. Vol. 66, No. 8, Aug. 1976,
pp. 618-630.
2. Scott, D.B.: Postoperative Pam Relief. American Society of Regional
Anesthesia. Suppl. 1982: 7:S110-S113.
3. Rochowanski, E., Kreiser, R.D., and Morris, L.E.: Caudal Anaesthesia
with Bupivacaine (Marcaine ) for Anal Surgery: A Clinical Trial. Cana
dian Anaesthetist's Society Journal 1971:18:18-22.

Adverse Reactions:
Reactions to bupivacaine are characteristic of those associated with
amide-type local anesthetics. A major cause of adverse reactions to
this group of drugs is excessive plasma levels, which may be due to
over-dosage, inadvertent intravascular injection, or slow metabolic
degradation. Other causes of reactions to these local anesthetics may
be hypersensitivity, idiosyncrasy, or diminished tolerance.
Excessive plasma levels cause systemic reactions involving the central
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Early Valve Replacement in Active Infective Endocarditis
►

►

Infective endocarditis is associated with
a high mortality, but previous studies
have suggested that the major complicar
tions of the condition might be
prevented by early surgery. Of 50 pa’
tients treated for infective endocarditis at
the Montreal Heart Institute from 1977
r to 1982, 30 were treated nonsurgically
^ and the remaining 20 underwent early
valve replacement before preoperative
4
antibiotic therapy was completed. Of
these 20, 14 had native valve endocar> h ditis and 6 prosthetic valve endocarditis.
The organisms involved were Streptocock * cus sp in 11, Staphylococcus aureus in
2, gram-negative organisms in 3 and
Candida parapsilosis in 1. Blood cultures
remained negative in three patients.
There were three early deaths (15%)
following operation and one late death
f
(5% ). Infection on implanted prostheses
' v did not recur, but reoperation was
required in one patient because of
r
prosthetic dehiscence 7 months after in
itial implantation. All resected valves
displayed evidence of infection. Follow
up was obtained in all survivors. After an
average follow-up of 26 months, 12 pa^ y. tients remained in functional class I and
4 in class II (New York Heart Association
> y classification). Early valve replacement
has resulted in improved survival of patients with infective endocarditis and is
now associated with a low operative
y mortality and morbidity.
v

L'endocardite infectieuse s'accompagne
|.d'une forte mortality. Des Etudes
anterieures ont indique que les complicai ► tions majeures de cette maladie
pouvaient etre evitees par une chirurgie
*■ precoce. Sur 50 patients trait6s pour
endocardite infectieuse a I'lnstitut de

cardiologie de Montreal entre 1977 et
1982, 30 ont regu un traitement medical
alors que les 20 autres subissaient un
remplacement valvulaire precoce avant la
fin d'un traitement antibiotique
preoperatoire. De ces 20 malades, 14
avaient une endocardite affectant les
valvules cardiaques naturelles et 6 une
infection de valvule prosthetique. Dans
11 cas, le microorganisme responsable
6tait le Streptococcus sp, dans 2 cas
Staphylococcus aureus, des bact6ries
gram negatif dans 3 et Candida parap
silosis dans 1. Les h6mocultures sont
demeurees negatives chez trois patients.
On a enregistre trois dbces (15% ) t6t
apres I’operation et un d£ces tardif (5%).
II n'y a pas eu de rgcidive d'infection de
prothese, mais une deuxi&me operation
s'avera necessaire chez un patient £
cause de la dehiscence d'une valvule
prosthetique 7 mois apres la pose
initiale. Toutes les valvules resequees
ont montre des signes d'infection. Tous
les survivants ont fait I'objet d'examens
de controle. Apres une periode de
surveillance moyenne de 26 mois, 12
patients se maintenaient dans la classe
fonctionnelle I et 4 dans la classe II
(selon la classification de la New York
Heart Association). Un remplacement
valvulaire precoce a ameiiore la survie
des patients atteints d'endocardite infec
tieuse et cette operation est maintenant
liee a un faible taux de mortalite et de
morbidite peroperatoires.
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Despite the availability o f many new and
potent antimicrobial drugs, infective en
docarditis still carries a high mortality,
owing to the severe complications of this
disease. Previous studies have shown that
congestive heart failure and systemic em
bolism occur frequently and are respon
sible for more than 75% of the deaths.1,2
Both complications might be prevented
by earlier surgical treatment. Therefore,
the proper timing o f operation appears to
be a major, and still unresolved, issue in
the management o f this condition. There
has been reluctance to recommend early
valve replacement in these patients
because implantation of a prosthetic

device in a septic environment is against
w ell-established surgical principles.
However, the poor results from the classic
treatm ent have stim ulated interest
towards a more aggressive attitude. This
paper describes our experience with 20 pa
tients who underwent valve replacement
early during the active phase o f infective
endocarditis.

Patients and Methods
From 1977 to 1982, 50 patients with in
fective endocarditis were treated at the
Montreal Heart Institute. There were 28
cases o f native valve endocarditis (half
were treated medically) and 22 cases o f
prosthetic valve endocarditis (16 treated
medically). During the same period, 980
patients underwent valve replacement.
Among the 22 patients treated for en
docarditis o f a prosthetic valve, 5 infec
tions occurred early (within 2 months o f
valve implantation) and 17 late. O f the
30 patients managed by medical treatment
alone, 4 (13%) died. Three o f them had
late prosthetic valve endocarditis. Among
the 26 patients in whom the infection was
successfully controlled by medical treat
ment, 7 (23%) underwent delayed opera
tion 2 to 11 months (mean 6 months) after
onset o f the disease, because o f late
hemodynamic complications following
termination o f antibiotic treatment. There
were no deaths following delayed valve
replacement.
Early valve replacement during the ac
tive phase o f infective endocarditis was
performed in 20 patients. There were 15
men and 5 women aged 18 to 69 years
(mean 46 years), 14 with native valve en
docarditis and 6 with late prosthetic valve
endocarditis. In the 14 patients with en
docarditis o f a native valve, the preex
isting valvulopathy was rheumatic in 8,
myxoid degeneration in 4 and a bicuspid
aortic valve in 2 patients. The aortic valve
was involved in seven patients, the mitral
in two and both valves in five cases. In
the other six patients, a mitral prosthesis
was infected in four, an aortic prosthesis
in one and both aortic and mitral pro
stheses in one patient. In 9 o f the 20 cases,
the site o f entry o f the infection was
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unknown. A dental infection was respon
sible for six cases, a urinary infection was
the cause in three, and otitis and skin in
fection were responsible in one patient
each. There were no cases of infective en
docarditis secondary to drug addiction in
our series. Responsible microorganisms
are shown in Table I. Active infection
was evident on pathologic examination of
resected natural or prosthetic valves in all
patients, most frequently vegetations
(Table II). Following surgery, the specific
antimicrobial therapy was continued un
til treatment had lasted for 6 weeks, in
cluding preoperative treatment.

Findings

Preoperative Management
Preoperative investigation included
echocardiography in 18 patients (vegeta
tions were indicated in 5), gallium scan
ning in 6 patients with two positive tests
and cardiac catheterization in 5 patients.
Indications for hemodynamic studies
were double-valve involvement in three
and a left-to-right shunt in one patient
and for coronary angiography in one pa
tient with previous angina. Antibiotics
were selected according to in-vitro sen
sitivity and administered intravenously.
None of these patients completed a full
6-week course of antibiotic therapy before
they underwent operation. The duration
of treatment preoperatively ranged from
1 to 40 days (average 21 days) (Fig. 1).
Early valve replacement was performed
because of the sudden appearance or pro
gression of congestive heart failure in 15
patients, resistance to antibiotic treatment
as evidenced by persisting fever after 3
weeks of treatment in 3 and major sys
temic embolism in 2 patients. Two of the
patients were in septic shock preopera
tively.

Postoperative Results and Follow-up
There were three early deaths (within
30 days), from uncontrollable hemor
rhage in two patients and from acute
renal failure in one. Two patients (14%)
in the native valve group died and one
(17%) in the prosthetic valve group.
There was one late death 2 months
postoperatively from intractable ar
rhythmias. All four deaths occurred in
patients who underwent complex surgical
procedures (double-valve replacement in
two, aortic valve replacement and closure
of ventricular septal defect in one and
mitral valve replacement associated with
coronary bypass grafting in one).
All 16 survivors were available for
follow-up, 12 to 60 months after opera
tion (mean 26 months). There were no
cases of reinfection of implanted prostheses in our series. One patient under
went reoperation because of massive
dehiscence of a mitral valve prosthesis 7
months after initial implantation for
fungal infective endocarditis. Antifungal
treatment was started preoperatively; am
photericin B was given intravenously for
18 days and flucytosine given orally for
4 days. Both drugs were discontinued on

the fourth postoperative day because of
rapidly progressive renal failure. A loud
mitral systolic murmur and severe con
gestive heart failure developed. At <
reoperation, the mitral prosthesis was
found to be torn from the annulus at A
three different sites but there was no
evidence of reinfection. The prosthesis ^
was replaced after scrubbing the endocar- i
dium with iodine solution. All cultures
taken at reoperation were negative. The _
patient showed no signs of recurrent in
fection following operation and he re<
mains well 36 months later. At last
follow-up, 12 of the 16 patients were in *• ‘
the New York Heart Association func
tional class I and 4 in class II. An aortic
diastolic murmur was noted in 2 of 13 pa-

T a b le I I — P a th o lo g ic Findings on
R e s e c te d V a lv e s
P a th o lo g ic fe a tu re

No.

V e g e ta tio n s

16
6
4

A b sc ess
L e a fle t p e rfo ra tio n
F is tu la o f sinus o f V a ls a lv a
R u p tu re d ch o rd a e

2
1

T a b le 1 -O rg a n is m s R es p o n sib le fo r In fe c tiv e E n d o c ard itis
in 2 0 P a tie n ts T r e a te d S u rg ic a lly *
O rg an ism

No.

%

Streptococcus
viridans g roup
faecalis
Peptostreptococcus
Staphylococcus aureus

11

55

G ra m -n e g a tiv e o rg an ism s

Haemophilus influenzae
Acinetobacter calcoaceticus
Actinobacillus actinomycetem-comitans
F ung us: Candida parapsilosis

9
1
1
2
3
1

10
15

1
1
1

5

* l n 3 p a tie n ts ( 1 5 % ) no o rg a n is m s w e r e c u ltu re d .

Surgical Treatment
The aortic valve was replaced in seven
patients (35%), the mitral valve in four
(20%) and both valves were replaced in
nine patients (45%). In addition, two pa
tients underwent closure of a ventricular
septal defect caused by a fistula from aor
tic valve endocarditis and one patient had
coronary bypass grafting in addition to
mitral valve replacement. A bioprosthesis
was implanted in 17 patients and a
mechanical valve in 3. Cold potassium
cardioplegia and pericardial irrigation
were used to protect the myocardium dur
ing operation in all patients. After opera
tion, complete atrioventricular block
developed in two patients and a perma
nent pacemaker had to be implanted.
384

FIG. 1—Duration of preoperative antibiotic treatment (mean 21 days, range from 1 to 40 y
days) in 20 patients who underwent early valve replacement for infective endocarditis.
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tients with an aortic prosthesis, and a
mitral systolic murmur in 1 of 10 patients
with a mitral prosthesis. Although
hemodynamic studies were not perform
ed, none of these regurgitation murmurs
appeared to be clinically important.
* Discussion

All patients who underwent surgical
treatment in our series presented with
definite infective endocarditis as defined
<- in the classification of Pelletier and
Petersdorf,3 since evidence of active
^ valve infection was demonstrated on
histologic examination in all cases. The
indications for and timing of valve
replacement in the treatment of infective
endocarditis are not yet well defined.
Y Before 1977, the mortality from infective
endocarditis was high. Before 1970 at the
^Montreal Heart Institute, only 67% of
patients survived the acute phase of in
fection and in a second series of patients
treated between 1969 and 1977, the
overall mortality was 44%, even though
k more patients were treated surgically.1’2
Since 1977, the mortality from this disease
a has decreased markedly to 14% (13% in
the nonsurgical group and 15% in the
surgical group). Besides the im
provements in antimicrobial drugs
available and in the surgical and myocar
dial protection techniques, earlier valve
replacement during the course of the
disease has played a major role in improv
ing survival. Death results from a major
t complication, which could have been
prevented by earlier surgical treatment in
75% to 90% of cases.1'3 Comparing the
results of nonsurgical and surgical
treatments of infective endocarditis,
Richardson and associates4 found a
y significant difference in the respective
mortality rates; they were 44% and 14%
r for native valve endocarditis, and 75%
and 43% for prosthetic valve endocar
ditis. They therefore recommended early
valve replacement when signs of pro

gressive heart failure develop, particularly
with aortic valve endocarditis, or if
systemic embolization occurs.
Few series of early valve replacement
during the active phase of infective en
docarditis have been reported (Table
III412). Among 431 patients collected
from 10 studies (including the present
one) since 1976, there has been a pro
gressive decline in early mortality, which
ranged from 18% to 37% between 1976
and 1980 to 16% or less since 1981. In
most series, prosthetic valve endocarditis
resulted in a higher surgical mortality
than native valve disease, but the dif
ference was small in our patients.
Although inserting a prosthesis in a
septic environment is against generally
recognized surgical principles, our ex
perience and that of others4'8,12 indicate
that the risk of reinfection of the im
planted prosthesis is minimal. We have
had no case of recurrent infection of a
prosthesis following operation and only
one case of dehiscence; this required
reoperation. Others reported similar
results, with reoperation rates ranging
from 5% to 14% (Table III). In only one
small series was there a high reoperation
rate — 33%.7
While the organism responsible for the
endocarditis can be identified in most pa
tients, the site of entry of infection re
mains unknown in almost half. When it
is known, dental and urinary tract infec
tions or manipulations are most often in
volved. Improved prophylactic treatment
in patients at risk should decrease the in
cidence of endocarditis secondary to these
well-established causes. Contrary to the
experience of most others, we have had
no cases of right heart infective endocar
ditis and none of our cases was related to
drug addiction.
Echocardiography is a useful noninvasive method for detecting valvular
vegetations.11’13,14 In our series, using
either the M-mode or two-dimensional
echocardiography, vegetations were
shown in only 28% of the patients. Thus,
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R e p o r t e d in t h e L it e r a t u r e
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5
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14
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9
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14
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17
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33

9

5

17

15

5

35

19

-

p r o s t h e t ic v a lv e e n d o c a r d it is .

a diagnosis of infective endocarditis can
not be excluded on the basis of a negative
echocardiogram. Cardiac catheterization
is not helpful for diagnosis and is seldom
indicated in these patients, except when
involvement of more than one valve is
suspected or when coronary angiography
is necessary to investigate concomitant
coronary artery disease.
Our results are similar to those of
Richardson and associates4 and confirm
their conclusion that patients with infec
tive endocarditis should undergo valve
replacement early during the course of
treatment if congestive heart failure pro
gresses or systemic embolization occurs,
regardless of the infective state. This more
aggressive attitude has resulted in a
marked decline in mortality. However,
early prosthetic valve endocarditis still
carries a high mortality whether treated
surgically or nonsurgically.4,15 In the
present study, five patients were con
sidered to have had early prosthetic valve
endocarditis (0.5% of all patients who
had valve replacement between 1977 and
1982). All responded to medical treat
ment. Prevention of this catastrophic
complication is the major consideration
and the prophylactic regimen used in our
patients, which includes skin cleansing
with chlorhexidine 0.05% solution and in
travenous administration of ampicillin
and cloxacillin 1 g every 6 hours for 4
days, starting just before operation, ap
pears to be effective. In addition, special
care is given to detection of dental pro
blems or of any active infection preoperatively.
The late results also justify our present
attitude, since after an average follow-up
of more than 2 years there has been no
late prosthetic reinfection and only one
valve dehiscence. At follow-up, prosthetic
regurgitation murmurs were found in
three other patients, but in only one of
these was the murmur greater than grade
2/6, and all three patients remained
asymptomatic with no evidence of a
hemodynamically important regurgita
tion. However, these patients must be
followed up carefully for at least 2 years
following operation to detect signs of
reinfection or of substantial paravalvular
leak. Lau and colleagues9 have stressed
the importance of carrying out complete
debridement of the annulus and of re
moving all necrotic tissue at operation; if
the remaining annulus is friable, stitches
reinforced with Teflon pledgets should be
used. Postoperatively, the antibiotic
regimen is determined by the in-vitro sen
sitivity of the organism involved and is
maintained for a minimum of 2 weeks
and up to 6 weeks.

11

Conclusions

Our results lead us to recommend earVOLUME 27, NO. 4, JU LY 1984 / THE CANADIAN JOURNAL OF SURGERY
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ly valve replacement during the treatment
o f infective endocarditis if congestive
heart failure progresses, major systemic
embolization occurs or if the patient does
not respond to medical treatment. Opera
tion should not be postponed in order to
complete the antibiotic treatment, since
in our experience late complications due
to prosthetic reinfection or dehiscence are
uncommon and do not justify the greater
risk of major systemic complications
from delaying definitive surgical treat
ment.
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Management of Gangrene in Diabetic Extremities
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*

The long-term complications of diabetes
mellitus occur despite insulin therapy.
One of these complications is gangrene
of an extremity which is a prime cause
of morbidity and mortality in diabetic
patients. Peripheral occlusive vascular
disease frequently underlies the gangrene
and this challenges the surgeon to revas
cularize the limb and to limit the amputa
tion to the gangrenous tissue. The
author describes six diabetic patients
with gangrene of an extremity treated at
the Riverside Hospital in Ottawa to illus
trate how this condition may be mana
ged by revascularization with no amputa
tion or with conservative amputation and
debridement. Major amputation was
avoided in all six patients.
Les complications a long terme du diabete sucre surviennent malgre I'insulinotherapie. La gangrene d'un membre
represente une de ces complications; elle
est une cause importante de morbidite et
de mortality chez le patient diabetique.
La maladie vasculaire obliterante peripherique est souvent sous-jacente a cette
gangrene et ceci incite le chirurgien a
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revasculariser le membre et 6 limiter
I'amputation au tissu gangreneux. L'auteur decrit six cas de gangrene des membres chez des patients diabetiques qui
ont ete traites a I'Hopital Riverside d'Ottawa afin d'illustrer comment cette mala
die peut etre traitee par revascularisation
sans amputation ou avec une amputation
conservatrice et debridement. Une ampu
tation majeure a ete evitee chez les six
patients.

l

fails to mention revascularization in its
discussion of gangrene in diabetics.
Between March 1981 and March 1983,
six diabetic patients with gangrene of an
extremity were referred to me at the
Riverside Hospital in Ottawa. In all six
patients major amputation was avoided
by revascularization with or without con
servative amputation.

v
4

’

\

Case Reports
Case 1

Gangrene is a major complication o f
diabetes mellitus and contributes ap
preciably to the morbidity and mortality
and to the health-care costs o f these
patients.1 The diabetic extremity is
susceptible to infection, neuropathy and
arterial occlusive disease, which poten
tiate each other and cause gangrene.2
Because accelerated atherosclerosis of
medium and large vessels is more impor
tant than microvascular disease in the
etiology of gangrene,3 surgeons are now
able to revascularize and salvage the limbs
of many diabetic patients. Often clini
cians do not consider revascularization of
diabetic extremities with gangrene and
even refer these patients to orthopedic
surgeons for major amputation or to
plastic surgeons for radical debridement
rather than to a surgeon who can
revascularize the extremity and limit the
tissue loss to that which is already dead.
A recent major textbook o f medicine1

A 76-year-old man with insulin-dependent
diabetes mellitus had painful gangrene of his
entire right fifth toe with erythema and edema
of the adjacent foot. The rest of the foot was
warm and pain-free with normal sensation; he
had no history of claudication or rest pain. The
popliteal pulse was present but the pedal pulses
were absent. Doppler blood pressure in the
posterior tibial artery was 100 mm Fig systolic
and the brachial blood pressure was 180 mm
Hg systolic. Transmetatarsal amputation of the
fifth toe failed to heal and the gangrene spread
to involve the fourth and third toes.
Angiograms showed a large patent posterior
tibial artery with proximal occlusion (Fig. 1).
An autogenous reversed saphenous vein graft
was inserted from the superficial femoral artery
to the posterior tibial artery (Fig. 2). The third
and fourth toes were amputated at the
transmetatarsal level and the foot healed. The
patient had no further trouble with his foot.
It was pain-free and fully weight bearing until
his death 18 months later.
Comment.— Angiography should be done
before any m ajor am putation. If the
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revascularization of the posterior tibial artery
had been done before the initial amputation,
the patient would have lost only one toe and
would have been out of hospital 2 months
earlier.

A
*-

Case 2
►

While vacationing in Florida, a 70-year-old
V ►insulin-dependent diabetic man had a callus
pared. Gangrene resulted, involving his left
third, fourth and fifth toes and adjacent foot.
One year previously, an ulcer of the same foot
i>- had healed with conservative treatment. Pedal
pulses were absent but he did not have
*
claudication or rest pain. On this admission,
the pedal pulses were absent to palpation and
► *- the Doppler blood pressure in the posterior
tibial artery was the same as the brachial
-v
pressure. The popliteal pulse was present and
angiography showed a tight stenosis o f the
y
posterior tibial artery, which was the only one
supplying the foot. Percutaneous transluminal
■
angioplasty of the posterior tibial artery was
done and a palpable pulse was restored at the
y r ankle; a transmetatarsal amputation o f the
third, fourth and fifth toes h e ie d with delayed
*
skin grafting. He was fully weight bearing with
a minimal limp postoperatively.
5
Four months after the initial amputation,
rest pain, ulceration and breakdown of the skin

grafts developed with necrosis of the second
toe. The posterior tibial pulse was absent and
angiography showed reocclusion of the
posterior tibial artery. A popliteal posterior
tibial saphenous vein graft was successful
although the second toe had to be amputated.
He was pain free and fully weight bearing with
a patent saphenous vein graft 18 months after
the initial amputation, when he died of
esophageal varices.
Comment.—Adequate collateral circulation
did not develop after the angioplasty and the
patient lost another toe when the artery became
occluded a second time. In the light of our pre
sent knowledge of angioplasty of the tibial
arteries, bypass grafting should have been done
initially rather than angioplasty.

Case 3
A 58-year-old man was seen in the emergen
cy department with gangrene along the lateral
edge of his right foot. The rest of the foot was
swollen, painful and warm. Pedal pulses were
absent but the popliteal pulse was present.
Although diabetes mellitus had not been
diagnosed previously, his blood glucose level
was 21.1 mmol/L. He had no history of
claudication or rest pain in his extremities.
Angiography showed diffuse disease in the
proximal tibial and peroneal arteries with a pa-

tent distal posterior tibial artery supplying the
foot. An autogenous reversed saphenous vein
graft was inserted from the popliteal to the
tibial arteries and the fifth toe and gangrenous
tissue were amputated. Further debridement
was done 1 week later. After 3 weeks of dress
ing changes to the open am putation site, the
area was granulating, so skin grafting was
done. At present, the saphenous vein graft has
been patent for 1V4 years and he is fully weight
bearing with a healed amputation site.
Comm ent.—High skin tem perature and
erythema may not indicate adequate perfusion
because a hyperdynamic circulation accom
panies the inflammatory response to infection
and gangrene. Revascularization should be
done as early as possible after gangrene
develops.

Case 4
A 48-year-old insulin-dependent diabetic
man had gangrene of his left fifth toe and ad
jacent foot. The foot was edematous and warm
without pedal pulses. No Doppler signal was
audible in either pedal artery; the popliteal
pulse was present. He had had no symptoms
of vascular insufficiency in the past.
Angiograms showed disease of the peroneal
and tibial vessels in the calf with the foot sup
plied by the terminal anterior tibial artery (Fig.

3).

i ».

Because his own saphenous vein was throm
bosed, an umbilical vein graft was inserted
from the popliteal to the anterior tibial artery
and the fourth and fifth toes were amputated.
Delayed skin grafting was done after the open

'

'

FIG. 1—Case 1. Large patent distal posterior
tibial artery fed by collaterals. Peroneal and
anterior tibial arteries cannot be seen.

FIG. 2—Case 1. Operative arteriogram
demonstrates saphenous vein graft filling
posterior tibial artery.

FIG. 3—Case 4. Patent posterior tibial
artery that makes minimal contribution to
blood supply of foot. Collateral with critical
stenosis (arrow) supplies large patent distal
anterior tibial artery, which is main vessel sup
plying foot.
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amputation site granulated with dressing
changes.
The umbilical vein graft became infected and
occluded after 4 months but the skin grafts had
healed by that time and the umbilical vein graft
was removed without adverse effect.
He is fully ambulatory and pain free 2 years
after the initial amputation.
Comment.—The umbilical vein graft provid
ed temporary revascularization while the
gangrene was treated, the skin grafts healed
and collaterals developed. Salvage rates are
usually higher than graft patency rates for this
group of patients. In retrospect, the saphenous
vein thrombosis may have been due to the
gangrene and the vein from the other leg may
have been suitable for grafting.

Case 5
Gangrene o f the tip o f the right middle toe
developed in a 61-year-old grossly obese
insulin-dependent diabetic woman. The foot
was warm and painful with erythema o f the
toe and foot adjacent to the gangrene. No
pedal pulse was palpable and a faint signal was
heard by Doppler in the dorsalis pedis artery.
The popliteal pulse was not palpable but the
femoral pulse was present. She had no history
o f peripheral vascular insufficiency. The
arteriogram showed a critical stenosis o f the
superficial femoral artery with some diffuse
disease. The anterior tibial and peroneal
arteries were thought by the radiologist to be
occluded and there was no flow in the distal
posterior tibial artery. Because o f the lack of
collaterals in the calf and the faint Doppler
signal in the pedal arteries, the surgeon thought
the problem was low flow rather than occlu
sion. A femoropopliteal umbilical vein graft
was inserted because her own saphenous vein
was thrombosed; good flow returned to both
pedal arteries. The tip o f her toe autoamputated and she is fully ambulatory and painfree 1V4 years postoperatively.
Comment. —Angiograms need to be inter
preted in the light o f the clinical findings and
a positive Doppler signal may indicate a pa
tent artery not visualized by angiography. An
umbilical vein graft can be used as an arterial
substitute when the patient’s saphenous vein
is not suitable.

Case 6
A 68-year-old man with insulin-dependent
diabetes mellitus had painful gangrene o f the
pulps of the left ring and fifth fingers. The
pulses of the left upper extremity were absent
and angiography showed occlusion o f the left
subclavian artery. An axilloaxillary saphenous
vein graft revascularized the left upper extremi
ty and the fingers have remained healed for 1
year. No amputation or skin grafting was
required.
Comment.—Diabetic gangrene may involve
the upper as well as the lower extremity.

Discussion
Diabetic patients with gangrene maybe
extremely ill initially due to infection ad
jacent to the gangrene and to uncontroled diabetes mellitus. Preoperatively,
fluid, electrolyte, acid-base and bloodglucose abnormalities are corrected and
388

antibiotics (usually an aminoglycoside)
are administered parenterally. The an
tibiotics can be changed postoperatively
as the culture results indicate. Roentge
nograms may show associated bone
destruction or gas in the soft tissues ad
jacent to the gangrene. Drugs such as
acetylsalicylic acid, dipyridamole4 and
ibuprofen5 are more effective in prolong
ing vein graft patency if they are begun
preoperatively, and there is evidence that
vitamin A 6 and prostaglandins7 are
beneficial although they are seldom us
ed. Cessation of smoking is imperative
and lipid abnormalities and obesity can
be dealt with postoperatively.
Vascular disease may occur in both
insulin-dependent and noninsulin-de
pendent diabetic patients; the exact rela
tion of the vascular lesions to the control
of blood glucose remains debatable.8
The large-vessel lesion in diabetes mellitus
is similar pathologically to that seen in
nondiabetic patients with atherosclerosis
although the diabetic atherosclerotic
lesions are more numerous and more
often complicated by ulceration, calcifi
cation and superimposed thrombosis.3
Peripheral occlusive vascular disease is
primarily due to atherosclerosis and is not
related to medial calcification, which is
also common in diabetic patients.1 The
degree of narrowing of a vessel required
to produce a detectable pressure gradient
or reduction in blood flow is called the
critical stenosis and this is present when
the cross-sectional area of the lumen is
reduced by 75% or the diameter by
50% .9 The pressure drop across a
stenosis varies with the flow which ex
plains why unimportant stenoses at rest
become important with the increased flow
of exercise, and claudication pain results.
The inflammatory response to an in
fected, gangrenous extremity is a hyper
dynamic circulation and this increased
flow makes a stenosis more important.
Arterial obstructions will be partially
compensated for by collaterals that in
crease as a result of the increased flow
velocity through the normal collateral
vessels or as a result of the abnormal
pressure gradient across the collateral
bed.10 The collaterals may look im
pressive by arteriography but their
resistance is always greater than that of
an unobstructed vessel. If a collateral
vessel is one-fourth the diameter of the
main artery, 256 vessels are required to
equal the resistance of the original
artery.9
The blood supply to a diabetic limb
with gangrene is difficult to assess clinical
ly, especially when active infection is also,
present and the inflammatory response to
infection increases the skin temperature,
causing erythema and edema that make
pulses difficult to feel. The circulation
may be hyperdynamic and cause arterial

stenoses to become more important. Dop
pler studies and pedal artery blood
pressures are useful and a positive Dop
pler signal may indicate a patent artery <
not visualized by angiography.11 The
clinical assessment is probably the best
A
method of determining the need for
revascularization; the surgeon should take A
into consideration skin temperature, rest
.
pain, rubor, trophic changes and *
palpability of pulses. Any diabetic patient „
with gangrene and absent pulses should
be considered for arteriography and
*
possible vascular reconstruction. Occa
sionally, infection and edema adjacent to * ‘
the gangrene will have spread to involve
the operative site of revascularization and * '
it is usually prudent to delay the revascu
larization in this situation because an- '
tibiotics, elevation of the extremity and
excision of the gangrenous area will usual
ly clear the infection and edema from the
.
operative sites of revascularization. The
angiographer should be informed that t i
details of the distal arteries are required
and that a hyperdynamic circulation may *
alter the film sequence. He should also
look for proximal disease which may be
*
occult.12
4
Although angiographic techniques can
frequently be used as an aid or alternative
to surgery,13 Johnston and associates14
have reported that percutaneous transluminal angioplasty of the tibial arteries
is associated with a high incidence of oc
clusion. However, angioplasty may be
useful for patients who are not candidates
for major reconstructive surgery, as a
temporizing measure while they are being prepared medically preoperatively, or
for proximal lesions in larger arteries.
Hess and associates15 have reported
arterial patency at 2 weeks in only 70 of
136 patients after the use of intra-arterial
streptokinase and transluminal angioplasty.
The basic surgical principle in treating
gangrene is to remove the dead tissue and
to preserve the remaining healthy tissue
by preventing the spread of infection and
necrosis. If the remaining tissue is
ischemic, antibiotics will not prevent the
spread of infection and gangrene and
revascularization will be necessary. The
revascularization procedure may challenge the ingenuity of the surgeon; he may
have to insert an extra-anatomic bypass
graft or a graft to a small artery such as
the tibial, peroneal or p ed al.16'20
Autogenous saphenous vein is the prefer
red material for grafting and sequential
grafts can be used from the femoral to the
popliteal and then to the tibial arteries if
the superficial femoral and tibial arteries
are both involved. Because gangrene of
a foot can cause thrombosis of the
autogenous saphenous vein, a preoper
ative venogram of the uninvolved leg
should be considered to assess saphenous
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vein patency because the vein from the
unaffected leg may be required. Verta21
has reported excellent results, grafting in"> to arteries of the foot using saphenous
vein and composite saphenous vein>
polytetrafluoroethylene (PTFE) as se
quential and nonsequential grafts. Poly‘ ^ tetrafluoroethylene used as a noncom^ . posite graft was not as successful. Reichle
~ and associates22'24 established the value
. of grafts from the common femoral
artery to the tibial or peroneal arteries
when the popliteal artery was occluded.
Feldman and colleagues25 have recently
1 reported patency in 7 of 11 grafts to the
distal tibial from the popliteal or prox’ K imal posterior tibial arteries. Umbilical
vein grafts are superior to PTFE grafts
' and should be used when the autogenous
^ vein is not available.26’27 The Prolene
mesh that now surrounds the umbilical
i *- vein grafts is designed to prevent
aneurysm formation that was a complicay y tion of the unprotected grafts. En
darterectomy is not recommended below
* the knee although popliteal endarterec
tomy is feasible.28 If more than one half
of the sole of the foot has been destroyed,
k the limb will never be suitable for weight
bearing despite effective arterial
i i reconstruction. Amputation should be the
initial treatment.29 Revascularization oc
casionally will allow a below-knee am
putation rather than an above-knee am*
putation. Failures of revascularization are
usually due to an inadequate outflow and
^
sympathectomy may be useful although
diabetic patients often have reduced sym
pathetic activity. Ideally, revasculariza► ►tion should be done before any amputa
tion because the earlier the blood supply
^ can be restored to an extremity the less
likelihood there is of further tissue loss.
r
Small areas of dry gangrene may be left
to autoamputate if there is no associated
‘
pain or infection; usually, however, conr servative amputation and debridement of
obviously nonviable tissue is required.
Unless the gangrene is dry with no
associated infection, delayed closure of
► the wound is indicated and it may be
several weeks before the site is suitable for
r closure. Even with revascularization and
after several weeks of open treatment, the
* graft beds may not be ideal because of ir
regularities, the presence of fascia, bone,
residual infection and microvascular
K diabetic changes. “ Postage stamp” split
thickness skin grafts can be used to avoid
r common causes of graft failure; these are
hematoma under the grafts, motion of the
' ► grafts and exudate from residual lowgrade infection.

I

A

Conclusions

The extremities of diabetic patients are
^ prone to peripheral vascular occlusive
disease and any resulting ischemia poten

tiates infection and gangrene. Absent
distal pulses in a diabetic extremity with
gangrene should alert the clinician to the
possibility of vascular reconstruction,
which should be done as early as possi
ble. The revascularization procedure,
which may involve extra-anatomic or
small-vessel grafting, will avoid a major
amputation; it is surprising how much
healing occurs when the blood supply has
been restored.
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Bon Mots
Morals being what they are, it is not surprising that parts of the body that are
well covered with skin, fat, hair and, formerly, by modesty, are now much
more exposed — for example, the public tubercle.
Due to discoveries of a Canadian biochemist, Copp, we know now that the
salmon is responsible for the production of a good amount of calcitonin. But
what of the lowly herring? Is that species responsible for the production of
heparing?
Pathologists, in particular, use foods to describe appearances of organs and
tissues. The surgeons are following suit. That is why gastroplasty is sometimes
followed by a dumpling syndrome.
Surgeons have described various types of rectal and anal repair in these pages
as pre- and post-, but surely not postal!
I can understand the word psychiatric to describe a person, a therapy, a phi
losophy or a discipline but what kind of person is a psychiatrick?
The other hospitals should drool with envy when I hear patients express a
preference for the Salivation Army Hospital.
J oseph L. Shugar , md , frcsicj

Senior Associate Editor
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Acute Dissection of the Descending Thoracic Aorta:
Repair in an Unusual Case
Acute tamponade, although a rare
manifestation of a descending thoracic
aneurysm, was the dominant clinical
feature of a classic type III dissecting
aneurysm (arising distal to the left
subclavian artery) in a 52-year-old man.
High-quality aortography confirmed the
diagnosis, ruling out any anomaly of the
ascending aorta and the aortic arch.
Surgical treatment was carried out 24
hours after the initial episode without
cardiopulmonary bypass. Through a left
thoracotomy, a Gott shunt was inserted
proximally at the apex of the left ventri
cle and distally in the left femoral artery.
Aortic repair with the interposition of a
30-mm woven Dacron prosthesis was
successful. Postoperative aortography
showed complete restoration of aortic
integrity.
La tamponnade cardiaque est une
manifestation plutot inattendue d'une le
sion aigue au niveau de I'aorte thoracique descendante. Nous I'avons observee
comme manifestation principale d'une
dissection aigue de type III. L'aortographie thoracique a confirm^ ie
diagnostic tout en eliminant la moindre
anomalie au niveau de I'aorte ascendante
et de la crosse aortique. La reparation
chirurgicale a ete realisee par
thoracotomie gauche avec la protection
d'une derivation externe (shunt de Gott)
inseree proximalement dans la pointe du
ventricule gauche et distalement dans
I'artere femorale gauche. Une interposi
tion d'une prothese de Dacron tissee de
30-mm a permis de retablir I'integrite
aortique observable sur I'aortographie
postoperatoire.

I and III.1 It is also a rare but usually
fatal outcom e o f som e dissecting
aneurysms arising distal to the left subcla
vian artery (type III).2 The mechanism,
as observed at autopsy, is usually a
retrograde dissection into the pericardium
with or without a second rupture of the
intrapericardial aorta. In our case, car
diac tamponade was the dominant clinical
picture in a type III dissecting aneurysm
without retrograde dissection.
Case Report
A 52-year-old man with a history of un
treated hypertension had sudden onset of chest
pain followed rapidly by shock. The pain was
localized to the interscapular area with radia
tion to the anterior middle part of the chest.
The patient complained of transient weakness
of the left lower limb. Signs of cardiac tam
ponade were obvious on examination. Blood
pressure was 80/70 mm Hg and the central
venous pressure was 26 cm H20 . The elec
trocardiogram was normal, ruling out a car
diac infarction, and the chest roentgenogram
showed superior mediastinal widening and a
double aortic knob contour (Fig. 1), suggesting
a lesion at this level.
At pericardiocentesis, 200 mL of nonclot
ting red blood were withdrawn. The patient im
mediately improved and allowed us time to
transfer him safely to the angiography
department.
Aortography demonstrated a classic type III
dissecting aneurysm (Fig. 2). Aneurysmal
dilatation was present distal to the left subcla
vian artery. The true lumen was irregular
because of compression by the clotted false
channel. The dissecting process extended to the
diaphragm.

Soon after the dye injection, the cardiac tam
ponade recurred, complicated by a supraven
tricular tachycardia (160 beats/min). A blood
pressure of 80/60 mm Hg was recorded
through a right radial arterial line and the cen
tral venous pressure was 30 cm H20 . Pericar
diocentesis allowed aspiration of 300 mL of red
blood and resulted in better and definitive heart
decompression.
The blood pressure stabilized at 180/90 mm
Hg and the central venous pressure at 15 cm
H20 . Full digitalization was initiated and
metabolic acidosis corrected. Nipride solution
was administered intravenously to lower the
blood pressure to between 100 and 120 mm Hg
systolic. The hyperkinetic heart was controll
ed with intravenous adm inistration of
propranolol.
The patient was operated on the following
morning. Supraventricular tachycardia, which
occurred upon induction of anesthesia, was
easily controlled with an intravenous injection
of propranolol.
Our standard procedure for lesions of the
descending thoracic aorta was used.
Blood pressure and gas levels were record
ed continuously through a right radial arterial
line. A standard endotracheal tube is prefer
red for full inflation of both lungs and max
imum oxygenation during the period of aortic
cross clamping. Autotransfusion is used. For
minor losses from the intercostal arteries, the
blood is saved in a reservoir primed with

Cardiac tamponade is a well-known com
p lication o f dissecting aneurysm s
originating in the ascending aorta (types
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FIG. 1— P lain film show s widened
mediastinum and double aortic shadow at level
of aortic knob.

FIG. 2—Type III dissecting aneurysm. Pre- *.
operative aortogram showing irregular true
lumen compresssed by clotted false channel, i
Ascending aorta is normal. Pathologic process
starts distal to left subclavian artery.
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diluted heparin and is retransfused when nor
mal aortic circulation is restored. During the
period of aortic cross-clamping, the aortic flow
is diverted through a Gott heparin-coated shunt
(Sherwood Medical Industries, St. Louis, Mo.),
placed between the ascending aorta proximally and the descending aorta or left femoral
artery distally. No systemic heparinization is
required. This method of aortic shunting pro
vides excellent proximal decompression of the
brain and the heart and optimal distal perfu
sion of all organs and of the spinal cord.
The lesion was approached through the bed
of the resected fifth rib. There was 300 mL of
free red blood in the left pleural cavity. All of
the aortic arch and the descending thoracic aor
ta had a reddish appearance; the adventitial
and pleural layers were under extreme tension.
The pericardium was opened anterior to the

FIG. 3—Postoperative thoracic aortogram
shows complete disappearance of false chan
nel. True aortic lumen has more normal
calibre.

FIG. 4—Postoperative abdominal aor
togram shows normal origin o f major aortic
branches from true aortic lumen.

left phrenic nerve and 100 mL of old blood
evacuated from the pericardial sac. No active
bleeding was identified. The ascending aortic
wall was normal to palpation but its surround
ing adventitia was quite infiltrated in continuity
with the mediastinal hematoma.
Because of its suspected friability, the
ascending aorta was thought unsuitable for
proximal cannulation and the apex o f the left
ventricle was used instead. The distal part of
the Gott shunt was introduced into a 10-mm,
side-branch, woven D acron prosthesis
anastomosed end-to-side to the left femoral
artery.
Vascular clamps were applied on the aortic
arch between the left carotid and the left
subclavian arteries, on the descending aorta
and on the left subclavian artery. The descend
ing aorta, where an obvious aneurysmal dilata
tion was noted, was incised distal to the left
subclavian artery. The dissecting process in
volved two thirds of the aortic circumference
and the false lumen was full of fresh clots. No
intimal tear was seen. Eight centimetres o f
aneurysmal dilatation was resected. The
dissected aorta was closed proximally and
distally by incorporating a Teflon strip between
the two separated medial layers. Then, a
30-mm woven Dacron graft was sutured pro
ximally and 8 cm distally to re-establish aortic
continuity. The postoperative course was
smooth and the patient was soon started on
long-term antihypertensive drugs.
On the 10th postoperative day, controlled
aortography was performed. The ascending
aorta and aortic arch appeared normal in size
and configuration (Fig. 3). The woven graft
with proximal and distal anastomoses was well
visualized and appeared normal. The descend
ing thoracic aorta had assumed a more n o r
mal calibre, although it was slightly irregular.
All the major abdominal arteries were perfus
ed normally through the true aortic channel
(Fig. 4).

Discussion
The source o f the cardiac tamponade
was o f concern in this case when emergen
cy aortography showed a type III dissec
ting aneurysm. Despite high-quality
angiography, no secondary intimal rup
ture could be identified in the intrapericardial aorta. The patient would
not have survived an intrapericardial
hemorrhage coming from a retrograde
dissection and a secondary intimal rup
ture in the ascending aorta. Based on this
clinical assertion, surgical repair was
planned as for a standard type III dissec
ting aneurysm.
The cardiac tamponade was explained
on the basis o f extensive subadventitial
dissection from the initial aortic wall rup
ture in the descending aorta. Blood under
pressure had separated the adventitial and
pleural layers towards the pericardial
reflection. Diffusion of blood under
pressure through the pericardium is possi
ble; this process may cause a hemothorax
when blood diffuses through the pleura.
A right hemothorax has been reported in
type III dissecting aneurysm.3 This
mechanism can also explain the hem o-

pericardium found in a few cases o f
traumatic rupture o f the descending
thoracic aorta without underlying cardiac
injury.4 We recently treated a patient
with a classic traumatic isthmic rupture
o f the descending thoracic aorta whose
main clinical feature was cardiac
tamponade.

Conclusions
Median sternotomy would have been
disastrous in our patient if it had been
taken for granted that the cardiac tam
ponade was coming from dissection o f the
ascending aorta. This case emphasizes the
need for complete, high-quality aorto
graphy in all cases involving the thoracic
aorta before an emergency surgical pro
cedure is performed.
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NOTICES
Call for Abstracts:
Stereotactic and
Functional Neurosurgery
The 9th meeting o f the World Society for
Stereotactic and Functional Neurosurgery
will be held July 4 -7, 1985 at the Chelsea
Hotel and the University o f Toronto,
Toronto, Ont. It will be immediately fol
lowed by the International Congress o f
Neurological Surgery.
Abstracts must be o f original work, not
previously presented or published or
accepted for publication, and they should
be no longer than 250 words. The dead
line for submission o f abstracts is Sept.
1, 1984. Proceedings o f both meetings will
be published in A p p lied N europhysiol
ogy.
In order that presentations may be
coordinated between the two meetings, all
abstracts should be sent to: Dr. R.R.
Tasker, Eaton Bldg. N orth 7-221,
Toronto General Hospital, 101 College
St., Toronto, Ont. M5G 1L7. For further
information please write Mrs. Rae Ryan,
Administrative Coordinator, Division of
Neurosurgery, Eaton Bldg. North 7-221,
Toronto General Hospital, 101 College
St., Toronto, Ont. M5G 1L7 or call (416)
595-3443.
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Recent Research Suggests...
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clindamycin concentrating in PMN lysosomes
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3.

clindamycin-laden PMN moving
toward the site of infection

-

Phosphate S.S.
enhances
HOST DEFENSE
Recent in-vitro research has shown that clindamycin concentrates within
the PMN in amounts greater than are found outside of the PMN.1 The
rates of chemotaxis, phagocytosis and killing of bacteria by PMNs are also
enhanced by the presence of this antibiotic.2’3 These characteristics may
help explain clindamycin’s outstanding record of clinical efficacy in both
anaerobic and gram-positive aerobic infections.
Since host defense factors may be crucial in determining the outcome of
an infection, selection of antibiotics based on host defense parameters
may become a trend in infectious disease therapy.
1) Klempner MS, et al (Nov 1981) J Infect Dis 144(5)
2) Johnson JD, et al (March 1980) J Lab Clin Med 95(3)
3) Gemmell C, et al (1980) Current Chemotherapy and Infectious Disease
(eds. J Nelson, C Grassi) Am Soc Microbiol Vol 2

5.

phagocytosis of the bacterium
by antibiotic-enhanced PMN

6. degranulation and killing
of engulfed bacterium
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Dalacin C Phosphate Phosphate S.S.
Recommended Applications
Action: Clindamycin exerts its antibacterial effect by causing cessation of protein synthesis and also

Clinical and Laboratory Findings: Patients treated d uring clinical trials of Dalacin C Phosphate

b y c a usin g a reduction in the rate of synthesis of nucleic acids.

(clindamycin phosphate) were followed with clinical laboratory tests, including complete hematology,
urinalysis and liver and kidney function tests. S om e of these tests were abnormal initially and return
ed to normal during therapy with Dalacin C Phosphate, while others were normal initially a nd becam e
abnormal during therapy. Overall evaluation of clinical laboratory values in these patients does not
indicate that Dalacin C Phosphate therapy has a toxic effect on the hematopoietic, hepatic o r renal
systems. Transient elevations of serum transaminases have occurred in some patients, but other liver
function tests (alkaline phosphatase, serum bilirubin) have not shown any tendency to increase and
there have not been clinical signs of dru g-ind u ced hepatic toxicity.

Indications: Dalacin C Phosphate (clindamycin phosphate) is indicated for the treatment of in fec
tions w here the oral route is not indicated or feasible.
Dalacin C Phosphate is indicated in the treatment of serious infections due to sensitive anaerobic
bacteria, such as Bacteroides species, peptostreptococcus. anaerobic streptococci, Clostridium
species a n d m icroaerophilic streptococci.
Dalacin C Phosphate is also indicated in serious infections due to sensitive Gram-positive organisms
(staphylococci, induding penicillinase-producing staphylococci, streptococci and pneum ococci) when
the patient is intolerant of, o r the organism resistant to other appropriate antibiotics.

Contraindications: The use of Dalacin C Phosphate (clindamycin phosphate) is contraindicated
in patients previously fo u n d to be hypersensitive to this com p ou nd , the parent c o m p ou nd , clin d a 
mycin, or clindamycin palmitate. Although cross-sensitization with Lincocin® (lincomycin hydrochloride)
has not b ee n demonstrated, it is recom m ended that Dalacin C Phosphate not be used in patients
w h o have dem onstrated lincom ycin sensitivity.
Until further clinical e xperience is obtained, D alacinC Phosphate is not indicated in the newborn
(infants below 30 days of age), or in pregnant women

« *

Symptoms and Treatment of Overdosage: N o cases of overdosage have been reported. No
specific antidote is known. Doses as high as 1200 m g every six hours (4800 mg/day) by infusion for
five days have been given without adverse effects.
DOSAGE A N D ADMINISTRATION

Adults
Intramuscular Injection: 600 m g/day in 2 equal doses.
Moderately severe infections: 600 to 1200 m g/day in 2 o r 3 equal doses.

Warnings: Some cases of severe and persistent diarrhea have been reported d u rin g or after ther
apy with Dalacin C P hosphate (clindamycin phosphate). This diarrhea has been occasionally asso
ciated with blood a nd m u cu s in the stools a nd has at tim es resulted in acute colitis. W hen e nd os
c o p y has been perform ed, som e of these cases have shown pseudom em brane formation.
If significant diarrhea o ccurs during therapy, this d rug should be discontinued or, if necessary, c o n 
tin ue d o nly with close observation. Significant diarrhea occurring up to several weeks post-therapy
should be m anaged as if antibiotic-associated.

Severe infections: 1200 to 2400 m g/day in 2 ,3 o r 4 equal doses. Intramuscular injections of m ore
than 600 m g into a single site are not recom m ended.

Intravenous Administration: Dalacin C Phosphate (clindamycin phosphate) must be diluted prior
to I.V. administration to a dilution of 3 00 m g in 5 0 ml of diluent (6 mg/ml) or more, and infused in not
less than 10 minutes. Administration of m ore than 1200 m g in a single 1 hour infusion is not recom 
m ended. Dalacin C Phosphate should not be injected intravenously undiluted as a bolus.

If colitis is suspected, e nd osco p y is recom m ended. Mild cases showing minimal m ucosal changes
m ay re sp on d to sim ple d ru g discontinuance. Moderate to severe cases, including those showing
ulceration o r pseudom em brane formation, should be m anaged with fluid, electrolyte, and protein
supplem entation as indicated. C orticoid retention enemas a nd systemic corticoids may be of help
in persistent cases. Anticholinergics and antiperistaltic agents may worsen the condition. Other causes
of colitis should be c onsidered.

M oderately severe infections: 900 to 1800 m g/day by continuous drip or in 2 or 3 equal doses, each
infused over 20 minutes o r longer.

Studies indicate a toxin(s) pro du ced by Clostridia (especially Clostridium difficile) m ay be a p rinci
pal ca use of clindamycin a nd other antibiotic-associated colitis. These studies also indicate that this
toxigenic Clostridium is usually sensitive in-vitro to vancomycin. W hen 125 mg to 5 00 m g of vanco
m ycin w ere administered orally four times a day for 5 -1 0 or m ore days, there was a rapid observed
disap p ea ra nce of the toxin from faecal samples and a coincidental recovery from the diarrhea.

Dilution and infusion rates:

It sh ould b e noted that serious relapses have occurred up to o ne month after apparently successful
treatment. A relatively p ro lon g ed period of continuing observation is therefore recom m ended.

Precautions: Dalacin C Phosphate (clindamycin phosphate), like any drug, should be prescribed
with caution in atopic individuals.
Dalacin C Phosphate must be diluted for intravenous administration. (See Dosage and Administration)
The use of antibiotics occasionally results in overgrowth of nonsusceptible organism s - particularly
yeasts. S hould superinfections occur, appropriate measures should be taken as dictated by the clin
ical situation.
As with all antibiotics, perfo rm culture and sensitivity studies in conjunction with d ru g therapy.
Since abnormalities of liver function tests have been noted o ccasionally in anim als a nd man, p eri
o d ic liver function tests should be perform ed during prolonged therapy. Blood counts should also
be m onitored during e xtended therapy.
Dalacin C Phosphate m a y be used in anuretic patients. Since the serum half-life of clindam ycin in
patients w ith im paired hepatic function is greater than that found in normal patients, the dose of
Dalacin C Phosphate shou ld be appropriately decreased. Hemodialysis and peritoneal dialysis are
not effective means of removing the com pound from the blood. Periodic serum levels should be deter
m ine d in patients with severe hepatic a nd renal insufficiency.

A d verse

R e actio n s: L o ca l.

(a) Intramuscular Injections: O f 404 patients treated with Dalacin C Phosphate (clindamycin phosphate)
intram uscularly (with a solution containing 150 mg/mL), six (1.5%) demonstrated local reactions as
follows: Two complained of pain at the injection site, two dem onstrated induration at the injection site
and tw o developed sterile abscesses.
(b) Intravenous Infusions: O f 192 patients treated with Dalacin C Phosphate by intravenous infusion,
14 (7.3% ) demonstrated local reactions. Eleven patients developed superficial throm bophlebitis and
one patient developed both superficial and deep throm bophlebitis. The majority of these cases
deve lo pe d in conjunction with the use of indwelling I.V. catheters and it is difficult to know how m uch
the d ru g contributed to the irritation. Two patients developed localized erythema, swelling a nd pain
at the site of the infusion.

Systemic Side Effects: Twenty-eight patients of 596 treated with Dalacin C Phosphate (clindamycin
phosphate) by either the intramuscular or intravenous routes developed systemic side effects as follows:
N u m b er o f Patients
R a s h ................................................................................................................................................................... 7
U rtic a ria .............................................................................................................................................................. 1
P r u r it u s .............................................................................................................................................................. 1
Fever, Leucocytosis........................................................................................................................................... 1
Nausea, with or without vo m itin g ..................................................................................................................1
D iarrhea (See also u n d e r ‘W arnings”) ....................................................................................................... 4
H yp o te n sio n ...................................................................................................................................................... 1
H y p e rte n s io n .................................................................................................................................................... 1
Shortness of Breath ........................................................................................................................................ 1
S up e rin fe ctio n*................................................................................................................................................. 4
C a rd ia c arrest’ * ................................................................................................................................................1
B ad o r bitter taste in m o u th ........................................................................................................................... 5
'S uperinfection is a com plication of antibiotic therapy in general and is not necessarily a true
side effect of clindam ycin phosphate.
**D u e to underlying myocarditis in this patient.
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Severe infections: 1800 to 2700 m g/day by continuous d rip or in 3 or 4 equal doses, each infused
over 20 minutes or longer. In life-threatening infections, doses of 2700 to 4800 mg/day by continuous
drip or in 3 or 4 equal doses each infused over 20 minutes or longer may be given.

Dose

Diluent

Time

300 mg
600 mg
900 mg
1200 mg

50 ml
100 ml
150 ml
200 ml

10 min.
20 min.
30 min.
45 min.

Alternatively, drug may be administered in the form of a single rapid infusion of the first dose followed
by continuous I.V. infusion as follows:
To maintain serum
clindamycin levels

R apid
infusion rate

M aintenance
infusion rate

A bove 4 mcg/ml
A bove 5 mcg/ml
A bove 6 mcg/ml

10m g/m in. for 3 0 min.
15m g/m in. for 3 0 min.
2 0 m g /m in . for 30 min.

0.75m g/m in.
1.00mg/min.
1.25mg/m in.

Children: (Over one month of age)
Intramuscular injection: 10 to 15m g/kg/day in 2 ,3 or 4 equal doses.
M oderately severe infections: 15 to 20 m g/kg/day in 3 o r 4 equal doses.
Severe infections: 20 to 30 m g/kg/day in 3 or 4 equal doses.

Intravenous Administration:
Moderately severe infections: 15 to 25 m g/kg/day by continuous drip or in 3 or 4 equal doses, each
infused over 20 minutes or longer. In severe infections, it is recom m ended that children be given no
less than 300 m g/day regardless of b o d y weight. (Dilute Dalacin C Phosphate Sterile Solution in the
same m anner as for adults.)

Dilution and Compatibility:
4 ml (600 mg) Dalacin C Phosphate w hen diluted with 1000 ml of the following com m only used in
fusion solutions was found to be physically com patible and demonstrated no significant change in
pH or antim icrobial potency over a period of 24 hours:
S odium chloride injection
Dextrose 5 % in water
Dextrose 5 % in saline
Dextrose 5 % in Ringer's Solution
Dextrose 5 % in half-strength saline plus 4 0 m E q potassium chloride
Dextrose 2 1/2 % in Lactated Ringer’s Solution (Hartmann's Solution).
Dalacin C Phosphate was not stable w hen a dd ed to Dextrose 5 % in water plus vitamins. Therefore
it is not recom m ended that Dalacin C Phosphate be mixed with any infusion solution containing B
vitamins.

Supplied:
Dalacin C Phosphate contains the following per ml of sterile solution:
Clindamycin phosphate equivalent to clindam ycin base 150 m g
Benzyl alcohol 5 mg
Disodium edetate 0.5 mg
Water for injection q.s.
When necessary the pH is adjusted with sodium hydroxide a nd/or hydrochloric a cid to maintain a
pH range of 5.5 to 7.0.
Dalacin C Phosphate is available in 2 ml a nd 4 ml ampoules.

NOTE: Do not store below 15°C.
Product M onograph available upon request,
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Right Ventricular Size and Ventricular Septal Motion after
Repair of Atrial Septal Defect in Children
An enlarged right ventricle and abnormal
ventricular septal motion are
characteristic echocardiographic features
of atrial septal defect and often persist
after the defect has been completely
^ closed, even when the operation clinical
ly is judged to be successful.
These features were examined
retrospectively 15 to 21 months after
operation in a group of children whose
atrial septal defect had been closed be
tween January 1976 and July 1979.
Despite satisfactory postoperative results
in all, about two thirds had an enlarged
right ventricular dimension and about the
same number had abnormal septal mo
tion when examined echocardiographically an average of 18 months after opera
tion. The best operative strategy seems
to be to operate while the right ven
tricular end-diastolic dimension is still
relatively small in echocardiographic
* terms.
L'augmentation des dimensions ventriculaires droites et un mouvement septal
anormal composent les elements
gchocardiographiques qui caracterisent la
communication interauriculaire. Cepenr dant ces signes persistent apr6s
fermeture chirurgicale complete, et ce
malgre un rgsuitat clinique satisfaisant.
Une revue des Etudes echocardiographiques fut conduite chez des enfants
dont la communication interauriculaire
fut r6paree entre janvier 1976 et
*- juillet 1979. Les deux tiers des patients
pr£sentent toujours une augmentation
des dimensions ventriculaires droites en
moyenne 18 mois aprfes chirurgie. Un
nombre a peu pr6s identique presente un
mouvement septal anormal. Ainsi, I'inter-
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vention devrait etre planifiee plus tot,
alors que les dimensions ventriculaires
droites sont dans les limites normales, a
I'echocardiographie.

Increased right ventricular end-diastolic
dimension (RVED) and abnormal ven
tricular septal motion are the charac
teristic echocardiographic features of
atrial septal defect; they often persist even
after clinically successful complete closure
of the defect.1-4
Postoperative data on right ventricular
performance have been reported recent
ly for 51 children by Meyer and as
sociates5 derived from serial echocar
diograms taken 3 months to 5 years after
closure of an atrial septal defect. The
mean RVED of the group decreased max
imally by 3 months with no further
decreases up to 5 years; the mean RVED
was always higher than that for 101 nor
mal children of comparable age and size.
Septal motion was normal in 55% by 3
months after operation and in 89% of
those examined at 5 years. The in
vestigators suggested that the persistent
enlargement of the right ventricle was due
to chronic overload and that surgical
closure in the first 3 years of life might
prevent it.
This study complemented the serial
echocardiographic study of Meyer and
associates. Our focus was on pre- and
postoperative echocardiographic findings
in individual children, related to the nor
mal range, and whether any preoperative
factors suggest a better operative strategy.

Patients and Methods
This study used echocardiographic
measurements in children whose secun
dum atrial septal defect was repaired be
tween Jan. 1, 1976 and June 30, 1979 in
our hospital.
All echocardiographic tracings for
these patients were reviewed. Only those
for which a right ventricular cavity and
septum could be identified were retained.
Two copies were made of that portion,
taken at or just below the level of the
mitral valve tip.

Both copies of each tracing and a
separate note identifying the child and
date of the echocardiogram were assign
ed a unique code number from a random
number table. This code number was the
sole identifier on the tracings, which were
arranged in numerical order and furnish
ed to two readers (S.N. and H .F.). The
code was not broken until after all trac
ings had been read, when clinical, cardiac
catheterization and operative data that
had been abstracted separately were
merged with echocardiographic data.
The two readers measured RVED and
classified septal motion as normal, flat or
reversed, or noted that one or both were
unmeasurable. Readings were reported
separately by each reader to the data
monitor (D.C.). If there was disagreement
over whether a tracing could be read, if
individual RVED measurements varied
more than 10% from the mean o f t^e two
measurements or if judgement about the
type of septal motion varied, the tracing
was submitted to the head of our echocar
diography service (W .J.D .) for arbitra
tion.
We located 119 echocardiographic trac
ings. Several otherwise acceptable tracings
were rejected when matched to clinical
data — two because the children had
Down’s syndrome, one because the child
had dextrocardia and one because the
echocardiogram was taken immediately
after operation for problems in the inten
sive care unit rather than as a normal
follow-up procedure. The final yield for
study was 98 tracings in which both
RVED and septal motion could be read:
24 preoperative tracings (group 1), 18
postoperative tracings (group 2) and 28
pairs of pre- and postoperative tracings
(group 3).
Echocardiographic Features
The right ventricular end-diastolic
dimension was measured from the en
docardium of the anterior wall of the
right ventricle to the right side of the sep
tum, at the level of the mitral valve, at
the beginning of the QRS complex. Three
complexes were measured on the majori-
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ty of tracings (93.9%), at the expiratory
phase which appeared to have the least
respiratory variation, and the average of
these measurements was taken for each
child.
In 44 of the 52 patients (84.6%) in
groups 1 and 3, the preoperative echocar
diograms were obtained within 1 week of
cardiac catheterization and in the remain
ing 8 patients (15.4%) from 2 to 46
months (mean 19.9 months) before the
catheterization.
Protocols in the Division of Cardiology
call for an echocardiogram 18 months
after repair of an atrial septal defect. Ex
aminations in groups 2 and 3 took place
from 0.2 to 51.1 months after operation
(mean 20.5 months).
The normal range for RVED was de
fined according to the criteria of Gutgesell
and Paquet,6 which relate RVED to the
cube root of weight.
Hemodynamic Features
All patients underwent right heart
catheterization before operation (Tables
I to III). Left-to-right shunt size was
determined by the Fick principle and ex
pressed as the pulmonary to systemic flow
ratio (Qp:Qs). Right ventricular and
pulmonary artery pressures were record
ed in every case.
Intraoperative Measurements
The major and minor diameters of the
defect were measured during operation
for every child. Estimates were made of
the defect area by assuming that all
defects were elliptical.

mal septal motion; in about half of them,
the septal motion was classified as
reversed.
The right ventricular end-diastolic
dimension correlated significantly
(p < 0.05) with the child’s age, with body
surface area and with a score for type of
septal motion, but not with any of the

measurements obtained at cardiac ca
theterization. The septal motion score
(1 = normal, 2 = flat, 3 = reversed
motion) correlated significantly only with
the RVED and the shunt at catheteriza
tion. There was no evidence that the type
of septal motion, shunt size or pressures
changed as the children aged; no child

Table 1-Group 1. Results
Preop echocardiographic
findings
Patient
no.
1

2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24

Catheterization

Age, mo

RVED,
mm

SM,
type

Age,
mo

Shunt,
ratio

RVP,
mm Hg

Age at
operation,
mo

4.0
22.9
37.6
39.6
43.6
44 .8
48.3
52.5
53.3
53.9
57.2
61.6
61.9
62.0
70.8
74.7
75.8
82.0
89.1
108.6
111.1
146.1
148.2
176.9

18
20
26
20
25
20
21
24
19
23
24
28
23
24
21
32
23
26
20
37
33
32
29
34

R
F
R
N
R
N
F
F
F
N
R
N
F
R
N
R
F
R
F
R
R
F
N
F

4.1
23.0
37.5
39.6
46.3
56.8
60.3
52.2
7.3
53.9
57.2
61.6
61.9
62.0
70.8
74.8
31.3
82.0
89.3
104.4
111.1
146.2
148.2
176.9

3.4
4.0
3.7
2.4
3.4
2.3
1.8
3.7
2.5
2.8
2.2
2.9
2.1
2.7
1.8
2.2
2.1
4.0
1.6
4.0
5.0
2.0
2.4
2.4

32
54
42
40
24
41
29
30
36
24
33
26
32
44
33
35
25
61
30
33
37
35
28
29

4.3
25.6
37.6
42.0
46.4
90.0
65.1
54.4
56.9
57.4
57.3
61.7
62.0
62.1
73.3
76.6
78.7
82.0
90.7
108.7
111.2
162.8
148.3
177.0

RVED = right ventricular end-diastolic dimension, SM - septal motion, RVP - right ventricular
pressure, N = normal, R = reversed, F - flat.

Statistical Methods
Table 11-Group 2. Results

Simple and multiple regression analyses
were carried out to seek the best ex
planatory variables for RVED and sep
tal motion. This involved a step-up pro
cedure to select the data that correlated
most strongly with RVED or septal mo
tion, or both. The relation of the change
in RVED after operation to shunt size and
right ventricular pressure at catheteriza
tion, age of the child and size of defect
at operation and length of follow-up was
examined by linear regression to deter
mine whether a particularly favourable
operative strategy could be derived.
P < 0.05 was considered significant.

Results (Tables I to III)
Preoperative (Tables I and III)
In all 52 children (groups 1 and 3) the
RVED was enlarged above the normal
99th percentile.6 All but nine had abnor
396

Catheterization
Patient
no.

Age,
mo

Shunt,
ratio

RVP,
mm Hg

Age at
operation,
mo

25
26
27

27.3
37.1
13.2

2.0
2.7
3.0

51
31
30

29.3
37.2
56.2

Postop echocardiographic
findings
Age, mo

RVD,
mm

SM,
type

24
F
N
18
F
21
N
23
28
30.1
2.3
40
47.9
N
22
29
54.1
54.1
56
3.1
F
23
30
36
50.2
8.5
2.5
F
16
31
57.7
58
60.7
3.0
12
F
24
32
2.1
11.8
50.1
N
14
33
52.5
35
2.3
54.3
F
18
34
68.6
4.2
50
68.7
N
18
35
72.6
2.2
40
73.4
23
F
36
72.3
1.9
41
80.1
21
N
37
66.1
3.0
35
70.2
N
19
38
46 .3
1.8
30
94.0
19
F
39
98.5
3.1
20
100.5
N
13
40
111.9
2.6
36
112.0
27
F
41
168.3
1.9
45
173.0
29
F
42
192.6
2.1
25
201.2
22
F
RVED = right ventricular end-diastolic dimension, SM - septal motion, RVP - right ventricular
pressure, N = normal, R = reversed, F = flat.
50.6
56.3
56.5
81.6
65.3
74.4
81.1
81.7
85.1
85.4
85.5
91.3
96.9
100.8
110.0
139.6
152.7
192.1
219.4
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had more than one preoperative catheter
ization.
^

Postoperative (Tables II and III)

^
In approximately one third of the 46
. y children (groups 2 and 3) who had
postoperative echocardiograms, the
► I RVED was in the normal range. The same
proportion had normal septal motion; no
*- child had reversed motion postoperatively

whose septal motion was normal preop
eratively (Fig. 1).
The greatest fall in RVED was in those
whose RVED had been largest before
operation. However, because it was so
markedly increased in these children, it
was the patients with relatively minor

Pre- and Postoperative (Table III)

^ ^

In the 28 group 3 children who had
echocardiograms both before and after
rr operation, the RVED fell after operation
in 25, remained the same in 1 but rose in
► 2. Before operation, all had RVED out
side the 99th percentile of the Gutgesell
'
and Paquet6 norms; after operation, 10
^ fell within the normal range at the first
postoperative echocardiographic exy amination and 2 more fell within the nor
mal range at a later examination. Septal
-i motion was normal in 9 (8 had abnormal
motion preoperatively), remained flat in
i * 6 patients and turned flat from reversed
motion in 12, but also turned flat in 2

k

k

preoperative increases in RVED who were
most likely to be in the normal range after
operation. There was little relation
statistically between the time that had
passed since operation and any decline in
RVED (i.e., there was no evidence that
a longer follow-up would produce more
cases of normal RVED).
There were no significant differences in
clinical factors between patients whose
cardiac status returned to normal
postoperatively and those whose status
did not, other than the fact that grade 2
murmurs were still heard (in 3 of 16 pa
tients) only among those with an abnor
mal RVED.
Regression analysis of the data on
change in RVED did not pinpoint any
preoperative strategy other than to
operate on children while the RVED is
still relatively small.
Discussion

FIG. 1—Preoperative and postoperative
right ventricular end-diastolic dimension
(RVED) and septal motion (normal = white
circles, flat = squares, reversed = black
circles) related to body weight (shown on cube
root scale) in 28 patients. Solid line = mean
normal RVED, upper dotted line = 97.5th
percentile, lower = 25th percentile.

Right ventricular end-diastolic dimen
sion is usually measured from the en
docardium of the anterior wall of the
right ventricle to the right side of the
septum,3,6'7 but the right ventricular wall
can be poorly resolved on echocardio-

Table Ill-G r o u p 3 . Results
Preop echocardiographic
findings

Postop echocardiographic
findings

C atheterization

Age at
operation,
mo

Age, m o

RVED,
mm

SM,
ty p e

5 1 .6
4 8 .5

6 9 .0
4 8 .8
7 3 .2

15
20
16

F
N
N

42
27
30
28
43
54
50
50
55
30
48
28
30
33
35
32

4 3 .7
5 5 .0
5 8 .2
5 8 .0
5 9 .8
6 6 .0
6 0 .2
6 1 .2
6 6 .5
6 2 .9
6 3 .8
6 4 .5
7 0 .6
7 3 .6
8 3 .0
8 3 .4

2 .4
1 .8
3 .0
2 .3
3 .4
2 .4
4 .2

36
23
26
38
33
35
32

8 5 .7
1 0 2 .7
1 2 6 .3
1 3 1 .7
1 6 6 .7
1 7 1 .7
1 7 5 .9

2 .0
3 .4
1.7

29
25
28

1 9 9 .3
1 9 9 .8
2 0 7 .0

7 5 .8
7 5 .2
7 9 .9
8 5 .8
7 7 .7
8 3 .1
8 8 .5
8 1 .6
8 3 .2
8 1 .1
6 4 .0
8 0 .2
1 0 5 .0
9 1 .5
8 8 .5
1 0 2 .3
1 3 1 .8
1 3 6 .8
1 0 2 .9
1 4 6 .2
1 4 9 .8
1 9 1 .2
1 9 3 .3
1 7 6 .2
2 0 5 .7
2 2 0 .6
2 2 3 .7
2 2 7 .3

13
21
22
19
18
14
21
21
17
15
19
24
15
16
17
19
17
22
16
17
14
22
24
28
24
29
26
34

F
F
F
F
F
M
F
F
N
F
F
F
N
F
N
F
N
N
F
F
N
F
F
F
N
F
F
F

Age, mo

RVED,
mm

SM,
type

Age,
mo

Shunt,
ratio

RVP,
mm Hg

43
44

3 3 .0
4 3 .2

18
23

F
N

3 3 .0
4 3 .1

3 .8
2 .0

30
30

45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60

4 3 .7
5 2 .6
5 3 .8
5 7 .9
5 9 .7
5 9 .9
6 0 .2
6 1 .1
6 1 .7
6 2 .9
6 3 .4
6 4 .5
7 0 .5
7 2 .0
7 7 .1
8 3 .3

30
21
24
29
26
21
26
27
22
20
29
21
20
20
26
24

R
R
R
R
F
F
R
F
F
R
R
N
F
F
R
R

4 3 .6
5 0 .6
5 3 .8
2 2 .0
5 9 .7
5 9 .9
6 0 .2
6 1 .1
6 1 .7
6 2 .9
6 3 .8
6 4 .4
7 0 .5
7 2 .0
7 7 .1
8 3 .3

4 .0
2 .9
2 .6
2 .5
3 .3
1 .5
1 .8
2 .2
2 .8
2 .3
3 .6
2 .2
1 .5
2 .2
2 .5
2 .6

61
62
63
64
65
66
67

8 3 .8
8 8 .5
1 2 4 .0
1 2 7 .5
1 6 5 .4
1 6 8 .6
1 7 5 .8

21
25
30
28
33
40
37

R
N
R
R
R
R
R

8 3 .8
8 8 .5
1 2 4 .0
1 2 7 .6
1 6 5 .4
1 6 9 .3
1 7 5 .9

68
69
70

1 9 9 .3
1 9 9 .7
2 0 3 .2

39
39
39

F
R
F

1 9 9 .2
1 9 9 .7
2 0 3 .2

Patient
no.

RVED - right ventricular end-diastolic dimension, SIV - septal motion, RVP -

right ventricular pressure, N - norm al, R - reversed, F - fla t.
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graphy.7 In our study, only those with a
clearly delineated right ventricular wall
and ventricular septum were included.
Meyer8 provided normal RVED values
for children arranged by age, weight and
height. However, the resulting normal
range is a series of flat steps with the same
normal RVED over fairly broad age
categories of several years. We preferred
to adopt the standard of Gutgesell and
Paquet,6 whose graph of RVED versus
the cube root of body weight for 85 nor
mal children gives a straight-line rela
tionship.
All of our 52 children who had preop
erative echocardiograms (groups 1 and 3)
had an abnormal RVED but 9 had nor
mal septal motion. Also, two with nor
mal motion preoperatively developed flat
motion after operation (in one the RVED
was in the normal range postoperatively).
Thus, normal septal motion does not
always mean that the RVED is within
normal limits nor does flat septal motion
postoperatively always accompany an in
creased RVED.
None of our postoperative echocar
diograms showed reversed septal motion.
In adults with an atrial septal defect,
reversed motion postoperatively has been
related to persistent right ventricular
dilatation while reversion to normal mo
tion was a feature of those with relative
ly mild dilatation.9
The results obtained on evaluating sep
tal motion may be ambiguous. In par
ticular, calling the septal motion “ flat”
may mean only that the motion is not
clearly either normal or reversed. Our two
readers did not agree about the type of
septal motion in 28 (23.5%) tracings,
which thus had to be submitted to arbitra
tion: only 7 (5.9%) of the 119 tracings in
volved one reader who believed motion
was normal while the other thought it
reversed. Similar proportions are found
in studies of the reliability of clinical
methods and judgement.10"12
Our data on diminished postoperative
RVED are broadly consistent with the
findings of Meyer and associates.5 Eigh
teen months after operation, two thirds
of our patients had an RVED outside the
normal range. Use of the mean RVED to
measure group change (as in Meyer’s
study) could mask the benefits of opera
tion in individual patients. We cannot ex
plain the marked disparity in findings on
septal motion (29% [8 of 28] of our pa
tients reverted to normal motion against
55% to 89% of theirs), but it is not clear
whether our patients and classification
criteria were sufficiently similar to permit
direct comparison. Finally, the conclu
sions of both groups about operative
strategy have similar effects although
grounded and phrased differently.
Our conclusions are based on single
follow-up echocardiograms, which most

patients had. (Four patients had a second
tracing sometime after operation; RVED
continued to decrease in three, and in two j
fell into the normal range on the later
tracing.) Because our patients, by and ^
large, were seen between 15 and 21
months after operation, the data are in- *
sufficient to plot immediate or long-term
postoperative changes. Future studies 1 <
should include serial echocardiograms, or
at least cross-sectional studies should use
different follow-up intervals from the one
used in this study.
Most of our patients were operated „
upon between 3 and 6 years of age. So
far, we have not repaired an atrial septal < ■■
defect at an earlier age unless the
pulmonary-to-systemic flow ratio was V
greater than 2.5:1. We found that the pa
tients with less extreme preoperative increases in RVED were most likely to be
in the normal range after operation. This ’
suggests that operative repair might best ^ ,
be carried out while the RVED, as
measured by echocardiography, is still \
close to normal.
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Omental Evisceration through an Abdominal Stab Wound:
Is Exploratory Laparotomy Mandatory?

k The authors reviewed and analysed the
records of 75 patients with omental and
bowel evisceration as a result of
abdominal stab wounds to discover
whether omental prolapse makes
laparotomy mandatory. Major intra
abdominal injuries were found in 82.7%
of the total group, 82.9% in those with
omental protrusion and 82.5% in pa
tients with bowel prolapse. The nature
of the injuries and the incidence of multi
ple organ trauma were similar in the two
groups. Negative laparotomy did not
cause important morbidity. The authors
^ conclude that omental herniation after
stab wounds of the abdomen should
routinely prompt exploratory celiotomy.
Les auteurs passent en revue et analysent les dossiers medicaux de 75
patients victimes d'une Evisceration de
I'intestin et de I'Epiploon a la suite d'un
coup de couteau a I'abdomen, dans le
v but de verifier si un prolapsus de I'Epiploon commande une laparotomie. Des
blessures abdominales graves ont EtE
constatees chez 82.7% du groupe, chez
82.9% du groupe ayant une protrusion
de I'Epiploon et chez 82.5% de ceux qui
avaient un prolapsus intestinal. La nature
des blessures et la frequence des traur matismes a de multiples organes etaient
semblables dans les deux groupes. Une
laparotomie negative n'entratne pas une
morbidite importante. Les auteurs concluent qu'une hernie de I’Epiploon devrait
entrainer systematiquement une laparoto
mie exploratoire.

have adopted the policy of “ selective
conservatism” ,4 omental or bowel
evisceration through stab wounds has
been a mandatory indication for
laparotomy. We have analysed our ex
perience to determine whether such a
practice is justified. We could find only
one other series9 in the English literature
specifically addressing the issue of ab
dominal stab wounds with evisceration.
Patients and Methods
We reviewed the records of all patients
admitted to the Lincoln Medical and
Mental Health Center between 1973 and
1983 with omental or bowel evisceration
as a result of knife wounds to the ab
domen. We did not include patients with
multiple stab wounds in addition to the
one with evisceration. We also excluded
three patients with inadequate documen
tation and seven patients from earlier
years of the study who were managed by
amputation of the extruded omentum and
clinical observation, because adequate
follow-up could not be documented from
their clinical records.
Seventy-five patients who satisfied the
criteria for analysis constituted the study
population. Seventy-two were men and 3
were women. The age range was 17 to 59
years. Five patients presented in shock
(systolic blood pressure less than 70 mm
Hg). The only other indication for
laparotomy was evisceration of omentum
(35 patients) and bowel (40 patients). All

patients were resuscitated initially with
Ringer’s lactate and type-specific blood,
if necessary, depending on hemodynamic
status. Antibiotics (ampicillin, gen
tamicin and clindamycin) were ad
ministered preoperatively.
In the operating room the eviscerated
bowel and omentum were copiously ir
rigated with normal saline and the bowel
was replaced. The extruded omentum was
amputated. The type of operative repair
of the injured organs followed standard
surgical principles. Small-bowel injuries
were treated by repair or resection of in
volved bowel and anastomosis; colonic
lacerations were managed by repair, col
ostomy or repair and exteriorization; pan
creatic lesions were repaired with
drainage; splenic wounds were treated by
splenectomy or splenorrhaphy and bileduct or vascular injuries were repaired.
The stab-wound site was routinely clos
ed by fascial sutures to prevent the subse
quent development of traumatic hernia.
For the purpose of this study,
laparotomy was considered positive only
if major visceral damage was found;
small mesenteric and retroperitoneal
hematomas were not considered signi
ficant.
Results
Sixty-two of the 75 patients (82.7%)
had serious intra-abdominal injury. The
number of positive explorations was
similar in the group with omental hernia-

►

Selective exploration of patients with stab
wounds of the abdomen, based on clinical
observation,1-3 local wound exploration,
peritoneal lavage4,5 or a combination of
these methods,6'8 has gained wide
popularity. At our institution, while we
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T a b le 1 -S u m m a ry o f O rgan Injuries

O rgan injured
Colon
Sm a ll bo w el
S to m a ch
Liver
Spleen
P a n c re a s
Kidney
M ajor blood v e s s e ls
D iaph ragm
E x tra h e p a tic bile d u c ts

N o . w ith
o m e n tal p ro lap se

No. w ith
b o w el p ro la p se

8
10

10
24

3
7
4
2
0
6
6
2

4
5
1
2
1
5

48

52
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(^Mefoxin
ANTIBIOTIC
ACTION
In v itro studies dem onstrate that the
bactericidal action of cefoxitin, a cephamycin
derived from cephamycin C, results from the
inhibition of bacterial cell wall synthesis.
Evidence suggests that the methoxy group in
the 7a position is responsible fo r the
resistance of cefoxitin to degradation by
bacterial beta-lactamases.

INDICATIONS AND CLINICAL USES
TREATMENT

The treatment of the following infections when
due to susceptible organisms:
1 - Intra-abdominal infections such as
peritonitis and intra-abdominal abscess
2 - G ynecological in fe ctio n s such as
endometritis and pelvic cellulitis
3 - Septicemia
4 - Urinary tract infections (including those
caused by Serratia marcescens and
Serratia spp.)
5 - Lower respiratory tract infections
6 - Bone and joint infections caused by
Staphylococcus aureus
7 - Soft tissue infections such as cellulitis,
abscesses and wound infections
Appropriate culture and susceptibility studies
should be performed to determine the
susceptibility of the causative organism(s) to
MEFOXIN* Therapy may be started while
awaiting the results of these tests, however,
modification of the treatment may be required
once these results become available.
Organisms p a rticularly appropriate for
therapy with MEFOXIN* are:
Gram positive

Staphylococci, penicillinase producing and
non-producing
Streptococci excluding enterococci
Gram negative (beta-lactam ase producing
and non-producing strains)

E. coll
K le b s ie lla s p e c ie s (in c lu d in g
pneumoniae)
Proteus, indole positive and negative
Haemophilus influenzae
Providencia species

K.

Anaerobes

Bacteroides fragilis
MEFOXIN* may also be appropriate for the
treatment of infections involving susceptible
strains of both aerobic and anaerobic bacteria.
Clinical experience has demonstrated that
MEFOXIN* can be administered to patients
who are also receiving c a rb e n ic illin ,
gentamicin, tobramycin, or amikacin (see
PRECAUTIONS and ADMINISTRATION).
Intravenous Administration

The intravenous route is preferable for
p a tie n ts w ith b a cte re m ia , b a c te ria l
septicemia, or other severe or life-threatening
infections, or for patients who may be poor
risks because of lowered resistance resulting
from such d e b ilita tin g c o n d itio n s as
malnutrition, trauma, surgery, diabetes, heart
failure, or malignancy, particularly if shock is
present or impending.
PROPHYLACTIC USE

MEFOXIN* may be administered perioperatively (preoperatively, intraoperatively and
postoperatively) to patients undergoing
vaginal or abdominal hysterectomy and
abdominal surgery when there is a significant
risk of postoperative infection or where the
occurrence of postoperative infection is
considered to be especially serious.
In patients undergoing cesarean section,
intraoperative (after clamping the umbilical
cord) and postoperative use of MEFOXIN*
may reduce the incidence of surgery related
postoperative infections.
Effective prophylactic use depends on the
time of administration. MEFOXIN* usually
should be given one-half to one hour before
the operation. Prophylactic administration
should usually be stopped within 12 hours. It
has been generally reported that continuing
administration of any antibiotic beyond
*®T rademark

24 hours following surgery increases the
possibility of adverse reactions but, in the
majority of surgical procedures, does not
reduce the incidence of subsequent infection.
If signs of postsurgical infection should
appear, specimens for culture should be
obtained for identification of the causative
organism(s) so that appropriate therapy may
be instituted.

CONTRAINDICATIONS
MEFOXIN* is contraindicated in persons who
have shown hypersensitivity to cefoxitin or to
the cephalosporin group of antibiotics.

WARNINGS
Before therapy with MEFOXIN* is instituted,
careful inquiry should be made to determine
whether the patient has had previous hyper
s e n s itiv ity re a c tio n s to MEFOXIN*,
cephalosporins, penicillins or other drugs.
MEFOXIN* should be given with caution to
penicillin-sensitive patients.
There is some clinical and laboratory evidence
of partial cro ss-a lle rg e n icity between
cephamycins and the other beta-lactam
antibiotics, penicillins and cephalosporins.
Severe reactions (including anaphylaxis) have
been reported with most beta-lactam
antibiotics.
Pseudomembranous colitis has been reported
with virtually all antibiotics. This colitis can
range from mild to life threatening in severity.
Antibiotics should therefore be prescribed
with caution in individuals with a history of
gastrointestinal disease, particularly colitis. It
is important to consider a diagnosis of
pseudomembranous colitis in patients who
develop diarrhea in association with antibiotic
use. While studies indicate that a toxin
produced by Clostridium difficile is one
primary cause of antibiotic-associated colitis,
other causes should also be considered.
Any patient who has demonstrated some form
of allergy, particularly to drugs, should receive
antibiotics including MEFOXIN* with caution.
If an allergic reaction to MEFOXIN* occurs,
ad m inistration of the drug should be
discontinued. Serious hypersensitivity
reactions may require treatm ent with
epinephrine and other emergency measures.

PRECAUTIONS
The total daily dosage should be reduced
when MEFOXIN* is administered to patients
with transient or persistent reduction of
urinary output due to renal insufficiency (see
DOSAGE AND ADMINISTRATION) because
high and prolonged serum a n tib io tic
concentrations can occur from usual doses.
In patients treated with MEFOXIN* a false
positive reaction to glucose in the urine may
occur with Benedict’s or Fehling’s solutions
but not with the use of specific glucose
oxidase methods.
Using the Jaffe Method, falsely high creatinine
values in serum may occur if serum
concentrations of cefoxitin exceed 100 pg/mL.
Serum samples from patients treated with
MEFOXIN* should not be analyzed for
creatinine if withdrawn within two hours of
drug administration.
Increased nephrotoxicity has been reported
following concomitant administration of
ce p h a lo s p o rin s and a m in o g lyco sid e
antibiotics.
The safety of MEFOXIN* in the treatment of
infections during pregnancy has not been
established. If the a d m in istra tio n of
MEFOXIN* to pregnant patients is considered
necessary, its use requires that the anticipated
benefits be weighed against possible hazards
to the fetus. Reproductive and teratogenic
studies have been performed in mice and rats
and have revealed no evidence of impaired
fertility or harm to the fetus due to MEFOXIN*.
Cefoxitin has been observed in the milk of
nursing mothers receiving the drug.
Prolonged use of MEFOXIN* may result in the
overgrowth of non-susceptible organisms.
Repeated evaluation of the patient’s condition
is essential and if super-infection occurs
during therapy, appropriate measures should
be taken. Should an organism become
resistant during antibiotic therapy, another
antibiotic should be substituted.
In children 3 months of age or older, higher
doses of MEFOXIN* (100mg/kg/day and
above) have been associated with an
increased incidence of eosinophilia and
elevated SGOT.

The safety and efficacy of MEFOXIN* for the
treatment of infections in infants from birth to
three months of age have not yet been
established.

ADVERSE REACTIONS

4

MEFOXIN* is generally well tolerated. Adverse
reactions rarely required cessation o f.
treatment and usually have been mild and"’
transient.
Local Reactions

4

T h ro m b o p h le b itis has occurred w ith
intravenous administration. Some degree^f ^
pain and tenderness is usually experienced
after intramuscular injections using water.
Induration has occasionally been reported. •*
Allergic

Maculopapular rash, urticaria, pruritus,-!
eosinophilia, fever and other allergic reactions
have been noted.
Gastrointestinal

Symptoms of pseudomembranous colitis can
appear during or after antibiotic treatment. Nausea and vomiting have been reported
rarely.
Blood

'T'

T ra n s ie n t e o s in o p h ilia , le u ko p e n ia ,
neutropenia, hemolytic anemia, and thrombo- 4
cytop enia have been reported. Some
individuals, particularly those with azotemia,
may develop positive direct Coombs tests
during therapy with MEFOXIN*.
j
Liver Function

a

>

Transient elevations in SGOT, SGPT, serum
LDH, and serum alkaline phosphatase have*
been reported.
|
Kidney

j

Elevations in serum creatinine and/or blood ^
urea nitrogen levels have been observed. As
with the cephalosporins, acute renal failura
has been reported rarely. The role of
MEFOXIN* in changes in renal function tests
is d iff ic u lt to assess, sin ce fa c to id *
predisposing to prerenal azotemia or to
impaired renal function have often been
present.

TREATMENT OF OVERDOSE
Other than general supportive treatment, no
specific antidote is known. MEFOXIN* can be
eliminated by dialysis in patients with renal '
insufficiency.
4

DOSAGE AND ADMINISTRATION

-<

TREATM ENT DOSAGE

j

MEFOXIN* may be administered intra*- >
venously or intramuscularly when required.
(See monograph for Preparation of Solution.)^
Adult Dosage

The usual adult dosage is 1g or 2g of
MEFOXIN* every 6 to 8 hours. Dosage andy
route of administration should be determined
by severity of infection, susceptibility of the. .
causative organisms, and condition of the
patient. The usual adult dosages are shown in
the Table below.
y —
Usual Adult Dosage
T y p e of
of infection
U n c o m p lic a te d
fo r m s * o f in 
fe c tio n s s u c h as
p n e u m o n ia ,
u r in a r y tra c t
in fe c tio n , s o ft
tis s u e

D a ily
Dosage
3 -4 g

F re q u e n c y
a nd R ou te
1 g e v e ry 6 -8 h
I.V . o r l . M .

^

-v

in fe c tio n

M o d e r a te ly
s e v e re o r s e v e re
in fe c tio n s

In fe c tio n s
c o m m o n ly
n e e d in g a n t i
b i o t i c s in h i g h e r
d o s a g e (e .g . g a s
g a n g re n e )

6 -8 g

12

g

1 g e v e ry 4 h
or
2 g e v e r y 6 - 8 h I.V . ^

2 g e v e ry 4 h
^
or
3 g e v e r y 6 h I.V .

j

’ Including patients in whomi bacteremia is
absent or unlikely

i

Therapy may be started while awaiting the
results of susceptibility testing.
*Antibiotic therapy for group A beta-hemolytic
streptococcal infectionsshould be maintained? <
for at least 10 days to guard against the risk of
rheumatic fever or glomerulonephritis. In
staphylococcal and other infections involving
a collection of pus, surgical drainage should
be carried out where indicated.

►
X

Y *

Dosage in Adult Patients with Impaired Renal
Function
MEFOXIN* may be used in patients with
reduced renal function but a reduced dosage
should be employed and it is advisable to
monitor serum levels in patients with severe
impairment.
In adults with renal insufficiency, an initial
loading dose of 1 g to 2 g should be given.
A fte r a lo a d in g dose, the fo llo w in g
recommendations for maintenance dosage
may be used as a guide:
RENAL
FUNCTION
M ild
im pairm ent
Moderate
im pairm ent
Severe
im pairm ent
Essentially
no function

CREATININE
CLEARANCE
mL/min

DOSE

50-30

1 -2 g

every 8-12 h

29-10

1-2 g

every 12-24 h

9-5

0.5-1 g

every 12-24 h

<5

0.5-1 g

every 24-48 h

FREQUENCY

In the patient undergoing hemodialysis, the
loading dose of 1 - 2g should be given after
each hemodialysis, and the maintenance dose
v
should be given as indicated in the Table
above.
Infants and Children
The recommended dosage in children three
months of age and oldens 80 to 160 mg/kg of
u y- body weight per day divided into four to six
equal doses. The higher dosages should be
used for more severe or serious infections.
*, The total daily dosage should not exceed 12g.
At this time no recommendation is made for
children from birth to three months of age (see
•A
PRECAUTIONS).
At present there is insufficient data to
j. recommend a specific dosage for children
with impaired renal function."However, if the
administration of MEFOXIN’ is deemed to be
. » essential the dosage should be modified
y consistent with the recommendations for
adults (see Table above).
PROPHYLACTIC USE
For prophylactic use, a three-dose regimen of
MEFOXIN is recommended as follows:
‘y
Vaginal or abdominal hysterectomy and
abdominal surgery
„
2 g ad m in iste re d in tra m u s c u la rly or
in tra v e n o u s ly ju s t p rio r to su rg e ry
(approximately one-half to one hour before
K initial incision).
The second and third 2g doses should be
administered at 2-6 hour intervals after the
-- ► initial dose.
Cesarean Section
k.
The first dose of 2 g should be administered
intravenously as soon as the umbilical cord
has been clamped. The second and third
2g doses should be given intravenously or
intramuscularly four hours and eight hours
after the first dose.
'Y

^ AVAILABILITY
Sterile MEFOXIN* is a dry white to off-white
powder supplied in vials containing cefoxitin
' sodium as follows:
No. 3356 1 g cefoxitin equivalent in boxes of
>10 vials
No. 3357 2 g cefoxitin equivalent in boxes of
y
10 vials.
V

PRODUCT MONOGRAPH AVAILABLE
ON REQUEST

T 1. Quintiliani, R.: Overview of cephalosporin
a n tib io tics in the 1980's, in "C onsiderations in the selection of anti
microbial chemotherapy, a round-table
discussion on treatment concepts”, Merck
>
& Co. Inc., 1982, pp 6-25.
2. Trunkey, D.D.: Cephalosporin in the
y
management of trauma, Ibid, pp 44-52.
” 4-587
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tion (29 of 35 patients, 82.9°7o) and with
bowel prolapse (33 of 40 patients,
82.5%). The visceral injuries encountered
are shown in Table I. Multiple organs
were injured in 13 patients with omental
herniation and in 12 with bowel
evisceration.
There was one death. This patient had
sustained a deep laceration of the right
lobe of the liver and a near-total transec
tion of the inferior vena cava. He died intraoperatively of uncontrolled hemor
rhage. Postoperative complications
developed in 10 of the 74 survivors. Of
the 13 patients who had no major organ
injury at laparotomy, only 1 had a com
plication of minor wound sepsis. Nine pa
tients who were found to have organ in
jury at laparotomy had the following
complications postoperatively: atelectasis
(three), pneumonia (two), wound infec
tion (one), wound dehiscence (one),
postoperative fever (one) and intestinal
obstruction (one). Thus, the incidence of
complications in the negative laparotomy
group was 7.7% and in the positive group
was 14.5%.
Discussion

Ever since the pioneering report of
Shaftan in I960,1 selective operative
treatment for stab wounds of the ab
domen has gained wide popularity.
Trauma centres have adopted their own
screening techniques to delineate those
victims of stabbing who require operative
exploration. These methods include serial
clinical observation of the patients for
signs of peritoneal irritation, peritoneal
lavage and local wound exploration,
alone or in combination.2 8 This policy
of “ selective conservatism” 4 has been
supported by several large series of pa
tients with stab wounds to the
abdomen.2"4
The m a n d ato ry indications for
celiotomy for knife wounds of the ab
domen, as stressed by several authors,1'8
include evidence of uncontrolled or con
tinuing hemorrhage, signs of peritoneal
irritation and clinical or radiologic con
firmation of internal organ injury.
Evisceration of bowel through a knife
wound has also been mentioned frequent
ly as an indication for mandatory
exploration.2"4 The optimal management
of patients with abdominal stab wounds
and omental herniation, however, has not
been adequately addressed in the
literature. Shaftan1 described a case of
omental extrusion through a knife wound
of the abdomen; the omentum was ligated
and excised and the wound debrided and
the patient observed closely. Thompson
and associates8 noted that all 17 of the
300 patients with abdominal stab wounds
who presented with omental herniation
underwent laparotomy, with a 29% in

cidence of negative exploration. Based on
this experience, they challenged the con
cept of mandatory celiotomy for all pa
tients presenting with omental prolapse
through knife wounds.
To our knowledge, the first report deal
ing entirely with a series of patients with
omental evisceration resulting from stab
wounds to the abdomen was published by
Granson and Donovan.9 In this study,
100 consecutive patients were explored
because of omental herniation. Sixty-nine
percent were found to have major intraperitoneal injury. The authors con
cluded that exploration is clearly indicated
under these circumstances.
Our experience lends support to this
policy. Aside from the five patients who
presented in shock, celiotomy was per
formed on the sole indication of the
presence of eviscerated omentum or
bowel. The number of patients in whom
no m ajor organ injury was found was
small and morbidity was minimal. The
nature and incidence of m ajor organ in
jury and the frequency of multisystem in
volvement were comparable in the pa
tients with omental herniation and those
with bowel prolapse. We conclude from
our data that omental prolapse or bowel
evisceration, or both, consequent to an
abdominal stab wound constitute man
datory indications for laparotomy.

References
1. Sh a fta n GW: Indications for operation in abdominal
traum a. A m J Surg 1960; 99: 657-64

2. NANCE FC, C o h n I JR: Surgical judgement in the
management o f stab wounds of the abdomen: a retrospec
tive and prospective analysis based on a study o f 600
stabbed patients. A n n Surg 1969; 170: 569-80

3. N a n c e FC, W e n n a r MH, J oh n so n LW, I n g ram JC
JR, COHN I JR: Surgical judgement in the management of
penetrating wounds of the abdomen: experience with 2212
patients. A n n Surg 1974; 179: 639-46
4. M c A lvan ah M J, Shaftan GW : Selective conservatism
in penetrating abdominal wounds: a continuing reap
praisal. J Trauma 1978; 18: 206-12

5. D a n to LA, T h o m a s CW, g o r e n b e in S, et al:
Penetrating torso injuries: the role o f paracentesis and
lavage. A m Surg 1977; 43: 164-70

6. T ha l ER: Evaluation o f peritoneal lavage and local ex
ploration in lower chest and abdominal stab wounds. J
Trauma 1977; 17: 642-8

7. G a lb r a it h TA , O reskovich MR, H eim b a c h DM,
H erm an CM, C arrico CJ: The role o f peritoneal lavage
in the management o f stab wounds to the abdomen. A m
J Surg 1980; 140: 60-4

8. T h o m ps o n JS, M oore EE, v a n D u zer -M oo re S,
MOORE JB, g a llo w a y AC: The evolution o f abdominal
stab wound management. J Trauma 1980; 20: 478-84

9. G ran son MA, D onovan AJ: Abdominal stab wound
with omental evisceration. Arch Surg 1983; 118: 57-9

VOLUME 27, NO. 4, JU L Y 1984 / THE CANADIAN JOURNAL OF SURGERY

401

Robert A. Zeldin , b math , md , frcsic]

Assessing Cardiac Risk in Patients Who Undergo
Noncardiac Surgical Procedures
To confirm the usefulness of the cardiac
risk index published by Goldman and
associates in 1977, the author did a
separate, prospective study of 1140
patients over the age of 40 years
who underwent noncardiac surgical
procedures. Four risk categories were
defined (classes I to IV, low to high risk
according to Goldman's point score).
Percentages of postoperative cardiac
events (life-threatening cardiac complica
tions or cardiac death) were tabulated.
The incidence of cardiac events for each
risk category, classes I to IV, was 0.7 % ,
3% , 15% and 30% , respectively. Com
parisons with Goldman's original study
demonstrate that the cardiac risk index is
a reliable, objective and valid method of
assessing cardiac risk in patients who
undergo elective surgery.
Afin de confirmer Futility de I'indice de
risque cardiaque public par Goldman et
collaborateurs en 1977, I'auteur a realise
une etude prospective independante portant sur 1140 patients de plus de 40
ans, soumis & une intervention
chirurgicale autre que cardiaque. Quatre
classes de risque ont ete definies (les
classes de I a IV correspondant a un ris
que de faible a eleve selon le systfeme de
cote de Goldman). Le pourcentage des
incidents cardiaques postoperatoires (les
complications cardiaques menaqant le
pronostic vital ou entralnant la mort) a
6t6 compile. La frequence des incidents
cardiaques pour chacune des categories
de risque a 6t6 de 0.7% , 3% , 15% et
30% pour chacune des classes de I & IV
respectivement. La comparaison avec
I'etude originate de Goldman ddmontre
que I'index de risque cardiaque est une
mdthode sure, objective et valable
d'evaiuer le risque cardiaque chez les
patients qui doivent subir une operation
non urgente.
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In the past, preoperative assessment of
surgical risk was formulated subjective
ly, using the American Society of
Anesthesiologists’ classification of
physical status.1’3 In 1977, Goldman and
associates4,5 reported a multifactorial ap
proach to predict cardiac risk in noncar
diac surgical procedures. They were able
to compute objectively a cardiac risk in
dex or score for each patient and classify
that patient into an appropriate risk
category, and then to observe the out
come. The present study extends their
work to a separate, prospective cohort.
Its purpose is to classify patients accord
ing to their cardiac risk index, observe
their course and test the model as a
predictor o f postoperative cardiac
outcome.
Patients and Methods
As a resident in surgery from July 1978
to June 1982, I was able to study all pa
tients under my direct care. Patients in
cluded in the study sample are those for
whom I was the operating surgeon or the
first assistant, responsible for the pa
tients’ pre- and postoperative care at

Age > 70 yr
Myocardial infarction
in previous 6 mo
S3 gallop or jugular venous
distension
Important valvular aortic stenosis
Rhythm other than sinus or
premature atrial contractions on
last preoperative electrocardiogram
> 5 premature ventricular contractions/min documented at any time
before operation
Operation - intraperitoneal,
intrathoracic, aortic
Emergency procedure
General medical status (Po2 < 60
or Pco, > 50 mm Hg, K< 3.0 or
H C0, < 20 mmol/L, BUN > 17.9
mmol/L urea or Creat > 265 pmol/L,
abnormal SGOT level, signs of
chronic liver disease, bedridden
from noncardiac causes)

CARDIAC RISK INDEX

Na“ » :
I D ,:

Points
5

3.
4.
5.
6.
7.
8.

10
11
3

7

7
3
4

__ _____________________
D ate:
___________
A tte n d in g S u rg e o n :
DATA BASE

1.
2.

Table I— Computation of the Cardiac Risk
Index after Goldman and Associates5
Risk factor

Mount Sinai, Toronto East General,
Toronto General and Toronto Western
hospitals. Every patient over 40 years of
age admitted to the general, vascular and
thoracic (noncardiac) surgery services in
which I worked was available for study.
Only those patients who had general
anesthesia were included; uncomplicated
endoscopies were excluded. In all, 1140
patients were studied. There were 870 pa
tients with general surgical problems (ab
dominal, pelvic, breast, head and neck,
soft tissue), 185 patients with thoracic
noncardiac problems and 85 patients with
vascular disease (aortic, peripheral
vascular). Women accounted for 54%
and men for 46% o f the study
population.
The nine risk factors identified by
Goldman and associates4 are listed in
Table I as are the corresponding points
they assigned to develop a cardiac risk in
dex. Using the same criteria, I filled in a
data sheet (Fig. 1) for each patient

9.

Age, y r [5]
Has p a t i e n t had MI w ith in
l a s t 6 mo? ( 1 0 )
S 3 g a l l o p p r e s e n t? ( I I ) *
JVD s i g n i f i c a n t ? ( 11)*
S i g n i f i c a n t a o r t i c s t e n o s i s ? (3)
L a s t ECG rhythm ? (1 - NSR,
2 ■ P A C 's, 3 ■ a ny o t h e r ) (7)
> 5 PV C 's/rain a t any tim e ? (7)
T horacotom y o r la p aro to m y or
o th e r ? (3)
I s t h i s an em ergency o p e r a tio n ? (4)

* I f b oth ite m s p o s i t i v e , s c o r e 11 p o i n t s o n ly o n c e .
GENERAL MEDICAL DATA I s c o r e 3 i f any v a lu e s abnorm al I
10.
11.
12.
13.
14.
15.
16.
17.
18.

PC02 ( > 50 mm Hg)
P02 K 60 mm Hg)
B ic a rb o n a te « 20 mmol/L)
P o ta ssiu m « 3 mmol/L)
BUN ( > 1 7 .9 mmol/L u r e a )
C r e a tin i n e (> 265 /im o l/L )
SGOT ( e l e v a t e d )
C l i n i c a l e v id e n c e o f l i v e r
d is e a s e (y e s/n o )
B e d rid d e n from n o n c a r d ia c
causes (y e s/n o )

TOTAL SCORE

C l a s s ( I - 5 , I I - 6- 12, I I I - 1 3 -2 5 , IV - 2 6 -5 3 )

3

□

FIG. 1—Data sheet for computing risk score
and category. MI = myocardial infarction,
JVD = jugular venous distension, ECG =
electrocardiographic, NSR = normal sinus
rhythm, PAC’s = premature atrial contrac
tions, PV C ’s = premature ventricular
contractions.
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preoperatively. Postoperatively, if a pa
tient had any clinical evidence to suggest
a cardiac problem, then a single elec
trocardiogram or serial electrocardio
grams were obtained. Similar criteria for
interpreting the electrocardiogram were
i used. Cardiac enzyme levels were deter
mined if there was any suggestion of
^ myocardial infarction. When the condi
tion was not clear, medical or cardiologic
consultations were obtained. Each patient
was seen daily through the hospital stay.
" The same definitions for postoperative
cardiac events that Goldman used were
k employed in this study.
Postoperative outcomes were classified
as follows: (a) no or minor cardiac comY plication or noncardiac death; (b) lifethreatening cardiac complication and (c)
cardiac death. The life-threatening car
diac complications were cardiogenic
pulmonary edema, myocardial infarction
and witnessed ventricular tachycardia. A
r cardiac death was diagnosed if the patient
. died from an arrhythmia or refractory
low-output state. Excluded were low
x cardiac-output states associated with a
primarily noncardiac condition such as
A. sepsis or respiratory failure. A noncardiac
death is one from a cause other than that
t causing a cardiac death. Total cardiac
events are represented by the sum of items
(b) and (c).
Proportional analysis was used to
measure statistical significance between
cardiac risk classes. With the use of the
central limit theorem, the normal approx► imation to the binomial distribution was
obtained.
Results
The patients were classified into the

four risk categories, classes I to IV, ac
cording to the point score from
Goldman’s nine risk factors (Table I):
class I patients scored 0 to 5; class II, 6
to 12; class III, 13 to 25; and class IV,
26 to 53.
Table II shows the categories and out
come of the patients postoperatively. The
percentage of cardiac events increased as
the risk class increased. In class I patients,
0.7% had some sort of cardiac event. For
classes II, III and IV, the percentages rose
to 3%, 15% and 30%, respectively.
Overall, 35 (3%) of the 1140 patients suf
fered a cardiac event.
The differences in incidence of cardiac
events between risk classes in this study
were significant (p < 0.02) for classes I
and II and classes II and III. While there
was a numerical difference between
classes III and IV (15% v. 30%), the
smaller numbers in each group made it
difficult to attach significance to the dif
ference. Closer study of the 23 class IV
patients revealed that they accounted for
7 (20%) of the 35 patients suffering a car
diac event, and 6 of these were fatal com
plications. Thus, 43% of the cardiac
deaths were in class IV patients.
The outcome for patients in the series
reported by Goldman and colleagues is
reviewed in Table III.4 Both studies had
a large and similar number o f patients
(1001 in Goldman’s study and 1140 in this
study). It is quite evident that Goldman
had far more class III patients (130 v. 74)
but fewer class II patients (316 v. 453).
The incidence of cardiac events in
Goldman’s series was 0.9%, 6% , 14%
and 78% for classes I to IV, respective
ly. Overall, the percentage o f cardiac
events in Goldman’s study was 6% (58 of
1001) compared with 3% in this study.

Discussion
This prospective study was designed to
match that of Goldman and associates as
closely as possible. In doing so its validi
ty could be tested. Given the model
Goldman proposed, one could study a
new, separate patient population and
observe the model’s value in predicting
outcome for this new group.
Part of the difference between class IV
patients in the two studies can be explain
ed by the small number of patients in this
class. Moreover, as a result of Goldm an’s
work, awareness of the high cardiac risk
o f class IV patients was increased and
may have led to better pre- and post
operative care, thus reducing the number
o f cardiac events in this group.
In reviewing the current status o f car
diac risk factor assessment in noncardiac
surgical patients, Rose and associates6
cited Goldman’s risk factors several
times. Although none of his risk factors
are disputed, some authors7-9 have in
cluded risk factors that Goldman found
were not significant. Goldman’s figures
did not include autopsy data so the in
cidence of postoperative cardiac death
could, in fact, be higher. I used only
Goldman’s risk factors as predictors but
also used autopsy results when they were
available.
Norm an,10 in 1978, called for the
assessment of tests of predictive indices
in new, subsequent studies. My study has
accomplished this. Norman also pointed
out that bias may be introduced towards
better patient care in assessing these risk
factors. This may well be the reason for
the lower incidence of postoperative car
diac events in this series. Certainly the pa
tients have benefited if such a bias existed.
Conclusions

>

Class
1
II
III
IV

No.
590
453
74
23
1140

Table II—Cardiac Risk Index - Postoperative Outcome
No, minor or
Life-threatening
noncardiac
complication,
complication, no. (%)
no. (%)
586(99.31
3(0.5)
440 (97)
912)
63(85)
8(11)
16(70)
1 (4)
1105(97)
21 (1.8)

Cardiac death,
no. (%)
1 (0.2)
4 (1 )
3 (4 )
6 (2 6 )
14(1.2)

Assessing cardiac risk using Goldman’s
multifactorial index is a rapid and objec
tive method of identifying the degree of
risk in patients about to undergo noncar
diac surgical procedures. The present
study confirms the findings of Goldman
and colleagues and demonstrates the
validity of their study. The cardiac risk
index can easily become part o f the
medical record for any noncardiac
surgical patient over the age of 40 years.
References
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Cardiac death,
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no. (%)
no. (%)
I
537
532(99.1)
4(0.7)
1 (0.2)
II
316
2 95(93)
16(5)
5 (2 )
III
130
112(86)
15(12)
3 (2 )
IV
18
4(22)
4(22)
10(56)
1001
943 (94.2)
39 (3.9)
19(1.9)
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Editorial note.—Dr. Zeldin examines and reaf
firms the usefulness of the Goldman cardiac
risk index, originally published in 1977, by stu
dying a number of patients who underwent
noncardiac surgical procedures, assessing the
cardiac risk factors, using Goldman’s multifac
torial index. Although the results of this pro
spective study are similar to those of
Goldman’s original findings, Zeldin was unable
to demonstrate that all four groups were
statistically separate and distinct. His study
shows that predictive tests such as Goldman’s

need to be assessed under different conditions.
It emphasizes the need to review carefully each
patient’s cardiac history for possible complica
tions so that appropriate precautions can be
taken. The data collection sheet for estimating
the cardiac risk index (Fig. 1) is informative
should another centre wish to undergo a similar
trial. Although Zeldin’s study may not be
original, it is reliable, has scientific importance ^
and points the way towards assessment of one ^
facet of risk for patients who undergo elective
surgery.

R .M . PRESHAW , MD, FRCS[C]

Seasonal Frequency of Testicular Torsion
The hypothesis that testicular torsion is
more common in winter was examined in
a retrospective survey of admissions to
three Calgary hospitals. No seasonal
peak in incidence of cases of torsion
w as identified from 1966 to 1982.
L'hypothfcse voulant qu'une torsion
testiculaire soit plus frdquente en hiver a
6t6 evaluee lors d'une enquete retrospec
tive des hospitalisations dans trois
etablissements de Calgary. Aucun pic
saisonnier n'a 6t6 identifie dans la fre
quence des torsions survenues entre
1966 et 1982.

In a series o f 46 cases of testicular tor
sion in Dublin, Ireland, 40 occurred when
the ambient temperature was less than
2°C. This finding suggested to Shukla
and associates1 that torsion of the testis
was causally related to cold-induced con
traction of the cremaster muscle. I have
reviewed all cases of testicular torsion in
Calgary, Alberta from 1966 to 1982, but
found no evidence to support this
hypothesis.

diagnostic coding “ testicular torsion” for
1966 to 1982 inclusive and for the month
of discharge from hospital. Actual patient
records were reviewed at random to assess
the accuracy o f the diagnostic coding on
discharge. Two hundred and seventy-two
cases of testicular torsion were identified
by the procedure outlined. Review of a
random 26 patient records revealed 24 pa
tients in whom the discharge diagnosis
had been confirmed surgically. In two pa
tients, no operation was done and there
was doubt as to the accuracy of the
diagnosis. This sample indicates an up
per confidence limit of the error rate in
the overall population of less than 25%
(p = 0.05, binomial expansion), which
might be expected after considering the
acute presentation and most likely
therapy for this condition.

Discussion

Patients and Results
Yearly diagnostic indices provided by
the Professional Activity Study (Commis
sion on Professional and Hospital Ac
tivities, Ann Arbor, Mich.) for three
Calgary hospitals were examined for the
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The duration of hospital stay for these
26 patients ranged from 4 to 29 days
(mean 6 days), confirming that the month
of discharge provides a reasonably ac
curate estimate of the date the torsion
A
occurred.
The month of discharge for the total
group of 272 cases is shown graphically
in Fig. 1, which also provides the mean
daily temperature for each month for
Calgary from 1941 to 1979.2 Using
Hewitt’s rank-sum criterion of season
ality,3 no significant difference in the
frequency of torsion was found either for
the 6 coldest months or any other sequen
tial 6-month period (for November to
April inclusive, rank sum 40, p = 0.5).
No seasonal trend was apparent when the
data were manipulated in other ways; in
particular, separating adults from
children (16 years or younger) caused no
■*
change in the pattern.

FIG. 1— Monthly frequency of testicular tor
sion for period 1966 to 1982 and mean daily
temperature in Calgary, Alberta from 1961 to
1979 inclusive.

Torsion of the testis is uncommon, but
this has not restricted speculation as to
its cause. Most authorities4'6 have con
centrated on predisposing anatomical <
variations, including abnormal reflection
of the tunica vaginalis upon the testicle,
complete tunica vaginalis investment of
the testicle and cord (bell-clapper defor
mity), an elongated mesorchium and
separation of the epididymis from the
testicle. On this basis it has been suggested .*
that the other testicle is also at risk for
torsion, presumably because of similar
minor malformations. Torsion has been
recorded as more likely in cryptorchid
ism,7 especially when associated with
malignant degeneration.8 Others have
commented on an association between w
torsion and violent exercise or even
trauma to the testicle.9
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In 1912, Uffreduzzi (quoted by H ar
rison5) suggested that one cause of tor
sion was contraction of the cremaster
muscle when subjected to a stimulus such
as sudden cold. This idea was supported
by an experimental study of the distribu
tion of cremaster by M uschat,10 who
showed a spiral insertion o f the muscle
►which could conceivably contribute to
rotation of the testis under some condi
tions. A similar etiology was proposed by
Donohue and U tley.11 Shukla and
associates1 found evidence for a seasonal
incidence of torsion in Dublin and related
this to an ambient temperature of 2°C or
lower. Two subsequent series, reported
briefly from centres in the United
Kingdom,12’13 offered support for a
seasonal incidence of torsion.14
Because there are greater extremes of
daily temperature in much of Canada
than in the British Isles, it is appropriate
to examine the frequency of testicular tor
sion under such conditions. The hypo
thesis for a peak incidence in cold weather
might find even more support under ex
tremes of climate. However, no evidence
was found to support a seasonal frequen
cy for torsion among a series of 272 cases
identified retrospectively in Calgary,
Alberta.

The reason for the difference between
these results and those from the three
series reported from the United Kingdom
and Ireland is not clear. It seems unlike
ly that using the hospital discharge date
rather than the date of occurrence of tor
sion would obscure any significant
seasonal trend. A more important
criticism of this kind of retrospective
study would be the rate of error in the
diagnosis at discharge. In testicular tor
sion, the admission diagnosis might be ex
pected to have a high rate of error
(because of confusion with acute epididy
mitis and other conditions) but it appears
likely that physicians would provide a
fairly accurate discharge diagnosis for this
relatively simple disease state. This is sup
ported by the finding in this series that
in 24 of the 26 patient records examined
at random, the diagnosis was confirmed
at operation. Perhaps other series should
be examined under different climatic con
ditions before the seasonal hypothesis is
rejected.
I thank the Directors of Surgery in Alberta
Children’s Provincial General Hospital,
Calgary General Hospital and Foothills
Hospital, Calgary, for access to patient
records.
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Acute Hemorrhagic Pancreatitis and Diabetes Mellitus
following Endoscopic Retrograde Cholangiopancreatography
Endoscopic retrograde cholangiopan
creatography (ERCP) is generally regard
ed as a safe and useful investigation in
the diagnosis and management of
diseases of the pancreas and biliary tree.
Asymptomatic hyperamylasemia is not
uncommon following this procedure, but
clinical pancreatitis is rare. The authors
report on a 56-year-old man who suf
fered life-threatening acute hemorrhagic
pancreatitis 2 weeks after ERCP was
performed for the investigation of ab
dominal pain. He subsequently had insulin-
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dependent diabetes mellitus, which was
not present at the time of ERCP.

La cholangiopancrgatographie endoscopique retrograde (CPER) est generalement
consideree comme une procedure sure et
utile pour le diagnostic et le traitement
des maladies du pancreas et de I'arbre
biliaire. Apres cette intervention, I'hyperamylasemie n'est pas rare mais la
pancrgatite tranche est rare. Les auteurs
signalent le cas d'un homme de 56 ans
qui a souffert d'une pancreatite hemorragique aigue ayant menace le pronostic
vital, 2 semaines apres une CPER pratiqu6e pour diagnostiquer les causes d’une
douleur abdominale. II a par la suite souf
fert d'un diabbte insulino-dependant qui
n'existait pas au moment de la CPER.

Endoscopic retrograde cholangiopan
creatography (ERCP) is frequently used
in the diagnosis and management of

diseases of the pancreas and biliary tree.
Asymptomatic hyperamylasemia is a
common sequela, but serious complica
tions are considered to be rare.1-7 We
recently encountered a case o f lifethreatening acute hemorrhagic pan
creatitis following ERCP performed for
the investigation of abdominal pain. The
examination showed that the ducts were
normal, but within days an acute ab
domen developed, and hemorrhagic pan
creatitis was present at laparotomy. The
patient recovered but subsequently
insulin-dependent diabetes m ellitus
developed.
Case Report
Nine years before the presenting illness, our
patient, a 56-year-old white man, had
undergone cholecystectomy for cholelithiasis,
following which he had recurrent episodes of
ascending cholangitis due to a bile-duct stric
ture. Endoscopic retrograde cholangiopan
creatography was performed; it showed a stric-
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ture of the common bile duct at the level of
the cystic duct, retained irregular stones in the
distal common bile duct and normal-appearing
pancreatic ducts. A choledochoenterostomy
was performed. He remained afebrile and with
no symptoms suggestive of common-duct
obstruction for 8 years. Then he began to suf
fer episodes of sharp epigastric pain, ag
gravated within 30 minutes by food and re
lieved by antacids and cimetidine. He had mild
hypertension that was controlled by pro
pranolol 40 mg twice daily. Because of the fre
quent episodes of pain, a second ERCP was
performed at the University of Alberta
Hospital. The pancreatic duct was cannulated
and visualized over approximately 21 cm; the
main duct and the secondary radicals appeared
normal and no areas of narrowing were seen.
An attempt was made to cannulate the com
mon bile duct, but only a small amount of dye
was seen in the proximal 2 cm; this portion of
the common duct appeared normal in calibre.
Following ERCP the patient returned home
500 km away. He was well for 2 weeks after
the ERCP but then he experienced epigastric
and left upper quadrant pain. The pain was
severe and became progressively worse; it was
associated with distension but there was no
vomiting. He was admitted to his local
hospital. There his abdomen was noted to be
ten d er, w ithout guarding or rebound
tenderness. His oral temperature was 38°C.
Plain abdominal roentgenograms indicated an
ileus. He was treated by nasogastric suction and
fluids, ampicillin and cimetidine given in
travenously. Ascites was present and the
amylase level o f the tapped fluid was increas
ed to 135 U /L , when the serum amylase level
was normal. The urinary amylase-creatinine
ratio was 3:100. The hemoglobin value was 120
g /L . A trace of blood was apparent in the
nasogastric aspirate. Two units of blood were
transfused. After initial improvement he rapid
ly deteriorated and his pain, distension and
ascites became worse. Twelve hours later he
was transferred to the University of Alberta
Hospital.
On admission he appeared acutely ill; the
pulse rate was 88 beats/min, blood pressure
140/80 mm Hg, respiratory rate 30/min and
oral temperature 36.9°C. There was no jaun

dice; his abdomen was distended and there was
shifting dullness and hypoactive bowel sounds.
There was marked, diffuse tenderness with
guarding and rebound tenderness in all four
quadrants. The nasogastric tube was draining
bile-stained material but no blood. The
leukocyte count was 14.6 x 109/L with 30%
polymorphonuclear band cells. The hemo
globin level was 120 g/L , serum amylase level
40 U /L and blood glucose 11.9 mmol/L. The
blood glucose was previously normal and the
hemoglobin 3 years previously was 170 g/L.
The serum electrolyte values were normal; on
room air the partial pressure o f oxygen in
venous blood was 57 mm Hg, and of carbon
dioxide was 37 mm Hg, and the pH was 7.49.
Abdominal ultrasonography demonstrated
normal biliary ducts, but the pancreas could
not be visualized because of overlying gascontaining bowel loops. A perforated viscus
was suspected. At laparotomy, the abdomen
contained 2 L of clotted and fresh blood. The
pancreas was about three times the normal size.
The diagnosis was hemorrhagic pancreatitis
with bleeding into the peritoneal cavity. No ab
normality was detected in the common bile
duct. The blood was evacuated and the ab
domen was lavaged with saline.
Recovery was slow. The blood glucose levels
were persistently elevated and the patient re
quired insulin, 10 units regular plus 12 units
lente every morning. He is now able to eat
without pain and his bowel habit has remain
ed normal with no appearance or characteristic
suggestive of steatorrhea.

Discussion
Complications following ERCP are
few and usually mild. In one third of pa
tients, benign hyperamylasemia or
hyperamylasuria will develop 1 or 2 days
following ERCP, but injection pan
creatitis with pain, fever and leukocytosis
is unusual.1-7 When this does occur, it
usually is seen 24 to 36 hours following
the ERCP, not 2 weeks later as occurred
in our patient. Injection pancreatitis may
occur more commonly in inexperienced

hands, but this was not true of our en
doscopist. There was nothing unusual in
the amount of dye used for the injection,
the pressure applied or the rate of injec
tion. Furthermore, the pancreatic ducts
visualized by ERCP were normal.
There was no obvious cause of the
hemorrhagic pancreatitis other than the
ERCP. The only medication the patient
had been taking was propranolol for
hypertension. He had been under treat
ment with this agent for 8 years; pro
pranolol is not thought to be associated
with the developm ent o f severe
pancreatitis.8 He had not been taking
thiazides, and his serum lipid and calcium
levels were not known to be elevated. No
stones were detected in the common duct
by ERCP or ultrasonography or at
operation.
We thank Dr. A. Kenyon for referring the
patient, Dr. S. Adams for reviewing the ERCP
films and Mrs. Jackie Polovick for typing the
manuscript.
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SESAP IV Critique
ITEM 17
The procedure depicted is a parietal cell vagotomy (proximal gastric vagotomy, super-selective vagotomy). Most
surgeons who use it do so as a definitive operation for peptic ulcer disease, without pyloroplasty or bypass of the
pylorus, which seems to be its chief advantage. It has not been associated with many of the postoperative complica
tions o f operative procedures that destroy or bypass the pylorus. Parietal cell vagotomy has not ordinarily been
considered appropriate for patients with gastroesophageal reflux. Some investigators do use this procedure for pa
tients with hemorrhage, obstruction, or perforation from peptic ulcer. Latarjet described the anatomy of the vagus
nerves, on which this operation is based, some 60 years ago.

m
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Refresher Course in
Genitourinary Radiology
The biannual Refresher Course in Geni^ tourinary Radiology, offered by the Uni
versity of Toronto, will be held Oct. 18
and 19, 1984 at the Mount Sinai Hospi
tal, Toronto, Ont. This course will deal
with recent advances in genitourinary
imaging and will review selected areas of
general interest. Topics will include digi^ tal subtraction angiography, computed
tomography, ultrasonography, nuclear
magnetic resonance, nuclear imaging,
interventional techniques and the inves
tigation of impotence.

For further information contact Dr.
Robin R. Gray, Course Director, Depart
ment of Radiology, The Wellesley Hos
pital, 160 Wellesley St. E, Toronto, Ont.
M4Y 1J3 or call (416) 966-6810.

For further information contact Dr.
Robert J. Demuth, Central Office, Ame
rican Association for Hand Surgery, 2564
Branch St., Middleton, Wise. 53562,
USA.

Practical Hand Surgery

international Meeting on
Vascular Pathology

The 14th annual meeting of the Ameri
can Association for Hand Surgery will be
held in conjunction with the Mexican
Society for Surgery of the Hand and the
Caribbean Society for Hand Surgery,
Nov. 25-28, 1984 at the Acapulco Prin
cess Hotel, Acapulco, Mexico.
The theme for this year’s meeting will
be the management of practical problems
of hand surgery. Emphasis will be on cost
effectiveness of accurate, quality, hand
surgery care.

The 14th International Meeting on Vas
cular Pathology will he held Oct. 22-24,
1984 at the Auditorium of the University
of Coimbra, Coimbra, Portugal. It has
been organized by the Department of Sur
gical Pathology, University of Coimbra,
and sponsored by the International Union
of Angiology.
For further information contact Mario
Blanco Peres, Rua Gonqalo Cristovao,
116-3°, 4000 Porto, Portugal.

CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f Surgery is pleased to accept suitable classified advertisements. The
deadline is 1 month before issue date. Regular classified rates (for each insertion): $35.00 for the first 40 words or less, additio
nal words 35C each (additional $13.00 for frame). Special Display under 75 words, 2 1/4 " X 2" $85.00. $5.00 charge (first inser
tion only) for CJS box numbers. Display rates available on request.
Copy should be mailed to the Canadian Journal o f Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.

St. Joseph’s Health Centre, located in Toronto’s west end, an 830-bed active-chronic
treatment and teaching hospital, affiliated with the University of Toronto, has an
immediate opening for a:

Chief, Department of Surgery
The person appointed will supervise the activi
ties of the Services of General Surgery, Plastic
Surgery, Orthopedic Surgery, Vascular Surgery,
Thoracic Surgery and Dental Surgery in accor
dance with the Departmental policies and the
By-Laws of the Health Centre.
Candidates must be eligible for Active Staff
Appointment, and have demonstrated teaching
abilities, and excellent clinical skills, together

with a flair for administration and proven leader
ship qualities.
Applicants are invited to submit an up-to-date
curriculum vitae, which should include an aca
demic history, published articles and any other
relevant information.
Appropriate documents should be addressed to:

Mr. J.J. Ruffo
Chairman—Search Committee
c/o Medical Director’s Office
St. Joseph’s Health Centre
30 The Queensway
Toronto, Ontario M6R 1B5
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M D , FRCS(C), Director, Surgical Intensive Care
Unit, Department of Surgery, University
Hospital, Saskatoon. SK S7N 0W0.
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practice in northwestern Ontario. Duties w ou ld in
clude general practice in a m odern clinic th a t ac
commodates fo u r practitioners w h o alternate call at
the area's 44-bed hospital. C om m unity has a stable
economic base and is located on a large lake —
recreational facilities are excellent. Underserviced
Area G rant available. Contact: Dr. V.W . Aniol, PO
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quired to join 10 fam ily p hysicia ns/1 obstetriciangynecologist grou p fo r an extended period.
Emergency orthopedic experience a definite asset.
Located in W hitehorse, Yukon T erritory, servicing a
population o f 23 000 people and 26 doctors. Ex
cellent location fo r someone w h o enjoys th e o ut
doors. Remuneration to be negotiated. Early opp o r
tu n ity fo r partnership. Please w rite , giving com plete
resume, or tel: J.L. Pollock, Clinic A d
ministrator, 406 Lambert St., Whitehorse, YT
Y1A 1Z7, (403) 667-4421.
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inVIAFLEX PLUS containers
Offers Significant Advantages Over Adm ixing
H2-Receptor Antagonists from Ampuls and Vials
Safety

Economy

Efficiency

Provides bold twocolour labelling,
assured concentration,
guaranteed sterility
and 18 month stability.

Eliminates cost of
admixing materials.
Reduces labour costs
and wastage.

Frees staff for other
clinical duties.

Tagamet leads the way in the treatment of
acid-related disorders.
Manufactured and distributed for
Smith Kline & French Canada Ltd. by
Travenol Canada Inc.
VIAFLEX is a registered trademark of Baxter Travenol Laboratories Inc.. U.S.A
© Smith Kline & French C anada Ltd., 1984
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Something
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without
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You told us that you liked using catgut but you didn’t like its
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Cyanamid Canada Inc.

soft and supple
easy to tie
less likely to curl, “pigtail” and tangle
easy to handle and control

Atria North, 2255 Sheppard Avenue East, Willowdale, (Ontario) M2J 4Y5
‘ Trademark American Cyanamid Company

